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Chronic pain (CP) is a costly, prevalent (20% of adults) and complex condition that often 
cannot be explained by a single medical diagnosis.  Although it has been shown to impact 
psychological well-being, research examining this relationship has typically adopted a diagnosis-
specific lens, rendering it inapplicable to most people with CP.  Understanding the psychological 
impact of CP from a general perspective is therefore important. 
The Australian public health system manages CP poorly.  Most people cannot access 
treatment, while those who do face lengthy indefinite waits, the impact of which is unknown.  
Improving access to CP treatment is a health service imperative, for which resource (re)allocation 
and service (re)design are important considerations.  However, there is no data (national, 
international) regarding staffing (amounts, types) that are employed within multidisciplinary pain 
clinics, or consensus about models of care that improve access and patient outcomes.  Clarification 
of the impact of lengthy waitlists and these service-related factors (staffing, care model) is needed. 
These issues were explored via four studies.  Study 1 meta-analysed data (Nstudies=110) 
comparing the psychological functioning of individuals with CP to that of healthy peers.  A general, 
not condition-specific, perspective was used in order to reflect the experience of most people with 
CP.  Results indicated that CP was associated with significant problems across a range of 
psychological domains; the largest being anxiety, especially pain anxiety/concern, and somatisation. 
Study 2 then explored the psychological functioning and health care utilisation of individuals 
indefinitely waitlisted for a first appointment at a tertiary CP service by prospectively following 339 
individuals for three years after referral.  Findings highlighted the importance of early intervention (<6 
months), especially for women, with deterioration in pain-related interference, distress and pain 
acceptance evident across longer-term waits; albeit with different sex-patterns. 
Next, Study 3 analysed staffing configurations within Australian multidisciplinary CP 
services.  Staffing was explored as an overall total and as a function of the amount of clinical activity 
x 
 
undertaken by the service, thus enabling calculation of individualised resourcing requirements.  
Results indicated a national consensus in the overall type and amount of staffing employed; the 
exceptions being psychiatry and occupational therapy.  However, clinics that undertook training and 
research activities appeared to employ comparatively greater medical staff per patient load, while 
those who did not employed comparatively more allied health. 
Finally, Study 4 evaluated whether a group-based pain education session — a resource 
neutral model designed to expedite treatment access — delivered immediately after referral to a 
tertiary CP service (pre-clinic) improved outcomes for waitlisted individuals (N=346).  Despite 
reasonable acceptance, session attendance was not associated with functional improvements, 
although referral to (not treatment by) the service was. 
Together, these findings suggest that CP profoundly impacts psychological well-being, 
especially anxiety, and this is exacerbated by lengthy indefinite waits for treatment.  Accordingly, 
treatment should include an anxiety focus and be delivered within six months of referral.  However, 
as staffing resources did not independently determine waitlist length, timely service delivery requires 
more than extra funds.  Pre-clinic education can facilitate this through service factors (e.g., non-
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Chronic pain (CP) is pain that persists beyond the usual period of healing and is typically 
characterised as occurring on most days for three or more months (Merskey & Bogduk, 1994).  It 
affects one in five people globally and one in three older individuals (>65 years) (Blyth et al., 2001).  
CP is most prevalent in females (Fillingim, King, Ribeiro-Dasilva, RahimWilliams, & Riley, 2009), 
indigenous Australians (Vindigni, Griffen, Perkins, Da Costa, & Parkinson, 2004; Vindigni et al., 
2005), Culturally and Linguistically Diverse (CALD) populations (Brand et al., 2014), and in socially 
disadvantaged people (McBeth & Jones, 2007; Portenoy, Ugarte, Fuller, & Haas, 2004).  It is 
associated with a significant societal burden, including an annual economic impact of up to USD 
$635 billion (Gaskin & Richard, 2013; Tracey & Bushnelly, 2009; Vos et al., 2012) and a personal 
impact that spans all facets of life including physical function, mood, interpersonal relationships and 
social connectedness (Dueñas, Ojeda, Salazar, Mico, & Failde, 2016). 
Once considered to be a purely physical phenomenon, it is now understood that CP and 
pathology are poorly linked (Sharp, 2001).  Instead, CP involves a complex interplay between 
physical, psychological, social and behavioural factors, which combine to determine the way a 
person experiences pain (Gatchel, 2004).  Accordingly, multidisciplinary treatment, which addresses 
this broad array of factors, is now endorsed as the gold standard for the management of CP 
conditions (Burke et al., 2016).  However, in order to access this treatment, many Australians must 
endure very long waitlists (Breivik, Collett, Ventafridda, Cohen, & Gallacher, 2006; Breivik, 
Eisenberg, & O’Brien, 2013; Hogg, Gibson, Helou, DeGabriele, & Farrell, 2012; Peng et al., 2007).  
These waits not only delay treatment access for those who are referred, but also actively deter a 
range of other referrals from being placed because doctors and/or patients choose not endure them 
(Department for Health and Ageing, 2016).  Restricted access to treatment perpetuates the cycle of 




help ameliorate the individual and societal impact of CP, but Australian health services are often 
failing to meet this need. 
Problem Statement 
It is important to first understand the impact of living with CP, in order to understand the 
impact that our current approach to service delivery has on those who are seeking treatment.  
Although there is clear evidence linking psychological factors with the CP experience (e.g., Jensen & 
Turk, 2014; Morley, Williams, & Eccleston, 2013; Williams, Eccleston, & Morley, 2012), much of the 
available research has defined its target population not only by the presence or absence of CP, but 
also by its medical diagnosis; focussing on pain associated with specific conditions such as 
fibromyalgia (Homann et al., 2012) or arthritis (e.g., Lerman, Smith, & Haythornthwaite, 2017).  
Although this research provides important insights for particular CP subgroups, many individuals do 
not fit into discrete diagnostic categories.  Instead, the majority of people presenting for care at 
tertiary CP clinics do not have a clear diagnosis for their pain (Blyth, March, & Cousins, 2003) and/or 
experience multiple physical comorbidities (e.g., diagnosed with arthritis, chronic fatigue syndrome 
and chronic low back pain) (Stanos et al., 2016).  The extent to which the findings from condition-
specific literature can be extrapolated to this large group of people is therefore unclear, leaving 
clinicians ill-informed about the lived experience of many of their patients and with an inadequate 
evidence base to inform therapeutic interactions. 
Added to this is the fact that poor treatment access has meant that many people with CP 
experience potentially avoidable consequences because they can’t access treatment that could 
improve their functioning and quality of life.  There are no data to demonstrate the impact of lengthy 
treatment delay on individual outcomes; undermining efforts to advocate for improved treatment 
access on grounds other than ethical concerns.  Accordingly, without additional funding to increase 
CP services, clinicians and health care providers are faced with the extremely challenging task of 




resources.  This requires a clear understanding of the amount of staffing and mix of disciplines that 
are required to operate a multidisciplinary CP service: data that is also not currently available.  
Moreover, it requires a change from a model of care that uses waitlists to funnel referrals through a 
focussed intake process, to one that uses new approaches to deliver earlier intervention and 
positively assist individuals as soon as possible after they are referred to a multidisciplinary CP 
service.  This data is also lacking, leaving clinical services struggling and patients facing longer than 
ideal waits. 
Aim and Scope of the Research 
The aims of this project were therefore two-fold.  The first was to investigate the 
psychological impact of CP and of waiting to access CP treatment.  The second was to examine 
factors related to service design/delivery that are associated with health care access.  Although a 
range of factors impact health care access, this thesis focussed on staff resourcing and a specific 
model of care.  An understanding of staff resourcing was important because staff profiles may 
contribute to wait-times and thus, may underpin health care access.  A pre-clinic education session 
was chosen as the model of care to examine because it had increasingly been adopted in varying 
formats in Australian pain clinics, but without adequate evidence to support this type of service 
reform.  In addition, it involved a cost-neutral change to service delivery, which increased the 
likelihood that it would be used to improve clinical practice, if proven effective.  The thesis focussed 
specifically on pain services that are delivered in tertiary settings because they are the primary 
providers of multidisciplinary treatment for Australians with CP.  Thus, staffing was explored in 
tertiary public multidisciplinary services and CP was conceptualised from a general, rather than 
condition-specific, perspective because the majority of individuals who access Australian tertiary 





Significance of the Research 
This project undertook to improve our clinical understanding of the issues relevant to health 
care delivery for individuals with CP and collect data that could usefully inform practice change to 
augment treatment access in this sector, recognising clear deficits in the current approaches.  In 
doing so, it provides important data regarding the impact of long and indefinite waitlists on 
individuals’ well-being and health care utilisation (HCU).  This is critical information that can inform 
health care providers and policy makers about the impact of current service delivery practices on 
patient outcomes.  This project also provides much needed data on multidisciplinary staffing profiles 
for tertiary CP services.  The articulation of staffing profiles for tertiary CP services provides essential 
information to aid service planning and improve treatment access within CP services.  Moreover, this 
project provides key data to augment clinical care, helping clinicians to understand the experiences 
of those with CP and providing useful information to guide therapeutic intervention and future 
research.  Indeed, the findings from this thesis have already been actively translated to clinical 
practice; influencing tertiary CP service design and delivery in the state of South Australia.  Data 
from Studies 1, 2 and 4 have informed changes to the model of care and intake processes used by 
the Pain Management Unit of the Royal Adelaide Hospital, while data from Study 3 enabled the 
calculation of staffing profiles for predicted levels of clinical activity within new and redesigned 
multidisciplinary CP services across the state. 
Structure of the Thesis 
This thesis reports the findings of a research project that involved one meta-analysis and 
three empirical studies.  All four papers have been published in peer-reviewed journals and are 
presented as separate chapters (Chapters 3-6). 
Chapter 1 summarises the current research, theory and practice surrounding CP and its 
treatment.  Chapter 2 provides an Australian context; briefly describing the Australian health care 




main research aims.  Next, the four published research articles are presented (Chapters 3 - 6); each 
being positioned within the broader research aims by a preamble. 
As indicated, the first aim of the project was to understand the psychological impact of living 
with CP and of waiting for treatment.  Although there is a large body of literature exploring aspects of 
psychological functioning in the presence of CP, it had not previously been synthesised and 
systematically examined.  This was an important first step because it provided a better 
understanding of the experience of people who are living with CP and therefore a more solid basis 
from which to contextualise any findings regarding the impact of being indefinitely waitlisted.  To this 
end, Study 1 (Chapter 3) details a meta-analysis that examined the psychological functioning of 
individuals living with CP, adopting a general, rather than condition-specific, perspective.  Study 2 
(Chapter 4) then builds on these findings by investigating the psychological functioning and HCU of 
individuals indefinitely waitlisted for a first appointment at a tertiary CP service.  This involved 
prospectively following-up 339 individuals over a three year period after their referral.  Due to the 
longitudinal nature of this study, it was the last of the research papers to be published. 
Having investigated the psychological impact of CP and of waiting to access treatment (Aim 
1), this thesis sought to investigate two of the service-related factors that are associated with health 
care access; namely staff resourcing and the model of care that a clinic employs (Aim 2).  
Specifically, it sought to document staffing in Australian tertiary CP services and to examine whether 
providing education to individuals at the point of referral to a tertiary service could improve outcomes 
beyond what was achieved by treatment as usual (waitlisting individuals until a first appointment is 
available and then providing input).  Using data that was collected as part of the Australian Pain 
Society ‘Waiting in Pain’ project, Study 3 (Chapter 5) outlines the multidisciplinary staffing profiles 
that are used by Australian tertiary CP services.  Importantly, these profiles are presented as a 
function of clinical activity, facilitating the calculation of individualised resourcing requirements 




Next, Study 4 (Chapter 6) evaluated whether a group-based pain education session 
provided at the point of referral to a tertiary pain service (pre-clinic) could improve the outcomes of 
individuals who were waitlisted for CP treatment.  This model of care was chosen because it was 
‘resource light’, which meant that it could be adopted using existing resources and implementation 
was therefore not dependent upon additional funding/resources.  Finally, the discussion (Chapter 7) 
draws together the research findings and considers the implications for clinical practice, policy and 
future research. 
References are located at the end of the thesis in a single list, followed by supplementary 
materials, which are presented in separate appendices for each paper (Appendix 1 - 4).  Tables and 
figures are numbered consecutively throughout the manuscript, and inserted at the appropriate place 





Chapter 1 : Chronic Pain – An Introduction 
1.1 Overview 
In any given month, approximately 67% of adults (aged over 15 years) in Australia 
experience some form of physical pain (Australian Bureau of Statistics, 2012a).  Although common, 
pain may be associated with significant levels of health impairment, disability and psychological 
distress, especially when chronic.  Contemporary conceptualisations have seen a paradigm shift 
away from viewing chronic, or persistent, pain as a purely biological phenomenon, instead 
recognising it as a complex interplay between physical, emotional and social variables (IASP: Task 
Force on Taxonomy, 1994).  As will be seen, this has established psychological factors as central in 
the understanding and treatment of the condition.  This chapter begins by defining chronic pain (CP) 
and reviewing its epidemiology, before discussing how pain models have evolved over time.  It then 
provides a brief historical overview of psychological approaches to CP treatment and how they have 
been integrated within multidisciplinary models of pain management. 
1.2 Definition of Chronic Pain 
The International Association for the Study of Pain (IASP) defines pain as “an unpleasant 
sensory and emotional experience associated with actual or potential tissue damage, or described in 
terms of such damage” (IASP: Task Force on Taxonomy, 1994, p. 210).  In its acute form, pain has 
an adaptive and evolutionary function: warning a person of imminent danger, preventing or 
minimising physical harm and supporting recovery (Morrison, Perini, & Dunham, 2013).  Acute pain 
typically has a clearly identified cause (commonly linked with physical injury or disease), promotes 
behaviour change to support healing, is often well managed with medication, and frequently remits 
without complication (Macintyre et al., 2010).  However, pain that persists beyond the normal period 
of healing is not adaptive and is considered to be chronic (Bonica, 1953).  This move to chronicity 
can occur as quickly as one month, or over longer periods, such as six or more months. 
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The commonly accepted definition of chronic, or persistent, pain is pain that occurs on most 
days in a three (or more) month period (Merskey & Bogduk, 1994).  Unlike acute pain, CP can be 
difficult to localise and is frequently resistant to medical treatments: standard analgesics may offer 
little or no relief and surgical intervention may even exacerbate symptoms (Jamison, 2011).  
Although CP may be related to an identifiable disease process, it is often more directly related to 
increased sensitivity within the nervous system than it is to physical pathology (Phillips & Clauw, 
2011), making definitive diagnosis difficult.  The shift to chronicity therefore triggers a concurrent shift 
in treatment focus, away from the curative aims of acute pain treatment, towards functional 
management despite persistent pain (Mills, Torrance, & Smith, 2016). 
Types of Pain 
Medical classification of pain.  Broadly speaking, pain can be medically classified at three 
levels: causal mechanism, type and location (see Figure 1.1).  The first level classifies pain as either 
nociceptive or neuropathic.  Nociceptive pain is caused by injury/damage to body tissue, or by 
physiological changes, such as the development of tumours or cancer cells.  It is typically localised 
to the area of damage/injury (Hudspith, Siddall, & Munglani, 2006), associated with inflammation and 
frequently described as sharp, aching or throbbing pain (Dworkin, Nagasako, & Galer, 2001).  
Neuropathic pain, on the other hand, is caused by damage to, or functional changes in, the nervous 
system.  Rooted in nerve dysfunction, descriptors such as burning, tingly, numbness or ‘pins and 
needles’ are frequently used (Johansen, 2010). 
Pain can also be classified by type; namely normal (physiological) or abnormal 
(pathological) processes, and by location, involving small body parts (e.g., nerves, tissue, bone) 
(Bennett, 2012) through to larger regions (e.g., back, pelvis).  This simplistic overview facilitates 
diagnostic pathways, explaining conditions such as diabetic neuropathy and rheumatoid arthritis 
(Birnbaum, Pike, Banerjee, Waldman, & Cifaldi, 2012), and sanctioning labels such as chronic low 
back pain (Hoy et al., 2014) and pelvic pain (Tripoli et al., 2011). 






Figure 1.1: Three-level classification of pain (Bennett, 2012, p. 3) 
 
 
Medically unexplained pain.  Although some pain diagnoses are clear, others are not, 
partly because the link between pain and pathology is moderate, at best.  In fact, pathology is not 
even a pre-requisite for pain to occur (Sharp, 2001), leaving an estimated 65% of individuals with no 
clear medical diagnosis for their pain (Blyth, March, & Cousins, 2003).  In the absence of an 
identifiable pathology, individuals may be diagnosed with labels such as ‘undifferentiated CP’, 
‘idiopathic pain’ or ‘chronic primary pain’ (Lipowski, 1990; Treede et al., 2015).  Although these 
experiences can be readily explained by our current models of pain (refer 1.6 - The Biopsychosocial 
Model of Chronic Pain) they are frequently, albeit inaccurately, labelled as medically unexplained; a 
term that often carries significant stigma for the individuals who live with it (Kirmayer, Groleau, 
Looper, & Dao, 2004). 
1.3 Prevalence and Risk Factors 
CP affects one in five people globally, with one in ten being newly diagnosed each year 
(Goldberg & McGee, 2011).  This rate increases to one in two (Helme & Gibson, 2001) or three 
(Blyth, et al., 2001) for older individuals (>65 years). Although less prevalent, young people with CP 
typically report that pain interferes more with their daily activities than do older people; possibly 
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because they are involved in more physically demanding roles (e.g., full-time employment, parenting 
young children). 
Clinical data additionally indicate that CP is more commonly experienced by women (20%) 
than men (17%) (Access Economics, 2007), and that it is associated with greater disability in women 
(Fillingim, et al., 2009).  Women have also demonstrated lower pain thresholds and greater 
sensitivity to experimentally-induced pain than men (Bartley & Fillingim, 2013; Wiesenfeld-Hallin, 
2005).  Conversely, men report greater erosion of life satisfaction in the presence of CP and less 
adaption to pain over time than do women (McNamee & Mendolia, 2014).  As with many sex-
differences, biological, psychological and social/cultural factors are all likely to contribute to these 
findings (Pieretti et al., 2016).  
The likelihood of experiencing CP also appears to be affected by socioeconomic status, with 
greater disadvantage associated with an increased prevalence of CP (McBeth & Jones, 2007).  This 
relationship has been demonstrated using multiple indices of socioeconomic status; including 
income, employment status, level of education and location of residence (Portenoy, et al., 2004).  
The fact that many of these factors pre-date the onset of CP suggests that they may be social 
determinants, rather than artefacts of the CP experience.  Socioeconomically disadvantaged people 
are also likely to experience greater pain-related disability and more comorbid chronic health 
conditions (e.g., diabetes, obesity) than those from more advantaged backgrounds (Everson, Maty, 
Lynch, & Kaplan, 2002).  Lastly, CP has been linked with a number of early life events (e.g., being 
raised in care, death of a parent, low birth weight) that, although not exclusively a marker of 
socioeconomic disadvantage, are more common in disadvantaged groups (Macfarlane, 2016).  Of 
note, the relationship between CP and socioeconomic status appears to be moderated by a number 
of variables, such as psychological well-being, lifestyle factors (e.g., smoking, diet) and working 
conditions (Bonathan, Hern, & Williams, 2013); many of which, as will be discussed, are amenable to 
therapeutic intervention. 
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The Australian Context 
Consistent with international data, CP affects one in five Australians each year, or one in 
three older individuals (>65 years).  This is particularly salient given Australia’s aging population; with 
CP rates predicted to increase from around 3.2 million people in 2007, to 5 million in 2025 (Access 
Economics, 2007). International findings concerning the risk factors for CP have also been replicated 
in Australia.  Specifically, Australian women report higher rates of CP than men (Blyth, et al., 2001) 
and social disadvantage (e.g. education level, income, employment status) is positively associated 
with the prevalence of CP in this country (Currow, Agar, Plummer, Blyth, & Abernethy, 2010).  
Similarly, native Australians (Aboriginal and Torres Straight Islanders) experience disproportionally 
high rates of CP and particularly low rates of treatment access (Vindigni, et al., 2004; Vindigni, et al., 
2005), as do Culturally and Linguistically Diverse (CALD) groups (Brand, et al., 2014). 
1.4 The Burden of Chronic Pain 
CP is closely associated with many of the primary contributors to the global burden of 
disease and disability — the largest being low back pain — and frequently results in marked 
economic and life burden (Hoy, et al., 2014).  The economic impact arises from several sources, 
including: decreased work productivity (Bonathan, et al., 2013), loss of employment, interference 
with activities of daily living, and increased rates of public health service usage (Blyth, March, 
Brnabic, & Cousins, 2004), surgery (e.g., estimated average of $15,000 per lumbar operation) 
(Gatchel & Okifuji, 2006), absenteeism (Hoffman, Papas, Chatkoff, & Kerns, 2007), disability and 
medication use (Douglas, Graham, Anderson, & Rogerson, 2004).  The annual economic impact of 
CP has been estimated to be as high as €200 billion in Europe (Tracey & Bushnelly, 2009) and 
USD$560-$635 billion in the United States of America; the latter exceeding America’s annual 
combined costs for cancer, heart disease and diabetes (Gaskin & Richard, 2013).  The life impact 
spans all facets of living from physical function, to mood, interpersonal relationships and social 
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connectedness (Dueñas, et al., 2016), which are discussed below (see section 1.6 The 
Biopsychosocial Model of Chronic Pain). 
The Australian Context 
In Australia, CP is commonly associated with the two greatest contributors to overall disease 
burden: cancer and musculoskeletal conditions (e.g., arthritis, tendonitis, back pain) (Australian 
Institute of Health and Welfare, 2014).  The annual cost of CP to the Australian economy was 
estimated to be around AUD$34.3 billion in 2007, over half of which was borne by those individuals 
who were living with the condition (Access Economics, 2007).  This figure increased to AUD$55.1 
billion in 2012 (Vos, et al., 2012). 
1.5 Early Theories of Pain 
There have been a range of theories postulated about how our bodies process pain.  
Originally conceptualised as a purely physical phenomena, theorists have gradually extended their 
models to account for an increasingly diverse range of stimuli and processing pathways.  Specificity 
Theory and Gate Control Theory have been two of the most influential of the early theories.  
Specificity Theory 
First proposed by Charles Bell in the mid-1800s (Bell & Shaw, 1868), Specificity Theory 
postulated that each sensory modality (e.g., touch, pain, temperature) is encoded via its own unique 
pathway and transmitted to the relevant centre in the brain.  CP was therefore defined as a purely 
physical phenomenon involving nociceptive (i.e., painful) sensory information that was transmitted 
through the body via an ascending pathway: from peripheral nerves, through the spinal cord and up 
to the ‘pain center’ in the brain (see Figure 1.2) (Moayedi & Davis, 2013).  Symptomatic of an 
underlying physical pathology, the amount/severity of the pain was thought to be indicative of the  
 





Figure 1.2: Descartes model of pain, circa 1664 (cited in Melzack & Wall, 2008) 
 
 
degree of change/damage (Gatchel, Peng, Peters, Fuchs, & Turk, 2007).  Thus, treatment required 
localising and changing/removing the underlying physical cause. 
Consistent with the principles of Cartesian Dualism (refer Rene Descartes, cited in Melzack 
& Wall, 2008), pain was attributed to a form of psychological pathology if no physical cause was 
identified, leading to various diagnoses such as hysteria stemming from disordered menstruation, 
hypochondria, sympathetic irritability and hallucinations (Hodgkiss, 1991).  In short, where pain was 
experienced in the absence of discernable pathology, the mind was implicated and mental illness 
was assumed.  Although our scientific understanding of pain has evolved, the stigma of mental 
illness and/or questionable validity remains when pain is experienced in the absence of any clear 
physical pathology (Kirmayer, et al., 2004).  Thus, the implication that it’s ‘all in your head’ poses 
particular difficulties for a large number of individuals who are labelled as having medically 
unexplained CP (Stone, 2014). 
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Despite its limitations, Specificity Theory remained the dominant model for many years.  
However, its inability to account for pain that occurs in the absence of any identified pathology (e.g., 
phantom limb pain) and pain severity that is discordant with the identified pathology (e.g., 
psychologically traumatised war veterans), ultimately led to its downfall; being replaced in the 
popular view by Gate Control Theory (Melzack & Wall, 1965). 
Gate Control Theory 
Wall and Melzack first published their Gate Control Theory in 1965 and it dramatically 
changed our understanding of how pain was processed within the body.  Gate Control Theory 
conceptualised pain as something that was perceived and, in doing so, made an explicit link 
between psychological function (perception) and the pain experience.  Rather than being a product 
of nociceptive sensory information that was unidirectionally transmitted via an ascending pathway to 
the brain, pain was now also thought to be moderated by descending pathways that run from the 
brain through the spinal cord.  In brief, Wall and Melzack (1965) postulated the operation of a neural 
‘gate’ (see Figure 1.3), situated at the dorsal horn of the spinal cord, through which both small and 
large nerve fibers passed; transmitting nociceptive and non-nociceptive (non-painful: touch, 
temperature) sensory information respectively.  The gate control system was hypothesized to 
operate via the substantia gelatinosa (SG), such that activity in the large fibres inhibited nociceptive 
transmission (closed the gate) and activity in the small fibres excited it (opened the gate).  Therefore, 
Gate Control Theory asserted that the amount of pain experienced by a person was affected not only 
by the intensity of the nociceptive stimulus (small fibres), but also by the strength of any non-
nociceptive information (large fibres) that was simultaneously generated at the pain site.  Moreover, 
this theory asserted that pain was also moderated by psychological processes (thoughts and 
emotions), which fed back to the gate via the descending pathway, either inhibiting or exciting 
nociceptive transmissions (Melzack, 1999; Melzack & Wall, 1965). 
 





Figure 1.3: Schematic diagram of the gate control theory of pain (Melzack & Wall, 1965, p. 975).  




Gate Control Theory, therefore, better accounted for clinical phenomena that were not 
explained by previous models, including: the phenomenon of referred pain, the nonlinear relationship 
that may exist between injury and pain, fluctuating pain severity and/or locations, and the fact that 
pain may persist after an injury has healed (Gatchel, et al., 2007).  Whereas Specificity Theory was 
limited to acute pain, Gate Control Theory was the first model to encompass both acute and chronic 
pain. 
Although several of its components have since been challenged (e.g., postulated distinctions 
between pre- and post-synaptic function; the role of substantia gelatinosa) (Wall, 1978), Gate 
Control Theory generated a vast amount of research; arguably more than any previous pain theory.  
Thus, Wall and Melzack were highly influential in highlighting the complex interplay between 
physical, cognitive, emotional, behavioural and social influences; factors that form the cornerstones 
of the currently-used biopsychosocial model of pain (Mendell, 2014). 
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1.6 The Biopsychosocial Model of Chronic Pain 
The more recently adopted biopsychosocial model takes a multifactorial approach to CP, 
treating it as a combination of both disease and illness; disease being the objective presence of 
physical pathology/change and illness referring to the subjective experience of symptoms and the 
impact of those symptoms on an individual’s life (Gatchel, 2004) (see Figure 1.4).  Illness is thought 
to be shaped by a range of psychological, social and behavioural factors within both the individual 
and their surrounding environment (past and present). 
 
 
Figure 1.4: Biopsychosocial model of health and illness (Gatchel, 2004, p. 798) 
 
 
Since its inception (for one of the earliest conceptualisations see Loeser, 1982), the 
biopsychosocial model of pain has been widely adopted and advanced, drawing evidence from a 
range of areas.  This evidence includes studies that have used functional magnetic resonance 
imaging (fMRI) to demonstrate a link between pain processing and the emotional and cognitive 
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areas of the brain (e.g., Koyama, McHaffie, Laurienti, & Coghill, 2005).  It also includes psychological 
studies that have demonstrated links between pain, disability and other factors — such as 
expectations (e.g., Clay et al., 2010), quality of life, emotion (e.g., Keeley et al., 2008) and social 
relationships (e.g., Dueñas, et al., 2016) — and studies with a physical focus that have 
demonstrated an interplay between pain, emotion (e.g., fear-avoidance) and functional capacity 
(e.g., Ledoux, Dubois, & Descarreaux, 2012).  This increased understanding of the multifactorial 
nature of the CP process has highlighted a range of psychological and social factors which influence 
how pain is experienced by an individual.  These factors will be discussed below, prior to exploring 
how they are addressed by psychological approaches to the treatment of CP. 
Psychological Factors 
Cognition.  Beliefs, or cognitions, provide a filter through which individuals interpret 
information (Turner, Jensen, & Romano, 2000).  Individual beliefs about symptoms or circumstances 
have been highlighted as powerful behavioural drivers (Janz & Becker, 1984).  There is now strong 
support for the role of cognitions in influencing the experience of CP, such that they mediate help-
seeking behaviour and treatment engagement, mood, behavioural activation and coping (Turner, et 
al., 2000).  For instance, an internal locus of control (the belief that an individual has the power to 
exert change) has been associated with an increased use of coping strategies and improved ratings 
of mood and quality of life, compared to an external locus of control (Crisson & Keefe, 1988; 
Skevington, 1983).  Similarly, individuals who report a greater sense of control over the pain itself 
have been found to report lower levels of pain-related interference in their daily activities, less 
psychological distress and an increased use of coping strategies (Jensen, Turner, Romano, & 
Karoly, 1991).  Conversely, repeated unsuccessful attempts to control pain can lead to a generalised 
sense of helplessness, which is a known risk factor for depression, disability and pain in CP samples 
(A. Hill, 1993; Keefe, Crisson, Urban, & Williams, 1990).  In fact, helplessness has been shown to be 
a more powerful predictor of pain and disability than fear of pain or passive coping (e.g., avoidance, 
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withdrawal) (Samwel, Evers, Crul, & Kraaimaat, 2006).  Beliefs about the appropriateness and/or 
utility of certain treatments have also been linked with treatment uptake (Jensen, et al., 1991). 
In the CP context, it is important to also consider the beliefs that are held by the self and 
others regarding the validity of a pain condition that occurs in the absence of any discernible 
pathology.  As noted, pain that could not be explained medically was once deemed to be 
psychogenic or psychopathological (e.g., “it’s all in your head”) (Hodgkiss, 1991).  Although we now 
know that the relationship between pain and physical pathology is often tenuous, and that pain 
without pathology is common, this understanding has not yet fully permeated societal views (Stone, 
2014).  Accordingly, where a diagnosis identifies a physical cause, the condition is often assumed 
(by self and/or others) to have occurred outside of the control of the individual, whereas a diagnosis 
that implies a psychological basis may suggest the opposite; that it is within the individual’s control.  
Thus, when symptoms continue despite treatment, a medical diagnosis may offer reassurance, 
facilitating coping and resilience.  Conversely, for those without a definitive diagnosis, treatment 
failure may promote anxiety and uncertainty, often leaving patients feeling blamed, judged, 
disbelieved or otherwise disadvantaged in both medical and social circumstances.  This can foster a 
sense of shame and worthlessness, and a strong desire to strive for proof of legitimacy (Kirmayer, et 
al., 2004; Stone, 2014; Weiner, Perry, & Magnusson, 1988), impacting their experience of pain, the 
way that symptoms are expressed and their interactions with others (Kirmayer, et al., 2004; 
Nettleton, 2006).  
Affect.  Research has consistently demonstrated that psychological problems are common 
in people with CP (Dersh, Polatin, & Gatchel, 2002).  The significant impact of pain on daily life and 
the often sub-optimal treatment outcomes can leave individuals experiencing a range of negative 
emotions, including depression (e.g., Bair, Robinson, Katon, & Kroenke, 2003), anxiety (general and 
health/pain-related) (e.g., McWilliams, Goodwin, & Cox, 2004), worthlessness, hopelessness and 
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anger (e.g., Fernandez & Turk, 1995).  Moreover, it can result in a sense of being judged, blamed 
and/or overwhelmed (e.g., Stone, 2014). 
Emotional distress has been linked with the CP experience in numerous ways; being 
variously conceptualised as a precipitant, consequence and/or perpetuating factor in the cycle of CP.  
As noted, affective factors have been shown to moderate pain via descending pathways; either 
exciting or inhibiting the transmission of nociceptive information (Melzack, 1999; Melzack & Wall, 
1965).  They have also been shown to impact on pain ratings (e.g., severity, tolerance), individual 
coping (e.g., activity level, use of coping strategies) and treatment outcomes (e.g., length of hospital 
stay, complication rates, treatment adherence) (Gatchel, et al., 2007).  Thus, emotions influence the 
experience and interpretation of pain, as well as physiological pain processes. 
The distinction between acute and CP is important in this context because it appears likely 
that the pain-emotion relationship is tied more closely to chronicity than pain onset (Banks & Kerns, 
1996; Fishbain, Cutler, Rosomoff, & Rosomoff, 1997).  However, the nature of the relationship 
between CP and emotion has proven to be complex.  Psychological distress, for example, has been 
variously described by researchers as a formal mood disorder (e.g., major depressive disorder), a 
symptom (e.g., flattened affect), or a general emotional state (e.g., “I’m feeling depressed) (Broome, 
Saunders, Harrison, & Marwaha, 2015).  Different methodologies have also been used to assess 
these constructs, including self-reports (e.g., psychometric questionnaires, patient reports), clinician 
assessments (e.g., unstructured or semi-structured clinical interviews) and/or historical information 
(e.g., case note reviews) (Dersh, et al., 2002).  Moreover, the diagnosis of psychological problems is 
further complicated by the fact that the symptoms of CP and emotional distress often overlap; 
particularly in the case of depression.  In fact, much of the early research into CP and psychological 
distress employed psychometric measures that focused on somatic content (e.g., BDI: Beck 
Depression Inventory; BAI: Beck Anxiety Inventory), potentially inflating diagnostic rates. 
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Similarly, the literature has tended to focus on specific pain diagnoses, such as neuropathic 
pain (Attal, Lanteri-Minet, Laurent, Fermanian, & Bouhassira, 2011) and fibromyalgia (Homann, et 
al., 2012); or on specific subgroups, such as older people (Falsarella et al., 2012) and trauma 
survivors (Peterlin et al., 2009), limiting its applicability to those who do not have a clear diagnosis or 
precipitant for their CP.  Indeed, one Australian survey found that 65% of people did not have a clear 
medical diagnosis for their CP and 33% could not identify a clear precipitant (Blyth, March, & 
Cousins, 2003).  CP is also associated with a large number of different medical diagnoses (e.g., 
whiplash, diabetes, nerve damage) (Breivik, et al., 2006), not all of which have been well-
researched, and many people with CP experience a range of medical (e.g., hormonal changes, 
sleep disorders) and psychological comorbidities (e.g., hopelessness, stress) that are not specific to 
a particular CP diagnosis or subgroup.  As such, it is difficult to compare rates of psychological 
distress between CP studies.  In addition, most studies have been retrospective in nature, making it 
difficult to determine whether there is a causal relationship between CP and psychological distress. 
Social Factors 
Although the biopsychosocial model identifies a large number of social variables/factors that 
have the potential to impact on CP, existing research can be grouped into three main categories: 
interpersonal relationships, treatment-related factors and work-related factors. 
Interpersonal relationships.  Just as the beliefs of the individual impact on his/her 
response to pain, the beliefs of significant others shape how they respond to the person who is 
experiencing pain, thus influencing the cycle of (dis)ability (e.g., Matos, Bernardes, & Goubert, 2017; 
Mogil, 2017; Peat, Thomas, Handy, & Croft, 2004).  For instance, overly solicitous spousal 
responses to pain-related behaviours have been associated with increased ratings of pain severity 
and decreased activity levels (Flor, Kerns, & Turk, 1987).  Similarly, it has been suggested that 
spousal beliefs regarding functional capacity may not only mirror those of injured workers, but 
sometimes involve greater expectations about permanent disability than those held by the worker 
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him/herself; thus supporting, and potentially reinforcing, the illness role (McCluskey, Brooks, King, & 
Burton, 2011).  Interpersonal relationships may also be eroded via other aspects of the pain-
(dis)ability cycle.  Behavioural withdrawal (e.g., missing social events), impaired communication 
(e.g., as a symptom of a negative mood state) and limited ability to plan (due to the unpredictable 
nature of pain) are commonly reported by individuals living with CP; while significant others (family, 
friends) may grapple with other issues, such as changing roles (e.g., spouse vs carer) and the 
impact of CP on their broader lifestyle (Dueñas, et al., 2016).  Together, these factors influence the 
mood, cognition and behaviour of all parties, thus shaping interpersonal interactions and the way 
that pain is experienced within that context.  
Treatment-related factors.  There is considerable evidence regarding the role of iatrogenic 
(i.e., therapy/clinician/practitioner-induced) factors in CP.  Practitioner beliefs about CP and its 
management influence the treatments they offer to patients and the messages they give to them 
about (in)appropriate responses to pain (Darlow et al., 2012; Gardner et al., 2017).  Similarly, 
practitioner perceptions regarding the patient him/herself (e.g., motivated vs unmotivated patient) 
influences therapeutic interactions, with implications for assessment, case conceptualisation and 
treatment selection (Sharp, 2001). 
Where pain exists in the absence of an identified pathology, it may be easier for practitioners 
to attribute inexplicable symptoms to characteristics of the patient, rather than limitations in medical 
science, because doing so neutralises the threat to the practitioner’s competence and shifts the 
treatment focus to a different type of health care (i.e., from medical to psychological/psychiatric) 
(Kirmayer, et al., 2004).  As noted, this type of pain is often associated with patient reports of 
disbelief and disconfirmation from treating practitioners (e.g., Stone, 2014), often leading patients to 
request additional scans, medical tests or interventions in a strive for legitimacy, and/or to display 
increasingly demonstrative behaviour during consultations (e.g., defensive, assertive, emotional 
behaviours).  The stigma associated with medically unexplained pain has been linked with higher 
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rates of over-investigation, over-prescribing and greater psychological distress (Kouyanou, Pither, 
Rabe-Hesketh, & Wessely, 1998).  Although intended as a strategy to improve health, this increased 
engagement with health care and strengthened desire to ‘find a diagnosis’ ultimately serves to focus 
a person’s attention on the pain, rather than health (or wellness) behaviours, thus reinforcing the sick 
role (Kouyanou, et al., 1998).  Moreover, it can leave practitioners feeling frustrated and/or anxious, 
perpetuating the cycle of poor communication, disbelief and pain behaviour (Kirmayer, et al., 2004; 
Stone, 2014). 
Work-related factors.  There is a wealth of research demonstrating that CP has a marked 
negative impact on work attendance, efficiency and productivity, and frequently results in early 
workforce withdrawal/retirement (Dueñas, et al., 2016).  Moreover, participation in a workplace 
insurance/compensation system has been shown to negatively impact on reports of pain severity, 
mood and pain-related disability (e.g., Blyth, March, Nicholas, & Cousins, 2003; Rainville, Sobel, 
Hartigan, & Wright, 1997), and has been associated with poorer treatment outcomes (Rohling, 
Binder, & Langhinrichsen-Rohling, 1995).  Although a detailed discussion of workplace injury and 
return to work is beyond the remit of this thesis, it is important to note that psychosocial factors have 
been highlighted as important contributors to pain and disability, and, therefore, to successful return 
to work (Bergbom, Flink, Boersma, & Linton, 2014; J. C. Hill et al., 2011; Nicholas, Linton, Watson, & 
Main, 2011).  An individual’s perception about the amount and type of workplace support and/or 
flexibility that is available to them, as well as the perceptions of their colleagues about their level of 
(dis)ability, have all been shown to impact workforce participation after pain onset (Brooks, 
McCluskey, King, & Burton, 2013; Wainwright, Wainwright, Keogh, & Eccleston, 2013). 
1.7 Psychological Approaches to the Treatment of Chronic Pain 
Although psychological treatments for CP may include a range of therapeutic modalities 
(e.g., hypnosis, biofeedback), the current discussion focuses on the three types of therapy that have 
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been most commonly used in this area: behavioural, cognitive and acceptance/mindfulness 
approaches. 
Behavioural Approaches 
Similar to the disease-illness distinction within the biopsychosocial model, behaviourists 
distinguish between nociception and the existence of a pain problem.  In short, behavioural 
approaches assert that any problem is defined by its outwardly observable signs, such that, although 
nociception may occur, in the absence of any observable pain behaviour(s), there is no pain problem 
(Fordyce, 1984).  Fordyce asserted that pain behaviours are susceptible to the same range of 
influences as other behaviours (e.g., social context, learning/conditioning, length of exposure to the 
stimuli); thus recognising the existence of a reciprocal relationship between the behaviours of the 
person with pain and factors external to the individual, each shaping and influencing the other. 
Behavioural approaches are predicated on the principles of operant and classical 
conditioning.  According to the operant model, behaviour that is followed by a reinforcing event 
(attainment of a positive consequence or avoidance of a negative one) will increase over time, while 
behaviour that is followed by a negative consequence will not (Lieberman, 1993).  Classical 
conditioning, on the other hand, asserts that individuals learn behavioural responses (conditioned 
response) by the repeated pairing of a conditioned stimulus with an unconditioned stimulus; such 
that the conditioned stimulus begins to elicit the conditioned response independent of the 
unconditioned stimulus (Schneider, Palomba, & Flor, 2004).  A behavioural approach to therapy 
therefore focuses on pain behaviours, rather than the physical condition, with clinicians seeking to 
identify and extinguish maladaptive contingencies (i.e., those maintaining the pain problem) and 
replace them with more adaptive behaviours that support wellness (Turk & Flor, 1984). 
Behaviour Therapy has been widely used in the treatment of CP and has provided a solid 
foundation upon which other psychological approaches have been developed.  In fact, behaviourists 
were some of the earliest advocates for physically-focussed treatments, such as relaxation training, 
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which continue to be used in multidisciplinary settings today (Jensen & Turk, 2014).  A thorough 
critique of Behaviour Therapy is beyond the scope of this thesis, but recent evidence suggests that, 
although it has contributed to our understanding of CP treatment, it offers limited benefit as a stand-
alone therapy, aside from small reductions in catastrophizing immediately after intervention (Day, 
Thorn, & Burns, 2012; Eccleston, Williams, & Morley, 2009). 
Cognitive Approaches 
An individual’s cognitions, or thoughts, have increasingly been thought to play an important 
role in many illnesses and there is now strong support for the role of cognitions in influencing the CP 
experience (e.g., Jensen et al., 2002; Jensen, et al., 1991; Lamé, Peters, Vlaeyen, Kleef, & Patijn, 
2005; Vlaeyen & Linton, 2012).  Most of this research has adopted models focussing on appraisal, 
attentional bias and communal coping.  The Appraisal Model asserts that an individual evaluates the 
potential threat of a stressor (primary appraisal) and then applies any relevant beliefs regarding 
perceived ability to cope (secondary appraisal), thus driving behavioural and cognitive responses 
(coping) (Severeijns, Vlaeyen, & van den Hout, 2004).  The Attention Bias Model, on the other hand, 
contends that the experience of pain is increased by a heightened focus on pain-related symptoms 
and experiences (see Dehghani, Sharpe, & Nicholas, 2004; Schoth, Georgallis, & Liossi, 2013).  
Finally, the Communal Coping Model defines negative cognitive responses (e.g., catastrophizing) as 
coping strategies that are designed to elicit supportive responses from the surrounding community, 
which, when successfully applied, ultimately reinforce the pain behaviour and therefore the sick role 
(Sullivan et al., 2001). 
All of these models are accommodated within a cognitive approach to treatment, whereby 
the therapeutic goal is to help individuals to understand the role of cognitions in the pain-(dis)ability 
cycle, identify and challenge unhelpful cognitions, and maximise the use of appropriate and helpful 
self-talk (Ehde & Jensen, 2010).  The three cognitions that have been highlighted as particularly 
important therapeutic targets are catastrophizing, fear-avoidance and self-efficacy.  
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Catastrophizing.  Catastrophizing is an exaggerated or magnified negative response to an 
aversive stimuli, typically associated with rumination and dire predictions for the future (Sullivan, 
Bishop, & Pivik, 1995, p. 524).  Throughout the literature it has been operationalized in ways that 
have variously focussed on worry, perceptions of negative expectation, helplessness, hopelessness 
and coping ability.  Catastrophizing has been shown to limit an individual’s ability to assimilate 
competing information, which might discredit their expectations, because anxiety-reduction is 
typically achieved by avoidance (Van Damme, Crombez, & Eccleston, 2002).  As such, it has been 
strongly linked with greater psychological distress and disability (see Quartana, Campbell, & 
Edwards, 2009), and reduced quality of life (Lamé, et al., 2005) and attentional capacity (Dick & 
Rashiq, 2007) in CP groups.  Moreover, catastrophizing has been associated with poorer outcomes 
after some invasive medical treatments (Forsythe, Dunbar, Hennigar, Sullivan, & Gross, 2008; 
Samwel, Slappendel, Crul, & Voerman, 2000; van Wijk et al., 2008), longer hospital admissions, 
increased ratings of experimentally-induced pain (Quartana, et al., 2009), and greater medication 
and health service usage (Keefe, Rumble, Scipio, Giordano, & Perri, 2004).  
Fear avoidance.  Fear-avoidance is the catastrophic belief that activity will lead to pain and 
(re)injury and so should be avoided (Vlaeyen & Linton, 2000).  As noted, this behavioural avoidance 
ensures that the opportunity to learn discordant information is also avoided, thereby eliminating the 
chance to challenge the belief (Van Damme, et al., 2002).  Moreover, because fear-avoidance is an 
anxiety response, avoidance of the activity itself becomes associated with anxiety reduction.  Thus, 
in the absence of competing information, situational avoidance reinforces future avoidance.  Fear of 
pain has been found to be a better predictor of activity avoidance than pain severity or physical 
pathology, and is a key component of the disability and disuse cycle that is frequently associated 
with CP (Vlaeyen & Linton, 2012). 
Self-efficacy.  Pain self-efficacy has been defined as a belief in one’s ability to perform a 
particular activity or to manage a particular situation in the presence of pain (Nicholas, 2007).  Based 
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on the work of Bandura (1977), who argued that change stems from cognitive factors, a person’s 
sense of mastery (self-efficacy) was believed to drive both the initiation of, and persistence with, 
coping responses.  Thus, Bandura proposed that the greater a person’s self-efficacy, the more effort 
they would exert and the longer they would persist in the face of an aversive stimuli.  However, 
where an individual believed that a stimulus was beyond their ability to manage (poor self-efficacy), 
no effort was expended and the situation was avoided completely.  As with other cognitions, 
Bandura asserted that self-efficacy beliefs were subject to change over time, shaped by experience 
and learning. 
Pain self-efficacy has been linked with higher levels of pain tolerance and engagement in 
activities, lower levels of psychological distress, and better outcomes after medical and 
psychological treatments (Keefe, et al., 2004).  Moreover, greater self-efficacy (as rated by the 
patient) has been associated with decreased pain- and avoidance-behaviours (Asgharia & Nicholas, 
2001), and lower spousal ratings of disability (Nicholas, Wilson, & Goyen, 1992). 
Cognitive behavioural therapy.  It is important to include cognitive components in a 
therapeutic approach for the effective treatment of CP, but they are rarely used in isolation; instead 
being combined with behavioural approaches under a cognitive behavioural framework.  Cognitive 
Behavioural Therapy (CBT) asserts that “an individuals’ pain-related cognitions, beliefs and coping 
behaviours play key causal roles in determining their adjustment to pain, including psychological 
distress, pain-related disability and health care utilisation” (Ehde & Jensen, 2010, p. 267).  As such, 
CBT targets cognitions, behaviours and/or social/environmental factors, resulting in varied 
therapeutic foci and treatment lengths.  Despite this inherent variability, all CBT approaches 
emphasise the individual as an agent of change, promoting the importance of self-management and 
life-engagement in the presence of pain (Jensen & Turk, 2014). 
Some of the techniques that are utilised under the CBT umbrella include relaxation training, 
cognitive restructuring (replacing unhelpful thoughts with more adaptive alternatives) (Traeger, 
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2013), behavioural activation (gradual increases in activity, designed to reduce avoidance) (Veale, 
2008), activity pacing (activity regulation to facilitate adaptive goal attainment) (Nielson, Jensen, 
Karsdorp, & Vlaeyen, 2013), goal setting, problem solving and other coping skills training (e.g., 
distraction, guided imagery, psychoeducation) (Keefe et al., 1990).  Although some forms of physical 
pathology (e.g., disc degeneration) are clearly not amenable to change via these techniques, many 
other aspects of the pain experience and associated comorbid conditions are (e.g., sleep 
disturbance, mood disturbance) (e.g., Eccleston, et al., 2009; Morley, Eccleston, & Williams, 1999).  
Treatment therefore frequently includes a concurrent focus on related issues, such as sleep 
disturbance, sexual concerns, relationships and communication, diet and nutrition, mood, and 
lifestyle factors (e.g., substance misuse) (Philips & Rachman, 1996). 
CBT is undoubtedly the most widely researched of all psychological treatments for CP 
(Morley, et al., 2013).  It has been shown to improve numerous patient outcomes, such as quality of 
life, mood, physical function, social engagement, workforce participation, pain-related interference in 
daily activities, pain severity, and both medication and health care usage (e.g., Castro, Daltro, 
Kraychete, & Lopes, 2012; Hoffman, et al., 2007; Morley, et al., 1999).  However, the significance of 
these findings have been questioned because early studies, in particular, were plagued with issues 
relating to poor research designs, study quality and therapist training (e.g., used provisional or 
trainee psychologists) (Eccleston, et al., 2009; Williams, et al., 2012).  Moreover, they tended to 
recruit highly restricted samples (e.g., very motivated participants who agreed to cease opioid 
medication and/or live away from their families for 4 weeks excepting weekends) (Peters & Large, 
1990; Williams et al., 1993), such that results could not be generalised to wider clinical populations.  
Recent meta-analyses have also indicated that immediate post-treatment gains frequently decrease 
over time (Eccleston et al., 2014; Eccleston, et al., 2009; Williams, et al., 2012).  Overall, the 
evidence suggests that CBT is moderately effective (small to medium effect sizes) for the treatment 
Chapter 1: Chronic pain - an introduction  
22 
 
of CP, with treatment benefits typically diminishing in the longer-term (Ehde, Dillworth, & Turner, 
2014). 
Acceptance and Mindfulness Approaches 
Despite the widespread use and success of CBT in the management of CP, there is 
evidence to suggest that a specific therapeutic focus on cognitive change may not be necessary to 
achieve clinical improvement (McCracken & Eccleston, 2003; McCracken & Vowles, 2014; Morley, et 
al., 1999; Wetherell et al., 2011).  In fact, it is now thought that changing the relationship that 
individuals have with their cognitions is more important than changing the content of those 
cognitions.  That is, rather than needing to replace unhelpful thoughts with a more adaptive response 
(as per CBT), it may only be necessary to help individuals disengage from their thoughts so that they 
are better able to recognise them as thoughts, rather than facts (Segal, Teasdale, & Williams, 2004).  
This has led to a ‘third wave’ of psychological therapies (S. C. Hayes, Luoma, Bond, Masuda, & 
Lillis, 2006): acceptance and mindfulness approaches. 
Just as behaviourists define a pain problem by the presence (or absence) of pain 
behaviours, acceptance and mindfulness approaches define it by the strength of an individual’s 
struggle with his/her pain: the greater the struggle, the greater the distress (Dahl & Lundgren, 2006).  
Aversive sensations (physical, emotional, cognitive) are a normal part of the human experience, 
which can neither be fully controlled nor completely avoided.  The more individuals are caught in an 
unwinnable struggle against these experiences (e.g., pain), the less opportunity they have to engage 
with meaningful activities; thereby increasing their suffering.  Mindfulness and acceptance 
techniques have been shown to help reduce this struggle and, within the CP context, are most 
commonly used under the theoretical frameworks of Mindfulness-Based Stress Reduction (MBSR) 
(see Grossman, Niemann, Schmidt, & Walach, 2004) and Acceptance and Commitment Therapy 
(ACT) (see Dahl, Wilson, & Nilsson, 2004). 
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Mindfulness-based stress reduction.  Founded on Buddhist teachings, MBSR focuses on 
improving self-regulation via the daily practice of mindfulness meditation.  This form of meditation 
involves an active and deliberate process by which individuals learn to view their world through a 
detached lens, noticing aversive stimuli without trying to control them, whilst practicing self-
compassion and a non-judgemental approach (Greeson & Eisenlohr-Moul, 2014).  MBSR 
proponents assert that the detached stance of meditation allows individuals to distinguish between 
the physical sensations of pain and their cognitive and emotional responses to it (e.g., fear, 
catastrophizing) (Kabat-Zinn, 1982).  This altered awareness can diminish the threat response to 
pain; thereby reducing suffering.  Thus, unlike traditional CBT, MBSR focuses on changing an 
individual’s relationship to their emotions and cognitions, rather than their content. 
Acceptance and commitment therapy.  ACT emphasises the use of an ‘observer’ stance 
in order to increase psychological flexibility and value-driven behaviour.  Similar to MBSR, ACT 
encourages individuals to focus on noticing aversive experiences as they occur – without judgement 
or attempts to control – while continuing to behave in ways that are consistent with their values and 
goals (Kerns, Sellinger, & Goodin, 2011).  However, unlike MBSR, ACT does not view active 
meditation as the primary (or even necessary) vehicle by which this occurs.  Instead, the central 
goals of ACT are to reduce entanglement with cognitions (cognitive defusion) and foster forbearance 
in aversive situations by minimising avoidance and increasing tolerance for distress.  Moreover, it 
encourages individuals to be more connected with the present moment and actively strive for value-
driven goal attainment, despite the presence of pain.  ACT aims to foster an individual’s ability to be 
flexible in their response to aversive stimuli (psychological flexibility) and increase their willingness to 
experience pain in order to participate in valued pursuits (McCracken, Vowles, & Eccleston, 2004). 
ACT and MBSR have both been shown to improve mood, sleep, health-related quality of life, 
life satisfaction, pain, disability, HCU and sick leave (see Dahl, et al., 2004; Greeson & Eisenlohr-
Moul, 2014; Rosenzweig et al., 2010; Wicksell, Ahlqvist, Bring, Melin, & Olsson, 2008).  However, 
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the outcomes for mindfulness-based approaches have been found to vary between pain conditions 
and the extent to which people engage with their treatment (session attendance, completion of 
homework); with greater engagement leading to larger improvements (Rosenzweig, et al., 2010).  
Overall, acceptance and mindfulness approaches have been associated with small to medium 
improvements, which are comparable to those achieved with traditional CBT; with ACT leading to 
greater improvements than MBSR (McCracken & Vowles, 2014; Veehof, Oskam, Schreurs, & 
Bohlmeijer, 2011). 
1.8 Multidisciplinary Treatment for Chronic Pain 
As the clinical understanding of pain has evolved, so too have treatment approaches and 
these advances have seen dedicated pain clinics become increasingly more common.  Early pain 
clinics adopted a predominantly medical focus, mostly employing anaesthetists due to their 
experience with the relevant medications and procedures (e.g., nerve blocks).  Contemporary 
services, however, take a more multidisciplinary approach, employing psychiatrists, psychologists, 
pharmacologists, physiotherapists and nurses who work alongside medical practitioners (Benjamin, 
1989; Bonica, 1977).  Models of multidisciplinary care are now widely adopted in the pain sector, but 
they have varying approaches to staffing and treatment across clinics and between countries.  In 
1990, the International Association for the Study of Pain (IASP) released guidelines regarding the 
optimal characteristics of pain treatment centres in a bid to address these inconsistencies (IASP: 
Task Force on Guidelines for Desirable Characteristics for Pain Treatment Facilities, 1990).  
Specifically, it was recommended that clinics employ at least three different medical or health care 
specialists of sufficient breadth to adequately cover the biopsychosocial aspects of CP.  The 
centrality of psychosocial factors to the CP experience was strongly endorsed, with the guidelines 
also stating that, at a minimum, at least one staff member should be either a clinical psychologist or 
a psychiatrist. 
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Multidisciplinary clinics are now considered the gold standard for the management of 
complex CP conditions and are found in many developed countries (Scascighini, Toma, Dober-
Spielmann, & Sprott, 2008).  In fact, after a detailed review of the high-quality evidence regarding 
multidisciplinary treatment outcomes, it has been strongly recommended that individuals with 
intractable CP be referred to a multidisciplinary pain management program that has a solid 
foundation in psychological therapies (Chou et al., 2009).  Such programs have been shown to 
markedly improve a range of individual (e.g., physical function, mood, quality of life), societal (e.g. 
work engagement) and health system (e.g., emergency department presentations, hospital 
admissions, HCU) outcomes (see Gatchel, McGeary, McGeary, & Lippe, 2014).  However, despite 
the aspiration of using specialised pain clinics to facilitate timely access to high-quality care (Bonica, 
1977), contemporary pain clinics frequently remain plagued by long waitlists, poor treatment access, 
inadequate funding and inconsistent models of care (Hogg, et al., 2012); the impact of which forms 
the focus of this thesis.  
1.9 Summary 
CP is a common condition that negatively impacts on the functioning and well-being of a 
large portion of the population (Goldberg & McGee, 2011) and carries a significant burden for the 
world’s economy (Hoy, et al., 2014).  More than a purely physical experience, CP is now understood 
to be a complex combination of physical, psychological, social and behavioural factors (Gatchel, 
2004).  There is clear evidence that psychological factors play an important role in the CP 
experience and that psychological interventions aid in the management of this condition (e.g., 
Jensen & Turk, 2014; Morley, et al., 2013; Williams, et al., 2012).  However, much of the research 
literature is focussed on specific conditions (e.g., low back pain, arthritis), despite the fact that the 
majority of individuals living with CP either have no clear medical diagnosis for their pain and/or 
experience multiple comorbidities, thus limiting the generalizability of findings to this large group of 
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people.  Moreover, although multidisciplinary pain clinics are now available in many developed cities, 
the models of care used by these clinics differ and large numbers of people with CP experience 
lengthy waits to access treatment (Breivik, et al., 2006; Breivik, et al., 2013; Hogg, et al., 2012; Peng, 




Chapter 2 : Challenges for Policy and Practice – The Australian Context 
2.1 Overview 
The preceding chapter provided an epidemiological and theoretical overview of CP, 
discussed our current understanding of the condition, and explored psychological approaches to CP 
management, which are central to multidisciplinary care.  This chapter provides a background to the 
Australian health care system and discusses how CP is managed within it, before presenting the 
specific aims of the research that follows. 
2.2 Health Care in Australia 
Health care in Australia is provided by a combination of private and public services (for an 
overview see Duckett & Willcox, 2015).  Public services are coordinated under the Medicare 
scheme; a government-run initiative that affords all Australian citizens and permanent residents 
access to free inpatient admission (hospital stay) and treatment (e.g., generalist and/or specialist 
treatment, medication, blood tests, imaging) at public hospitals.  It also provides for a range of free, 
or subsidised, outpatient treatments (at public hospitals or medical clinics) with health professionals 
such as general practitioners, medical specialists, dentists, optometrists and allied health (Australian 
Bureau of Statistics, 2012b).  Medicare is funded through the taxation system, primarily via an 
income levy that is paid by all wage earners in this country (Biggs, 2016).  It is underpinned by the 
Medical and Pharmaceutical Benefits Schemes which are formal listings of the services/treatments 
(Medical Benefits Scheme) and prescriptions (Pharmaceutical Benefits Scheme) that are covered by 
Medicare, along with the scheduled fee that the government has determined is appropriate for each 
item. 
Australians also access health care via private services; most commonly when treatments 
are not available at public clinics, when individuals want to choose their own health care provider 
(which is not possible in the public system), or to avoid the often lengthy waits that are frequently 
Chapter 2: Challenges for policy and practice 
28 
 
associated with public clinics.  However, private treatment can involve additional ‘out-of-pocket’ 
expenses because Medicare rebates are lower for services offered in private hospitals (Medicare 
Benefits Schedule Review Taskforce, 2015) and private fees do not need to be tied to the Medical 
Benefits Scheme schedule, leaving practitioners free to determine their own rates. 
The costs of private health care can be partially offset by purchasing private health 
insurance, which itself is tiered, depending on what level of out-of-pocket expenses a person is 
prepared to pay.  The Australian Government offers an income-tested tax rebate to partially 
subsidise the cost of private health insurance premiums for low to middle income earners, in a bid to 
increase rates of health insurance cover within the community and reduce the drain on public health 
services (Australian Taxation Office, 2017).  Currently, around half of the Australian population is 
covered by private health insurance: 47% have purchased hospital (inpatient admission) cover and 
56% have general outpatient (community-based care) cover (APRA, 2017).  However, despite the 
government rebate, private insurance rates are lowest (33%) in areas of greatest social 
disadvantage (Australian Bureau of Statistics, 2013).  Lower socioeconomic status is also associated 
with disproportionately higher rates of health care needs (Armstrong, Gillespie, Leeder, Rubin, & 
Russell, 2007) and lower levels of discretionary income.  This, combined with the fact that health 
insurance premiums and health expenditure in Australia have almost doubled in the past decade 
(Australian Institute of Health and Welfare, 2014), has meant that private health care is too costly for 
many and so individuals are increasingly relying on the public system.  Accordingly, the remainder of 
this thesis will focus on treatments that are provided at no cost through the public health care 
system. 
2.3 Primary Health Care and Chronic Pain 
It is estimated that more than 25% of a general practitioner’s workload in Australian is CP 
related (Department for Health and Ageing, 2016), with individuals who have CP presenting for care 
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nearly five times as often as those without (Blyth, et al., 2004).  CP is also associated with increased 
rates of emergency department presentations and hospital admissions in this country; rates that 
increase exponentially with increased pain-related disability (Access Economics, 2007).  This is 
consistent with international data regarding the primary HCU of individuals with CP (Andersson, 
Ejlertsson, Leden, & Scherstén, 1999; Hasselstrom, Liu-Palmgren, & Rasjo-Wraak, 2002; 
Mantyselka et al., 2001).  For the majority of Australians, their pain management remains in the 
primary health care setting, with less than 0.2% accessing tertiary CP services (Semple & Hogg, 
2012).  Despite this, Australian general practitioners who have a specialist interest in CP remain 
scarce (Department for Health and Ageing, 2016). 
As noted, many public outpatient treatments in Australia are partially, or fully, subsidised by 
the Medicare scheme.  However, despite the demonstrated role of psychological therapies in 
ameliorating the negative impact of CP and improving the lives of people who are living with it 
(Eccleston, et al., 2009), publicly-funded community-based psychological services are limited.  
Under the Medicare ‘Chronic Disease Management’ scheme (refer Australian Government 
Department of Health, 2014), individuals with chronic health conditions can access up to a maximum 
of five publicly-funded community-based allied health sessions per calendar year, irrespective of the 
allied health discipline.  Although this includes psychology, evidence-based care for CP also 
recommends treatment from a range of other allied health professionals, such as physiotherapists 
(Semmons, 2016), occupational therapists (W. Hill, 2016) and dietitians (Brain et al., 2017).  Five 
sessions of allied health treatment per calendar year is, therefore, grossly inadequate to meet the 
health care needs of people with CP.  Moreover, the effectiveness of any intervention that is 
provided under this funding model may be limited by the fact that many community-based 
psychologists have inadequate training in the management of CP (Darnall et al., 2016; Fishman et 
al., 2013).  Reliance on the tertiary sector therefore remains high and, as will be shown, numerous 
publicly-funded CP services struggle to meet demand (Hogg, et al., 2012).  Consequently, many 
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people are never referred for tertiary service care (Department for Health and Ageing, 2016), 
rendering 80% of Australians with CP unable to access treatments that could improve their 
functioning and quality of life (Blyth, et al., 2001; National Pain Summit Initiative, 2011). 
2.4 Tertiary Health Care and Chronic Pain 
Multidisciplinary treatment is a widely endorsed model of care for the management of CP 
and is the foundation upon which tertiary CP services are designed (Pagé, Ziemianski, & Shir, 2017).  
Co-ordinated multidisciplinary interventions lead to a range of demonstrable clinical improvements 
across all three domains of the biopsychosocial model (e.g., Gatchel, et al., 2014; Guzman et al., 
2001; Haldorsen et al., 2002; Nicholas, 2008).  In Australia, it is estimated that there are 
approximately 26 public multidisciplinary CP services; with at least one in every state and territory of 
the nation (Hogg, et al., 2012).  Although models of care vary significantly between services 
(National Pain Summit Initiative, 2011), they can all be classified as Level 1 centres or Level 2 
clinics, because they provide interdisciplinary (integrated or co-ordinated multidisciplinary care) 
patient care, with Level 1 centres additionally participating in research and training activities (IASP, 
2009). 
With a population of over 24.7 million people (Australian Bureau of Statistics, 2018a), of 
which over four million are adults living with CP (Access Economics, 2007; Australian Bureau of 
Statistics, 2017), Australia has approximately one tertiary CP service for every 156,000 people who 
have the condition.  This, combined with poor access to affordable evidence-based care in the 
community, means that the clinical demand for tertiary CP services is very high and wait-times to 
access treatment are typically long.  Although these lengthy waits are often acknowledged by 
clinicians, they are grossly underestimated in the literature because the reported median waits often 
include individuals who have been triaged for rapid access (e.g., cancer and palliative patients).  
Hence, many published wait-times are in the order of seven to 231 days (Fashler et al., 2016), which 
Chapter 2: Challenges for policy and practice 
31 
 
is substantially lower than the two or more years that many Australians with CP experience (Hogg, et 
al., 2012).  The long actual wait-times experienced by many people with CP appear to be universal, 
with international data suggesting that waits of two years are common (Breivik, et al., 2006; Breivik, 
et al., 2013) and that this has extended to five years in some regions (Lynch et al., 2007). 
2.5 Current Challenges for the Effective Treatment of CP in Australia 
Despite the high incidence of CP and the significant burden that it places on individuals, 
communities and health services, access to appropriate treatment remains out of reach for many 
Australians.  The lengthy waits associated with tertiary CP clinics have direct implications for patient 
outcomes; with pain duration being negatively associated with return to work rates (Mallen, Peat, 
Thomas, Dunn, & Croft, 2007) and increased wait-times linked with poorer patient functioning and 
adjustment (Fogarty & Cronin, 2008).  In fact, significant deterioration in health-related quality of life 
and well-being has been postulated to occur even during the six months between referral and 
service provision (Lynch, et al., 2007).  Although there is an inverse relationship between wait-time 
and adjustment, there are no data to identify when this deterioration becomes significant or the 
impact of waiting longer than six months for treatment (Lynch et al., 2008). 
In fact, there is a paucity of research specifically targeting the impact of waiting for CP 
treatment on patient outcomes.  Instead, the extant waitlist research is typically focussed on 
treatment efficacy, rather than waiting, and involves participants who are either waiting for a 
surgical/invasive procedure or who have been recruited (often via advertisements) from community 
settings; both of which differ from treatment-seeking individuals who have been waitlisted for public 
CP services.  Moreover, waits for CP services are commonly ill-defined because waitlists are 
continually adjusted on the basis of updated clinical information and/or incoming triage demands, 
leaving many people with CP uncertain about when they will be able to access treatment.  This 
uncertainty has been linked with increased psychological distress, impaired concentration and 
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reduced life-engagement for indefinitely waitlisted individuals (Fogarty & Cronin, 2008); factors which 
can, in turn, impede effective management of the condition and lead to poorer patient outcomes.  
Lengthy indefinite waitlists are almost universally condemned (IASP: Task Force on Wait-Times, 
2010), but exactly when long becomes too long is unclear.  As such, health care decision-makers 
are currently unable to determine the true cost of their choices regarding resource allocation or the 
impact of delayed treatment. 
Drivers of Poor Access to Tertiary Chronic Pain Services 
The limited access to evidenced-based care that is experienced by many Australians with 
CP may be tied to a range of factors.  From a tertiary service perspective, the three most important 
drivers of access to treatment are the coding practices, funding models and staffing resources used 
by Australian public health care providers. 
Funding for Australian public health services is allocated via a complex algorithm that 
includes diagnosis-related groups (see Independent Hospital Pricing Authority, 2017).  Diagnosis-
related groups are used to code a range of clinical conditions and to collate data about prevalence, 
length of stay, clinical outcomes, treatment costs etc.  Accordingly, they drive the funding allocation 
and clinical focus of health services.  Prior to July 2017, CP was not included in the national list of 
diagnosis-related groups that was used by major public health agencies (Australian Consortium for 
Classification Development, 2017).  Instead, acute hospital presentations were coded according to 
the medical condition that was considered to be the primary source of the pain (e.g., cancer, 
arthritis), thereby overlooking the role of chronicity in the presentation (Commonwealth Department 
of Health and Aged Care, 1998) and poorly representing CP in Australian health data.  In the 
absence of an established mechanism by which to drive the collection of data to articulate the full 
extent of the problem, CP has been frequently overlooked in major Australian health care reform 
agendas. 
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Funding of evidence-based treatment for CP is similarly problematic under the Medical 
Benefits Scheme.  The Medical Benefits Scheme lists a range of medical procedures for the 
treatment of CP that the government has chosen to fund/subsidise; from imaging, through to 
invasive procedures (e.g., insertion of intrathecal pumps or spinal cord stimulators) and surgery 
(Department of Health, 2018).  Although some of these procedures are congruent with current 
evidence regarding best-practice treatment for the management of CP, many are not.  Conversely, 
the Medical Benefits Scheme does not currently include item numbers for a range of treatment 
options that are supported by the best-practice literature for CP, including multidisciplinary group 
programs and allied health interventions.  As such, it has been suggested that the current Medical 
Benefits Scheme schedule inadvertently supports perverse incentives, such as tying individuals to 
inappropriate, but affordable, procedures and encouraging clinics/practitioners to offer treatments on 
the basis of remuneration (Medicare Benefits Schedule Review Taskforce, 2015). 
Without data to demonstrate the extent to which CP underpins HCU and impacts treatment 
outcomes in this country, CP clinics will continue to struggle to secure sufficient funding to expand 
their services in line with clinical need.  Similarly, health service expenditure for the provision of 
evidence-based care will remain costly until the funding schedules for treatment services are tied to 
best practice guidelines.  A common approach to managing this tension is to align service provision 
with available resources; often involving strict clinical prioritization of new referrals.  Although fiscally 
prudent for health service managers in the short-term, this approach is frequently detrimental for 
patients because it exacerbates waiting periods, further hampering their access to timely treatments. 
An alternative approach is to tailor the available resources to clinical need.  However, 
despite considerable evidence to inform multi-disciplinary therapeutic guidelines for CP (e.g., Chan 
et al., 2011; Eccleston, et al., 2009; Hassett & Williams, 2011; Louw, Diener, Butler, & Puentedura, 
2011; Morley, Williams, & Hussain, 2008; Morlion, 2011), there are currently no data regarding the 
staffing resources that are required to effectively enact these treatments in tertiary clinical settings.  
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Thus, evidence-based resource design is currently not possible for these multidisciplinary CP 
services. 
Opportunities for Improvement 
Government-level improvements.  The Australian Government has recognised some of 
the current challenges to effective health care delivery and commenced efforts to address them.  
The first of these involved adding CP to the national diagnosis-related groups list, effective July 
2017.  Public hospital coders are now tasked with ensuring that accurate CP data is collected so that 
it can be used to inform future health reforms.  The second involved assembling a taskforce that has 
been charged with reviewing all Medical Benefits Scheme item numbers (> 5,700), with the aim of 
aligning the schedule to best-practice treatment guidelines (refer Department of Health, Australian 
Government http://www.health.gov.au/internet/main/publishing.nsf/content/mbsreviewtaskforce).  
Although needed, it will take time before the impact of these reforms is felt at a service level.  Until 
then, the onus is on health care providers to do what they can to improve treatment access for 
individuals living with CP. 
Service-level improvements.  The often treatment-resistant nature of CP means clinicians 
may employ a management, rather than curative, approach; similar to the chronic disease models 
used with conditions like diabetes (Deyo, Mirza, Turner, & Martin, 2009) and heart failure (McAlister, 
Stewart, Ferrua, & McMurray, 2004).  Models of chronic disease management are positioned within 
a framework of education, active self-management and health coaching from care providers, and 
emphasise the importance of this activity occurring within the primary health care setting (Dennis et 
al., 2008; Reynolds et al., 2018).  Unfortunately, as noted, primary health care in Australia is not 
currently well-positioned to deliver this model of care and so individuals with CP are frequently left to 
languish on tertiary service waitlists, with little assistance available between referral and 
appointment.  However, it has been suggested that tertiary services may be able to ameliorate this 
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treatment gap by providing some brief intervention to people while they are waiting for their CP clinic 
appointment (pre-clinic period) (Davies et al., 2011). 
One of the first models of pre-clinic education to be piloted in Australia was the Self-Training 
Educative Pain Sessions (STEPS) model, devised by the Pain Medicine Unit at Fremantle Hospital.  
Briefly, STEPS is a two day (or six session/eight hour) pre-clinic group program that was designed to 
educate patients about contemporary understandings of pain processes and promote active self-
management.  Three-month follow-up data indicated that, although STEPS did not impact patient 
mood, it did result in significant improvements in a range of other areas for both patients (i.e., 
improved self-efficacy, reduced disability, impression of change, greater use of strategies) and the 
service (i.e., reduced wait-times, service costs and need for individual follow-up appointments, and 
improved attendance rates and patient satisfaction with treatment) (Davies, et al., 2011). 
Numerous clinics around Australia have since incorporated pre-clinic education within 
routine intake processes.  Although the formats differ, all are based in the principles of increasing 
people’s understanding about pain processes and fostering active self-management.  For instance, 
Monash Health in Victoria runs the Pain Management Pre-Clinic Education (PACE) programme 
(refer http://monashhealth.org/services/services-o-z-monash-health/pain-clinic/); a two session 
intervention which takes a total of 5 hours.  An even briefer model is run by the Interdisciplinary 
Persistent Pain Centre in Queensland, where a 90 minute introductory session is offered as the first 
step in the Treatment Access Pathway (TAP: refer 
https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=373328).  However, this initial brief 
session is designed to be run in conjunction with a subsequent 5 hour group education and 
assessment session, and consequently, is positioned as an introduction that is augmented by the 
later session, rather than a stand-alone education session of independent merit.  A similar program 
is run by Hunter Integrated Pain Service in New South Wales (refer 
http://www.hnehealth.nsw.gov.au/Pain/Pages/Pain.aspx), where patients attend a 90-minute 
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introductory education session, followed by a 5-hour individual or group education and assessment 
program. 
Given the lengthy wait for services that is experienced by many people with CP, the idea of 
brief intervention at the point of referral is compelling.  However, despite considerable debate, 
optimal program intensity has yet to be determined for either pre-clinic or clinic interventions (British 
Pain Society, 2013; NSW Agency for Clinical Innovation, 2013).  One suggestion is that intensity 
should be proportional to the degree of disability (physical and psychological) experienced by an 
individual, with the most disabled requiring the most intensive input.  Other research, however, has 
indicated that even single brief education sessions can have a significant impact on the pain 
catastrophizing and fear (de Jong et al., 2005), physical performance (Moseley, Nicholas, & Hodges, 
2004) and return to work rates (Engers et al., 2008) of individuals living with CP.  Although brief 
education is offered by both the Interdisciplinary Persistent Pain Centre and Hunter Integrated Pain 
Service, the introductory sessions are positioned as part of a larger intake pathway, rather than as 
stand-alone sessions.  Thus, neither service has examined the specific impact of brief single-session 
pre-clinic education on patient outcomes (Smith, Jordan, White, Bowman, & Hayes, 2016; 
Vandermost, 2016).  As such, the clinical utility of this model has not been fully evaluated, nor have 
the service-related impacts of moving resources away from traditional care and, instead, investing 
them in pre-clinic activities. 
2.6 Summary 
The preceding two chapters indicate that CP is a common condition that is best 
conceptualised under a biopsychosocial framework.  There is clear evidence linking each part of this 
model with the experience of CP, but the relationships are complex.  For instance, although many 
aspects of the CP experience are physical in nature, CP frequently occurs in the absence of an 
identified physical pathology, leaving many individuals with no clear diagnosis for their pain.  
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Similarly, although emotion has been shown to influence CP, the diagnosis of psychological distress 
in this patient group is complicated by an overlap between the somatic symptoms of CP and 
psychological distress.  This makes attributing causality for symptoms challenging, impacting clinical 
definitions of distress and the interpretation of outcomes from diagnostic tools that have a high 
reliance on somatic items.  Moreover, the existing literature that explores the CP-psychological 
distress relationship has tended to focus on people who have specific pain diagnoses, despite the 
fact that the majority of individuals do not experience the condition in this way; instead having no 
clear diagnosis for their pain and/or multiple CP comorbidities (Blyth, March, & Cousins, 2003).  
Thus, a more global/general understanding of the psychological problems that are associated with 
CP is required; one that includes the majority of people with CP and better meets the needs of 
clinicians working with this group. 
Although associated with serious economic and life impacts, CP is not well-managed within 
the Australian health care system.  Private health care has become unaffordable for a large portion 
of the community and publicly-funded community-based services are insufficient to meet the needs 
of people who are living with CP.  Less than 0.2% of Australians with CP are able to access a 
publicly-funded multidisciplinary service (Semple & Hogg, 2012) and, when they do, many face very 
long indefinite waits for treatment.  Although an inverse relationship between wait-time and 
adjustment has been suggested, both the time-point at which clinically significant deterioration 
begins and the impact of waiting longer than six months are unknown (Lynch, et al., 2008).  Because 
waits for public multidisciplinary CP treatment commonly extend well beyond six months, long-term 
data is needed so that health care decision-makers can determine the true cost of their choices 
regarding resource allocation and the impact of delayed treatment. 
It is imperative that access to evidence-based treatment for CP is improved.  While funding 
reforms have commenced in Australia, the benefits will not translate to clinical practices for some 
time to come.  In the interim, the onus is on health service providers to explore ways that they can 
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increase treatment access for people with CP.  Two possible mechanisms by which to achieve this 
aim involve resource reallocation and/or service redesign.  However, it is not possible to consider 
reallocating resources within tertiary pain services until it is first understood what resources are 
currently available (amount and type of staffing).  Similarly, although pre-clinic education is now 
being widely adopted across Australian tertiary pain services, there is no consensus regarding the 
optimal amount or type of education that should be offered, or indeed the impact of providing this 
service. 
2.7 Aims of the Current Research 
Given the large number of people living with CP in this country, most of whom have mixed 
and/or unclear diagnoses for their pain, and the fact that many of them will experience lengthy waits 
to access treatment in a public multidisciplinary CP clinic, it is essential that clinicians and health 
care decision makers improve their understanding of the impact of these wait-times on patient 
outcomes and actively address ways to improve access to evidence-based care.  Thus, the broad 
aims of this research were: (a) to explore the psychological impact of living with CP and of waiting to 
access treatment (Studies 1 & 2); and (b) to document the existing staffing resources within 
Australian tertiary CP services because differences in waiting periods may be linked to differences in 
staffing (Study 3) and to trial a novel way of deploying existing staff resources in order to facilitate 
more timely service access and improve patient outcomes (Study 4).  
The specific aims of this research were: 
Study 1: To systematically document the psychological functioning of people living with CP 
from a broad, rather than diagnosis-specific, perspective in order to better inform 
clinical understanding of the majority of people with CP; that is, within the context of 
comorbidities, symptom variation and/or unclear diagnoses (Chapter 3).  To this end, 
a meta-analysis was conducted in order to synthesise a large body of research that 
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has used standardised assessment tools to examine the psychological functioning of 
adults with CP, relative to their healthy peers.  Specifically, this study: (a) compared 
and contrasted the psychological functioning of individuals with CP to that of healthy 
controls, and (b) identified those aspects of psychological well-being that were most 
negatively affected in people with CP. 
Study 2: To investigate the impact of a long indefinite wait for treatment on the psychological 
adjustment and HCU of individuals with CP (Chapter 4).  This involved conducting a 
longitudinal follow-up of over 330 people who were newly referred to a tertiary pain 
service.  Baselines were established across a range of outcome variables (pain-
related interference, pain severity, psychological distress, chronic pain acceptance, 
quality of life, HCU, medication impact and changes) at the point of referral and 
individuals were then prospectively followed-up at two months post-referral and then 
at six-monthly intervals until they received their first appointment.  Specifically, this 
study examined: (a) the impact of being on a long indefinite waitlist on the 
psychological adjustment and HCU of individuals with CP, (b) the potential mediating 
role of sex in determining the impact of waiting; and (c) whether there was a critical 
period following which outcomes noticeably worsened. 
Study 3: To describe and systematically examine staffing profiles (amount and disciplines) in 
Australian tertiary CP services, while taking into account the associated levels of 
clinical activity, in order to better understand and predict clinical resource needs, 
thereby providing important benchmark data to inform future service design and 
delivery (Chapter 5).  Utilising data from the ‘Waiting in Pain’ survey conducted by the 
Australian Pain Society, this study compared staffing (medical, nursing, psychiatry, 
psychology, physiotherapy, occupational therapy, administrative) across tertiary CP 
services in Australia.  The specific aims were to (a) explore state-based staffing ratios 
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as a function of clinical activity, (b) compare these ratios across all Australian 
states/territories, and (c) examine the allied health staffing requirements used by 
clinics to provide a pain management group program. 
Study 4: To assess the ability of a brief pre-clinic intervention, delivered at the point of referral, 
to enhance outcomes for individuals waiting to access a tertiary CP service (Chapter 
6).  Using a randomised controlled design, new referrals were allocated to either a 
‘treatment as usual’ (TAU: waitlist only) or ‘experimental’ condition (EXP: waitlist 
PLUS attendance at a three-hour educational session, delivered by a multidisciplinary 
team of experts).  Participants were assessed at intake and followed up at two weeks 
and six months after attending the session (or equivalent for TAU group).  The 
intervention was designed to provide individuals with information and strategies that 
they could utilise while waiting for their appointment and, as such, was expected to 
improve psychological well-being and quality of life for those who attended the 
session, compared with those who did not.  A secondary aim was to explore the 




Chapter 3 : Chronic Pain and Psychological Functioning 
3.1 Preamble 
The previous review highlighted the fact that a very large number of people with CP do not 
have a clear diagnosis for their pain and/or experience multiple comorbidities (e.g., diagnosed with 
arthritis, chronic fatigue syndrome and chronic low back pain).  Despite this, much of the research 
examining the impact of CP on psychological functioning has focused on specific 
conditions/diagnoses (e.g., arthritis, back pain), with the applicability of these findings to the wider 
CP cohort being unclear.  It is therefore important to gain a better understanding of the impact of CP 
on the psychological functioning of this broader group. 
As such, this first study meta-analysed research that had examined the psychological 
functioning of people living with CP and compared it to that of their healthy peers.  Importantly, it 
took a general, rather than a diagnosis-specific, perspective in order to capture the outcomes of the 
majority of people with CP who are seen in tertiary pain clinics. 
Tables and Figures have been inserted within the text to make it easier for the reader, but 
supplementary information is presented in Appendix 1 at the end of this thesis.  The specific 
contents of Appendix 1 are as follows:  
 Detailed search strategies for each database (Supplementary Table 3.A), 
 Summary demographic information for each of the individual meta-analysed studies 
(Supplementary Table 3.B), 
 A list of the psychological domains and what studies examined each of these domains 
(and the specific test/measure that they used) (Supplementary Tables 3.C - 3.G),  
 Cohen’s d effect sizes for each psychological domain, overall and broken down by 
specific measure (Supplementary Figures 3.A - 3.E),  
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 A numbered reference list of all included studies (Appendix 1.3) that cross-references to 
Supplementary Tables 3.B - 3.G and, 
 A copy of the published article, reproduced with permission (Appendix 1.4). 
 
All of the references cited within this chapter are provided as part of a complete references 
list at the end of this thesis. 
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Objectives: Chronic pain (CP; >3 months) is a common condition that is associated with significant 
psychological problems.  Many people with CP do not fit into discrete diagnostic categories, limiting 
the applicability of research that is specific to a particular pain diagnosis.  This meta-analysis 
synthesised the large extant literature from a general CP, rather than diagnosis-specific, perspective 
in order to systematically identify and compare the psychological problems most commonly 
associated with CP. 
Methods: Four databases were searched from inception to December 2013 (PsychInfo, Cochrane, 
Scopus, PubMed) for studies comparing the psychological functioning of adults with CP to healthy 
controls.  Data from 110 studies were meta-analysed and Cohen’s d effect sizes calculated. 
Results: The CP group reported experiencing significant problems in a range of psychological 
domains (depression, anxiety, somatisation, anger/hostility, self-efficacy, self-esteem and general 
emotional functioning), with the largest effects observed for pain anxiety/concern and somatisation; 
followed by anxiety and self-efficacy; then depression, anger/hostility, self-esteem and general 
emotional functioning. 
Conclusions: This study demonstrates, for the first time, that individuals with CP are more likely to 
experience physically-focussed psychological problems than other psychological problems and that, 
unlike self-efficacy, fear of pain is intrinsically tied to the CP experience.  This challenges the 
prevailing view that, for individuals with CP, problems with depression are either equal to, or greater 
than, problems with anxiety; thereby providing important information to guide therapeutic targets. 
  




Approximately 20% of the world’s population experiences persistent or chronic pain (CP) 
(Goldberg & McGee, 2011) - pain that occurs on most days for three or more months (IASP: Task 
Force on Taxonomy, 1994).  With low back pain now the largest contributor to global disability (Hoy, 
et al., 2014), CP has been shown to negatively impact on many areas of life, including work 
attendance and productivity (W. F. Stewart et al., 2010), physical function and quality of life 
(Douglas, et al., 2004), engagement in social or recreational activities (Haythornthwaite & Benrud-
Larson, 2000), and medication and health-service usage (Blyth, et al., 2004; Douglas, et al., 2004). 
The subjective experience of pain involves a complex interplay between physical, 
psychological and environmental variables (Flor & Hermann, 2004; Nicholas, 2008).  Consequently, 
many studies have examined the psychological aspects of CP, with research consistently 
demonstrating that psychological problems are common in people with this condition (Dersh, et al., 
2002).  Whereas American data indicate that CP is associated with comparable rates of anxiety and 
depression (Von Korff et al., 2005), Australian data suggest that depression and adjustment 
disorders are more common (Access Economics, 2007). 
Numerous aspects of psychological functioning may impact on, and be affected by, an 
individual’s experience of CP including, but not limited to, mood (e.g., depression, anxiety, stress), 
feelings of self-mastery (e.g., self-efficacy, self-esteem), attributions about responsibility (e.g., guilt, 
shame) and grief/loss.  Although these have been explored to varying degrees in the CP literature, 
most research has focussed on depression and anxiety.  Similarly, research has tended to focus on 
specific diagnoses, such as neuropathic pain (Attal, et al., 2011) and fibromyalgia (Homann, et al., 
2012); or on specific subgroups, such as older people (Falsarella, et al., 2012) and trauma survivors 
(Peterlin, et al., 2009). This focus on specific diagnoses/subgroups is limiting because many people 
with CP do not have a clear diagnosis or precipitant for their pain.  Indeed, one survey found that 
65% of people had no clear medical diagnosis for their CP and 33% identified no clear precipitant 
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(Blyth, March, & Cousins, 2003).  Moreover, CP is associated with a large number of different 
medical diagnoses, not all of which have been well-researched, and many people with CP 
experience a range of medical and psychological comorbidities that are not specific to a particular 
CP diagnosis or subgroup. 
Thus, while it is undeniably important to understand CP from these specific perspectives, 
especially where CP is known to be associated with syndrome-specific sequelae (e.g., cancer 
(Urbaniec, Collins, Denson, & Whitford, 2011), spinal cord injury (North, 1999)), a more global 
understanding of the psychological problems that are associated with CP is also needed; one that 
includes the majority of people with CP and better meets the needs of clinicians working with this 
group.  Therefore, this study sought to meta-analyse all quantitative research that used standardised 
assessment tools to examine the psychological functioning of adults with CP (including specific and 
non-specific CP diagnoses), relative to their healthy peers. We sought to synthesise this very large 
literature in order to provide a better clinical understanding of the CP experience and the underlying 
evidence-base.  Self-report measures of emotional functioning were targeted because they are the 
most frequently used method of assessment in the literature and are also commonly used in clinical 
practice. 
3.4 Materials and Method 
Literature Search 
Information sources.  Four databases (PsychInfo, Scopus, PubMed and The Cochrane 
Library) were searched for studies that examined the psychological functioning of individuals with 
CP, published prior to 2014. The searches included singular and plural forms of each term, and 
regional variations in spelling (e.g., behaviour/behavior) (see Appendix 1 - Supplementary Table 3.A, 
for search terms).  The initial search was very broad in order to ensure that all relevant papers were 
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identified because CP is an umbrella term that encompasses a variety of labels, is attributed to a 
range of conditions and has been examined by a number of disciplines. 
Eligibility criteria.  Studies were only included in the current meta-analysis if they met the 
following criteria: they recruited a chronic pain sample that (a) was aged ≥16 years (commonly-used 
age for adult pain services) and (b) experienced CP – specifically defined as pain on most days for a 
period of ≥ 3 months; and the study (c) included a healthy control group that was matched to the CP 
group; (d) investigated the psychological functioning of both groups utilising standardised self-report 
assessment tools; (e) was published in English and documented original quantitative research 
(excludes reviews); (f) was not a case study (n > 1); and (g) provided data in a format that permitted 
the calculation of Cohen’s d effect sizes (e.g., mean and SD, t-statistic or exact p-value).  
Medical and psychiatric conditions that have syndrome-specific sequelae, and therefore 
require separate consideration, were excluded because the aim was to examine the general CP 
experience.  Specifically, excluded conditions were: (a) spinal cord injuries; (b) particular medical 
disorders/conditions (e.g., cancer, cardiac, renal); (c) neurological disorders (e.g., stroke, traumatic 
brain injury); (d) terminal/palliative conditions; (e) psychiatric conditions (e.g., factitious disorder, 
psychosis); and (f) personality disorders.  Studies examining acute pain onset and/or tolerance were 
similarly excluded, because the current study was designed to examine people living with CP. 
Study appraisal and selection.  Critical appraisal and eligibility assessment were 
performed by the primary author (ALJB).  If there was any ambiguity, papers were independently 
appraised by the full panel of authors and eligibility determined by consensus, following group 
discussion.  If it was not possible to definitively determine eligibility based on the available 
information, clarification was sought from the corresponding authors.  If no response was obtained, 
that study/variable was excluded from analysis.  Where data for the same sample were reported in 
multiple papers, the paper with the largest sample was included.  Matching of the CP and healthy 
control groups was a key factor in the critical appraisal of studies as it served to minimise extraneous 
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between-group differences, thereby increasing confidence in the validity of the results.  CP and 
healthy control groups were deemed to be matched if there was either a deliberate attempt to match 
groups on at least one demographic variable (e.g., age, sex) or post-hoc analyses indicated that 
groups were demographically comparable.  Studies that did not meet either of these criteria for 
matching were excluded from the meta-analysis.  Similarly, all studies were required to use 
standardised assessment tools to ensure only good quality studies were included.  The scope and 
size of the current study precluded more detailed qualitative evaluation and rating of individual 
studies.  However, both the application of strictly defined eligibility criteria and the weighting of data 
by the inverse variance (Lipsey & Wilson, 2001), served to minimise the potential impact of poor-
quality empirical studies. 
Data Extraction and Organisation of Studies 
Data relating to: the study (e.g., sample size, country), participants (e.g., age, sex, race), 
pain (e.g., diagnosis/location, duration) and the measures of psychological functioning (test, scoring 
method and direction, means and SDs, or exact t- or p-statistics) were extracted from each study via 
a detailed data extraction form.  As different aspects (e.g. cognitive, emotional, somatic) of 
psychological functioning have been assessed by a large number of alternative measures, the most 
meaningful way to explore the data was to group measures on the basis of psychological domains 
(e.g. depression).  Different measures varied in their focus, assessing either positive or negative 
mood-states, consequently scores were re-scaled where necessary (sign inverted but scores 
unchanged) so that they could be consistently interpreted.  For positive domains (self-esteem and 
self-efficacy), higher scores indicated better outcomes.  For all other domains, higher scores 
indicated greater psychological distress (poorer outcomes).  In all cases, positive effects indicated 
greater levels of the domain in the control group and negative effects indicated greater levels in the 
CP group.  Thus, for depression, a positive effect indicates greater depression in the control group, 
whereas a negative effect indicates the CP group are more depressed. 




Data were analysed using the ‘Comprehensive Meta Analysis’ program (Borenstein, 
Hedges, Higgins, & Rothstein, 2005).  Where a study recruited multiple CP and/or control groups 
and reported data separately, scores were pooled to provide an overall score for each group (CP, 
controls).  If studies provided multiple scores for a single domain (e.g. more than 1 depression 
score), a mean effect was calculated; thereby ensuring that each study only contributed a single 
score to the overall mean when the effect sizes from different studies were averaged (Lipsey & 
Wilson, 2001).  Information relating to pain-related litigation and socio-economic status were 
collected to evaluate whether these variables acted as moderator variables, however, there were 
insufficient data to analyse these relationships.  Similarly, although active treatment-seeking may 
have reflected an important difference between the CP groups (treatment-seekers may have had 
more severe conditions and/or comorbidities, and more psychological problems), this could not be 
examined because it was frequently unclear whether samples recruited from non-treatment settings 
were receiving care.  Thus, any analysis of recruitment source was unlikely to be reliable or 
informative. 
The effect size used in the current analysis was Cohen’s d (Cohen, 1988); providing a 
measure of the standardised difference between the means for the CP and control groups.  Effect 
sizes were interpreted using Cohen’s (Cohen, 1988) guidelines, with d = 0.2, 0.5 and 0.8 indicating 
small, medium and large effects, respectively.  Consistent with Hopkins and colleagues (Hopkins, 
Marshall, Batterham, & Hanin, 2009), d = 2.0 and 4.0 were labelled very large and extremely large 
effects. 
Heterogeneity analyses, using the I2 statistic, were performed to assess whether differences 
in the effect sizes from individual studies reflected chance-based sampling differences 
(homogeneous effects) or additional sources of variance, possibly reflecting methodological 
differences between studies (heterogeneous effects).  As might be expected, given CP was 
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examined from a general, rather than diagnosis-specific, perspective, many of the heterogeneity 
analyses (I2) were significant (I2 > 50); indicating substantial variability in the findings.  Therefore, a 
more conservative random-effects model was used instead of the traditional fixed-effects model 
(Higgins, Thompson, Deeks, & Altman, 2003).  The latter assumes a ‘true’ effect that is common 
across all studies, while a random-effects model assumes that there are differences between studies 
(e.g., samples and/or diagnoses).  In addition, when calculating mean effects, individual effects were 
weighted by the inverse of their variance in order take into account differences in the precision of the 
effect size estimates obtained from different studies (Lipsey & Wilson, 2001). 
Ninety-five percent confidence intervals (95% CIs) were calculated to test whether the 
population mean group difference differed significantly from zero; indicated by a CI that does not 
span 0.  Finally, fail-safe N’s (Nfs) were calculated to examine the impact of publication bias on the 
results obtained: Nfs indicating the number of unpublished studies with non-significant findings that 
would be required to render the current results insignificant (Zakzanis, 2001).  Calculations were 
based on the formula outlined by Lipsey and Wilson (2001), using a 0.2 (small effect) (Orwin, 1983).  
A Nfs was considered adequate if it was larger than the number of studies meta-analysed for a given 
measure. 
3.5 Results 
After removal of duplicate records, the initial search identified 11,211 records, for which the 
title and abstracts were assessed against the inclusion criteria by the first author (ALJB).  This initial 
review excluded 10,525 articles because they failed to meet the specified criteria (see Figure 3.1).  
Full-text versions of the remaining 686 articles were then sourced and the contents systematically 
evaluated against the inclusion/exclusion criteria.  Following thorough review, 110 papers were 
retained and their data extracted and meta-analysed. 
  





















































Figure 3.1: PRISMA flow diagram of study selection process 
   



























686 full text articles assessed 
for eligibility 
10525 records excluded: 
- unpublished (n=120) 
- not original research (n=68) 
- off topic (n=2391) 
- review articles (n=1022) 
- specific medical conditions 
(n=1941) 
- no representative healthy 
control group / not target 
population (n=4974) 
- descriptive studies (n=9) 
14725 records identified 
through database searching 
3514 duplicates removed 
110 studies included in meta-
analysis 
576 full-text articles excluded: 
- off topic (n=180) 
- no representative healthy 
control group / not target 
population (n=146) 
- used study specific measures 
(n=16) 
- data not reported in format 
consistent with inclusion 
criteria (n=226) 
- repeated sample (n=7) 
- article unable to be sourced 
(n=1) 




All studies were published between 1986 and 2013, with most published in the past 13 years 
(n = 86, 78%).  The final sample comprised 67,554 participants (CP + controls), aged 17 to 102 
years, most of whom were female (n = 30,981, 57%).  As seen in Table 3.1, few studies provided 
information relating to relationship and employment status, education, ethnicity, BMI and, 
surprisingly, pain duration (see Appendix 1 - Supplementary Table 3.B for demographic/background 
details for individual studies).  Some studies provided data in a format that did not permit between-
study comparisons (e.g., categorical data for age).  Where reported, the majority of participants were 
Caucasian, married/partnered, had some form of employment and had completed secondary 
schooling.  The CP group had experienced pain for one to 15 years (M = 8.0 years, SD = 3.7).  Most 
studies originated from Europe or America, explored mixed pain conditions, examined deliberately 
matched samples, and recruited their CP group from treatment settings and controls from the 
general community (see Table 3.1). 
Psychological Function 
Although there are many forms of psychological functioning that may be relevant to CP, the 
areas found to be most commonly examined by researchers were depression and anxiety (general 
and pain-related) and, to a lesser degree, somatisation, anger/hostility, self-efficacy, self-esteem and 
general emotional functioning (overall mental/emotional health, perceived stress) – thus, subsequent 
analyses focussed on these areas.  The mean effects for each domain are summarised in Figure 
3.2.  As can be seen, there were moderate to large, significant and robust differences in the 
psychological functioning of persons with CP, relative to their healthy peers, in all areas.  Moreover, 
the limited overlap in the CIs indicates that there were significant differences in the extent to which 
many of these domains were affected. 
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Table 3.1:  Summary demographic information for the included samples and studies 
 Chronic Pain Healthy Controls 









 Not married/partnered 
Employment status 
 Employed 
 Not employed 
Years of education * 
Ethnicity 
 White 
 Not White 
Body Mass Index (BMI) * 
Pain duration (years) * 
 
25084  (37) 
45.6  (11.0) 
 
6901  (36) 
12318  (64) 
 
6514  (63) 
3775  (37) 
 
1372  (64) 
780  (36) 
12.7  (3.3) 
 
7220  (76) 
2339  (24) 
27.0  (1.3) 




















42470  (63) 
44.4  (11.1) 
 
16375  (47) 
18663  (53) 
 
5809  (62) 
3587  (38) 
 
1845  (71) 
753  (29) 
13.7  (3.4) 
 
6928  (69.7) 
3010  (30.3) 































 Pelvic / abdominal 







 Not matched 
 Not reported  
Recruitment source 
 Treatment seeking 
 Community-based 
 Primary care 
 Mixed 
 Students 




48  (44) 
46  (42) 
9  (8) 
6  (5) 
1  (1) 
 
44  (40) 
16  (15) 
12  (11) 
12  (11) 
8  (7) 
7  (6) 
7  (6) 
3  (3) 
1  (1) 
 
75  (68) 
31  (28) 
4  (4) 
 
58  (53) 
17  (15) 
4  (4) 
20  (18) 
3  (3) 
6  (5) 

















































3  (3) 
55  (50) 
8  (7) 
13  (12) 
3  (3) 
21  (19) 


























































Note. CP = chronic pain; HC = healthy control; Nfs = Failsafe N’s; I2 > 50 indicates significant heterogeneity. 
 
Measure Nstudies Sample size Cohen’s 95% CI Nfs I2 



















































































Greater domain scores 
Chronic Pain 
Greater domain scores 
Health Controls 
Greater domain scores 
Chronic Pain 
Greater domain scores 
Healthy Controls 




Depression was the most commonly assessed area of psychological functioning (Nstudies = 
82, see Appendix 1 - Supplementary Table 3.C and Supplementary Figure 3.A), with the majority of 
studies (n = 77) using one of 14 measures.  Only five studies used multiple measures.  The most 
frequently used measure was the Beck Depression Inventory (BDI; Nstudies = 33, 40%) (Beck, Ward, 
Mendelson, Mock, & Erbaugh, 1961), followed by the Centre for Epidemiological Studies Depression 
scale (CES-D) (Radloff, 1977) and the Hospital Anxiety and Depression Scale (HADS-D) (Zigmond 
& Snaith, 1983).  Although the overall mean effect for depression was moderate (d = -0.46) (see 
Figure 3.2), there was considerable variation between the effects for different measures.  However, 
with the exception of the Kessler Psychological Distress Scale (K-10) (Kessler et al., 2003), which 
was only used by one study and had an unsatisfactory Nfs statistic, all effects were moderate to very 
large.  Moreover, they were significant and negative, indicating consistently higher levels of 
depression in the CP group. 
Anxiety 
Anxiety was examined by a total of 40 studies (see Appendix 1 - Supplementary Table 3.D 
and Supplementary Figure 3.B); 36 of which used a single measure of anxiety, while others used two 
scales.  The HADS-A was the most commonly used measure, reported in 12 studies, followed by the 
State Trait Anxiety Inventory (STAI-S, Nstudies = 8) (Spielberger, Gorsuch, Lushene, Vagg, & Jacobs, 
1983).  Across all measures, the CP group showed consistently higher levels of anxiety than the 
controls (negative d), resulting in a large and significant overall mean effect for this construct (d =      
-0.82) (see Figure 3.2).  Significant moderate to very large effects were found for the majority of 
measures; with the two exceptions having unsatisfactory Nfs statistics, raising concerns about the 
reliability of those findings. 




‘Pain anxiety/concern’ comprised measures assessing catastrophizing, fear of 
pain/movement and pain anxiety.  In total, 18 studies investigated various aspects using 15 different 
measures (see Appendix 1 - Supplementary Table 3.E and Supplementary Figure 3.C); most 
commonly the Pain Catastrophising Scale (PCS) (Sullivan, et al., 1995), with total and/or subscale 
scores being reported by 10 studies (56%).  Twelve studies employed a single measure of pain 
anxiety/concern, while the remainder used two, three or six scales (Nstudies = 3, 2, 1, respectively).  A 
large overall mean effect (d = -1.15) was found for this construct (see Figure 3.2), with most 
measures returning large to very large and significant effects.  Of note, the only measure to yield a 
small and non-significant effect for pain anxiety/concern - the Fear of Pain Questionnaire (FPQ-III) 
(McNeil & Rainwater, 1998) - was only used in a single small-scale study.  Moreover, unlike other 
measures that examine fears relating to the specific CP experience (e.g., it will make my back pain 
worse), the FPQ-III explores fear of pain in relation to a range of activities (e.g., gulping a hot drink 
before it has cooled), none of which are specifically tied to CP. 
Somatisation 
Somatisation was assessed in 16 studies using eight measures (see Appendix 1 - 
Supplementary Table 3.F and Supplementary Figure 3.D); the most common being the somatisation 
subscale of the Revised Symptom Checklist-90 (SCL-90-R-S; Nstudies = 6) (Derogatis, 1994).  The 
overall effect for somatisation was large, negative and significant (d = -1.2) (see Figure 3.2), 
indicating that the CP group consistently reported higher levels of somatisation than controls.  With 
the exception of the Wahler Physical Symptom Inventory (WPSI) (Wahler, 1968), which had a 
moderate and significant effect that was susceptible to publication bias, all other measures revealed 
large and significant effects. 




Eight studies explored anger/hostility using four different measures (see Appendix 1 - 
Supplementary Table 3.F and Supplementary Figure Chapter 3.D).  Two studies used multiple 
measures.  While the overall effect for this domain was moderate (d = -0.38) (see Figure 3.2), there 
was marked variability in the range and significance of findings for individual measures.  
Interestingly, while the largest effect was found using the Brief Symptom Inventory (BSI-H) 
(Derogatis & Melisaratos, 1983), its longer counterpart (SCL-R-90-H) yielded non-significant results 
(p = 0.125).  Non-significant results were also found for the State-Trait Anger Expression Inventory 
(STAXI-AE) (Spielberger, 1988) (p = 0.463).  Of note, the findings for these latter two measures were 
susceptible to publication bias (Nfs < Nstudies).  Overall, the findings lacked consistency, suggesting 
that the relationship between anger/hostility and CP is unclear. 
Self-Efficacy 
Self-efficacy was examined by four studies, with one using multiple measures in order to 
examine both general and pain-related self-efficacy (see Appendix 1 - Supplementary Table 3.F and 
Supplementary Figure 3.D).  Not surprisingly, there was a large and significant difference (d = 0.96) 
between the self-efficacy levels of CP patients and their healthy peers, with the CP group showing 
substantially less confidence in their ability to bring about change and demonstrate mastery in their 
lives (see Figure 3.2).  When the specific measures were considered, although not significant, the 
between-groups difference for pain-related self-efficacy, as measured by the Pain Self-Efficacy 
Questionnaire (PSEQ) (Nicholas, 2007), was considerably larger (d = 1.12) than that found for the 
more general measures of self-efficacy (General Self-Efficacy Scale; GSES, d = 0.64) (Schwarzer & 
Jerusalem, 1995) or life control (Multidimensional Pain Inventory Life Control subscale; MPI-LC, d = 
0.80) (Kerns, Turk, & Rudy, 1985).  Thus, as might be expected, while the pain group consistently 
reported lower levels of self-efficacy than did controls, they indicated feeling somewhat better able to 
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exert control over their life in general, than they did to exert control over the pain itself and their 
ability to function in its presence. 
Self-Esteem 
Self-esteem was examined by three studies using one of two measures (see Appendix 1 - 
Supplementary Table 3.F and Supplementary Figure 3.D).  Overall, a moderate and significant 
positive effect (d = 0.44) was found (see Figure 3.2).  Although the total sample used to explore this 
construct was limited (CP: n = 146, Controls: n = 162) compared to other domains, these results 
suggest that healthy controls consistently reported having more positive feelings about themselves 
and their overall self-worth, than did the CP group. 
General Emotional Functioning 
Finally, general emotional functioning (sometimes conceptualised as distress) - a more 
global construct - was examined by 36 studies (see Appendix 1 - Supplementary Table 3.G and 
Supplementary Figure 3.E).  Most of the 14 measures of this domain were used by between one and 
four studies, the exception being the Mental Health subscale of the 36 item Short-Form Health 
Survey (SF-36-MH) (A. L. Stewart, Hays, & Ware, 1988), which was used by over 50% of studies.  
After inversing the effect sizes for specific scales (SF-12, SF-20, SF-36, Profile of Mood States: 
POMS (McNair, Lorr, & Droppleman, 1992), World Health Organisation Quality of Life Assessment – 
Brief: WHOQOL-BREF (Hawthorne, Herrman, & Murphy, 2006)) so that they all measured 
impairment in psychological functioning (rather than positive mood), the weighted overall effect for 
this domain was moderate and significant (d = -0.54), indicating that the CP group consistently 
reported experiencing greater levels of emotional distress than healthy controls (see Figure 3.2).  
The effects for individual measures varied greatly (d = -0.04 to d = -3.85), with very low Nfs statistics 
indicating that the results for four measures were vulnerable to publication bias. 




Life with CP is a complex experience that cannot be adequately understood in purely 
physical terms or reduced to neat diagnostic groupings.  Therefore, it is important that clinicians, 
planners and policy-makers understand the psychological aspects of the CP experience from a 
general perspective because comorbidities, symptom variation and/or unclear diagnoses confound 
interpretations of diagnosis-specific CP research.  Consequently, this meta-analysis was designed to 
synthesise the large CP literature from a broad perspective in order to systematically document the 
psychological functioning of people living with CP. 
Our search of the CP literature revealed a substantial amount of research using diverse 
constructs and measures to examine a range of different psychological domains; particularly in 
recent years.  Compared with controls, the CP group consistently reported experiencing significant 
and substantial problems in all aspects of psychological functioning.  Not surprisingly, the greatest 
impact was on those domains that are directly tied to the physical experience of pain; namely pain 
anxiety/concern and somatisation.  One measure of general emotional functioning (BSI) was also 
particularly compelling because a finding of this magnitude indicates almost no overlap (<3%) 
between the scores of CP and healthy individuals on this measure (Zakzanis, 2001). 
Although somatisation was associated with the largest group difference (effect size), this 
result is somewhat difficult to interpret because the term is used inconsistently throughout the 
literature.  For instance, in their recent meta-analysis of somatic symptoms, Zijlema and colleagues 
(2013) interpret somatisation in two quite different ways: the tendency to (a) report/emphasise 
physical symptoms in the absence of, or to a greater extent than would be expected by the, identified 
organic pathology; and (b) “experience and communicate somatic distress in response to 
psychosocial stress” (p 459).  Using the first interpretation, it is not surprising that people with CP 
showed significantly elevated rates of somatisation: CP is not purely a physical experience and 
commonly lacks clear organic causes.  Further, the range of comorbidities often experienced with 
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CP may impact scores on these scales.  However, the second interpretation suggests something 
different: that individuals living with CP are more likely to experience emotional distress in physical 
ways, possibly due to a heightened tendency to notice (and respond to) physical sensations, 
especially ones that are directly related to their pain.  The current analysis does not distinguish 
between these alternative interpretations. 
Overall, our findings confirm that CP is associated with a range of impairments in 
psychological functioning.  However, they do not support the assertion that depression is the most 
commonly experienced problem.  Instead, we found that, although individuals with CP were 
consistently more depressed than their healthy peers, they were comparatively more anxious (see 
Figure 3.2) – both in general and in response to pain.  Similarly, self-efficacy was also found to be 
broadly affected across general and pain-related areas.  However, of note, the elevated levels of 
pain anxiety/concern found in the CP group were specifically tied to the CP experience – although 
the CP group was understandably anxious about exacerbating their condition, they were not more 
anxious about general pain experiences (e.g., hitting your head). 
If an adjustment disorder is defined as a larger-than-expected emotional response (of mixed 
symptomatology) that impairs a person’s ability to cope with a stressful experience or significant life 
change (World Health Organisation, 1990), it could be argued that many of the domains considered 
here fall into this broad category.  However, it is not possible to comment more definitely here about 
the frequency of adjustment disorders in CP because researchers have rarely assessed ‘adjustment 
disorders’, per se.  Rather, our current findings suggest that, of the psychological domains that were 
assessed, physically-orientated problems (somatisation, pain anxiety/concern) are greater than 
depression and general impairments in emotional functioning. 
It is well documented that the physical symptoms of CP overlap with the symptoms of 
depression; so much so that an accurate diagnosis of this type of mood disorder can be challenging 
in a CP setting (Cheatle, 2011; Wong et al., 2011).  Indeed, it is possible that this overlap in 
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symptoms made it difficult for individuals to determine the origin of their symptoms when completing 
the self-report scales.  However, this is unlikely to explain why the CP group were comparatively less 
depressed than they were anxious, for two reasons.  First, the measures do not ask respondents to 
identify the cause of their symptoms – they merely ask them to indicate whether they experience 
those symptoms – which should have resulted in higher depression scores (symptoms would be 
reported, irrespective of cause) and narrowed the difference between depression and anxiety.  
Second, measures that had fewer somatic items (e.g., HADS, Depression Anxiety and Stress Scale: 
DASS (Lovibond & Lovibond, 1996)) did not yield noticeably smaller effects than scales with higher 
somatic content (e.g., BDI).  This suggests that, contrary to current clinical thinking, the level of 
somatic content in the measures did not have a major impact on the results. 
With that in mind, there are a number of limitations to this study that warrant consideration.  
First, research has been inconsistent in its terminology and operationalization of various 
psychological domains (e.g., somatisation, anger/hostility), making it difficult to interpret some of the 
current findings and indeed, to select appropriate search terms (e.g. disease versus illness).  
Second, the study size precluded detailed qualitative evaluation of individual studies to exclude 
sources of potential bias other than publication bias, sample inconsistency and low quality 
assessment.  Third, because this study focussed on the adult CP population from a general 
perspective, results may be less applicable to specific groups, especially those with syndrome-
specific sequelae.  Similarly, this study focussed exclusively on self-report measures.  Further 
research examining specific cohorts (e.g. older people, children, indigenous populations) and other 
methods of mood assessment (e.g. ICD-10 diagnosis) is now needed.  Moreover, we are unable to 
comment on whether the identified difference predated or resulted from the CP due to the research 
designs of the original studies.  Such information could help improve our understanding of the factors 
that may pre-dispose and/or protect individuals from transitioning from acute to CP. 
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In addition, many CP studies that explored treatment outcomes used CP controls, rather 
than healthy controls, necessitating their exclusion from this meta-analysis.  Somewhat surprisingly, 
an even larger number of studies were excluded because they did not report the basic data required 
to calculate Cohen’s d effect sizes.  Standards for data reporting have been under increasing 
scrutiny over recent years, with a strong push for authors to report more detailed data (including 
effect sizes) when publishing research (American Psychological Association, 2010; Moore et al., 
2010).  Adoption of these reporting principles in future research would facilitate more comprehensive 
meta-analyses. 
It was intended that this meta-analysis assist in determining the clinical utility of specific 
measures, but this did not prove to be the case.  With the exception of the measures used to assess 
anger/hostility - where inconsistent findings suggest that the definition and/or measurement of this 
domain require more careful consideration and examination - the most commonly used measures 
consistently discriminated between CP and their healthy peers, suggesting that they were suitable 
for use in clinical contexts. 
Finally, there were insufficient data to examine the impact of other variables (e.g., 
employment, relationship status etc.) on psychological functioning.  Again, more detailed reporting 
would enable an examination of these variables. 
Conclusions 
In summary, CP is a common condition that is associated with a range of psychological 
problems.  This study revealed that those aspects of psychological functioning that are most closely 
tied to the physical experience; namely pain anxiety/concern and somatisation, are most affected in 
people who are living with CP.  This challenges previous assertions that depression levels in this 
population are equal to, or greater than, anxiety levels (Access Economics, 2007; Von Korff, et al., 
2005).  Not surprisingly, in all areas, the pain-related aspect of the impact was paramount.  Although 
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self-efficacy was globally eroded, pain anxiety/concern remained closely tied to the CP experience 
and did not extend to more general pain events. 
Of note, this study supports the earlier findings of McWilliams and colleagues (2004) who 
asserted that anxiety in CP populations requires greater attention because anxiety was often more 
strongly associated with CP than depression in their sample.  Interestingly, the relative strength of 
the depression-CP and anxiety-CP relationships have gone largely unchallenged over the last 
decade. 
Overall, these findings suggest that people with CP are in a debilitating bind.  The chronic 
physical pain that they experience is associated with considerable psychological distress, which is 
most commonly focussed on physical aspects of the overall experience.  Although this physical 
focus is not surprising in the circumstance, it is likely to heighten their level of attention to, and lower 
their threshold for, physical symptoms.  This may, in turn, further increase the chance that they will 
notice physical symptoms and interpret them as threatening, thus heightening their distress and 
discomfort, and perpetuating the cycle.  This cycle is discussed in detail in the CP literature, but the 
present study is the first to quantitatively consolidate the existing research findings and, in doing so, 
enable a direct statistical comparison between different areas of psychological functioning.  Although 
pain anxiety/concern, somatisation and self-efficacy (particularly pain-related self-efficacy) are 
common considerations when working with individuals who experience CP, the degree to which they 
are prioritised in therapy varies greatly.  The current meta-analysis suggests that, in order to help 




Chapter 4 : The Impact of Waiting to Access Treatment for Chronic Pain 
4.1 Preamble 
The first study sought to help clinicians better understand the experience of the majority of 
people with CP who present to tertiary pain clinics for care; namely individuals who have mixed 
and/or unclear diagnoses for their pain. It did this by systematically examining the literature that 
explored the psychological functioning of people with CP and contrasted it to that of their healthy 
peers – an examination that was conducted from a general, rather than diagnosis-specific, 
perspective.  In doing so, it identified the psychological domains that have most commonly been 
explored in the literature and demonstrated that all were adversely affected in those with CP.  
Importantly, the study also revealed that it was the anxiety-related domains that were the most 
profoundly affected; thus challenging the frequent focus on depression in the presence of CP and 
guiding clinicians to other important treatment foci. 
When examining psychological functioning, the meta-analysis was not able to consider the 
independent contribution of CP versus other variables, such as waiting for treatment, because it was 
often not clear where in the treatment cycle individuals were placed.  Accordingly, this next study 
was designed to build on these findings by investigating the impact of waiting for treatment on the 
psychological functioning and HCU of individuals with CP; thus articulating the impact of the long 
indefinite waits that are experienced by many of the people who are referred for tertiary 
management.  Specifically, it did this by prospectively following individuals who were triaged for a 
long wait at a public multidisciplinary CP service from the point of referral through to receiving their 
first appointment.  Participant sex was highlighted as a covariate and so this was also considered in 
analyses. 
Importantly, due to the three year nature of this study, data collection was commenced 
before the results of the meta-analysis were available.  The literature review and preparation for 
Study 3 informed the domains that were assessed, but the findings for specific measures could not 
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be factored into the design because of the need to get ethical approval and recruitment underway.  
Accordingly, psychological distress was operationalised in way that fit with the current practices of 
the clinic and minimised participant burden, but was ultimately less nuanced than the findings of the 
meta-analysis would go on to suggest. 
Of note, the Journal of Health Psychology (where this study was published) requested two 
specific modifications to the manuscript as a consequence of space constraints: that the flow chart 
detailing the number of participants at each follow-up be removed and that Table 4.3 be condensed 
so that only significant results were reported.  Thus, the flow chart (Supplementary Figure 4.A) and 
complete findings (Supplementary Table 4.E) were, instead, provided in on-line supplementary 
materials in order to ensure that the study met the Journal Article Reporting Standards (JARS) of the 
American Psychological Society (American Psychological Association, 2010).  Further, after revising 
the manuscript in line with the recommendations of reviewers, it then needed to be condensed in 
order to meet the word limit of the journal; necessitating the removal of some interesting findings 
regarding changes in self-reported work status from the published article.  This information will be 
explored in the overarching discussion for this thesis (Chapter 7). 
Reviewers for this article also expressed concern about participant attrition across the study.  
Attrition is an inherent component of all waitlist research, especially for clinically-triaged waitlists.  
This poses significant problems for research that involves longer-term follow-up because waitlist 
lengths are non-standard between individuals.  Clinical triage determines an individual’s initial 
position on the waitlist, based on information received in the referral, but this is continually updated 
as it is balanced against other factors, such as competing clinical demand for the service and 
updated clinical information for the individual.  Indeed, this may very well be one of the main reasons 
for the lack of published data on this topic, with long-term follow-ups potentially having been 
abandoned or relegated to the file drawer due to uncontrollable variances in factors such as waitlist 
time and clinical triage.  The lack of an evidence-base leaves clinicians poorly supported at a time 
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when patient numbers are growing and resources are scarce, and the individuals who are 
experiencing these long and indefinite waits poorly understood because their clinical trajectories are 
not represented in the extant literature.  Information concerning the impact of being waitlisted is 
therefore needed, in order to inform future practice and policy.  Our biostatistician indicated that the 
analyses were robust through to 2.5 years of waiting/follow-up and, as such, it was agreed that the 
longer-term (18 months - 2.5 years) data would be maintained within the manuscript, but presented 
briefly and in a more tentative way than the findings concerning the first 12 months of waiting. 
Once again, Tables and Figures have been inserted within the text to facilitate ease of 
reading, and all supplementary information is presented in Appendix 2: 
 The flow chart of participants through each stage of the study, including reasons for loss 
to follow-up (Supplementary Figure 4.A),  
 The Royal Adelaide Hospital Pain Management Unit’s triage codes (Supplementary 
Table 4.A),  
 Summary data (means, SDs) for age and each of the key outcome variables, broken 
down by time/follow-up (T2-T7) and participation status (continuing participant, received 
PMU appointment, opted-out, referral cancelled) (Supplementary Table 4.B),  
 Data (estimated means, standard error) for each of the key outcome variables, broken 
down by time/follow-up (T1-T7) and participant sex (female, male) (Supplementary 
Table 4.C),  
 Data (estimates of significant interaction effects) for outcome variables for which there 
was a significant combined effect of time/follow-up (T1-T7) and participant sex (female, 
male) (Supplementary Table 4.D),  
 Data (estimates of main effects) regarding the individual impact of time/follow-up (T1-
T7) and participant sex (female, male) on outcome variables (Supplementary Table 
4.E), and  
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 A copy of the published article, reproduced with permission (Appendix 2.3). 
 
As with the previous chapters, the references have been included in a complete reference 
list at the end of this thesis.  
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Despite many patients waiting more than two years for treatment at publicly-funded multidisciplinary 
chronic pain services, waitlist studies rarely examine beyond six months.  We investigated 
psychological adjustment and health care utilisation of individuals (N=339) waiting ≤30 months for 
appointments at an Australian tertiary pain unit.  Outcomes were relatively stable during the first six 
months, but longer-term deteriorations in pain-related interference, distress and pain acceptance 
were evident; albeit with sex differences.  Sexes also differed in uptake of new treatments.  
Medication use increased over time, but pain severity and medication relief did not.  Results suggest 
early intervention is important, especially for women. 
 
  




Chronic pain (CP) is associated with a range of physical (Taylor et al., 2016), psychological 
(Burke, Mathias, & Denson, 2015), social (Dueñas, et al., 2016) and economic consequences, many 
of which improve with treatment (Gatchel & Okifuji, 2006).  Although Australians are eligible for 
universal health care – including government-subsidized hospitals, diagnostics, specialists and low-
cost medications – high demand and limited resources mean that public CP outpatient clinics 
struggle to provide timely treatment (Fashler, et al., 2016).  Up to 80% of Australian adults with CP 
are denied treatment that could improve their functioning and quality of life (National Pain Summit 
Initiative, 2011), while others wait over two years for treatment (Hogg, et al., 2012; Peng, et al., 
2007); far longer than the eight-week maximum recommended wait (IASP: Task Force on Wait-
Times, 2010).  In Europe, around 33% fail to receive treatment for their CP; almost 50% report 
inadequate pain management; and only 2% are managed by specialist services, many with lengthy 
waits (Breivik, et al., 2013).  Although clinicians frequently report long wait-times, published statistics 
often underestimate the problem because they include rapid access cases (e.g. palliative care), with 
median waits varying from seven to 231 days (Fashler, et al., 2016); far less than the waits 
experienced by many patients. 
Wait-times, even up to six months, may be associated with poorer health-related quality of 
life (QOL) and well-being, and increased pain, disability and distress (Fogarty & Cronin, 2008).  
Accordingly, access to CP treatment is now a key consideration in European health care (Societal 
Impact of Pain Grünenthal Group, 2017).  Although short-term data suggest an inverse relationship 
between wait-time and adjustment (Fogarty & Cronin, 2008), the point at which clinically-significant 
deterioration begins, and the impact of longer waits, are unknown (Lynch, et al., 2008).  Research 
specifically examining the impact of waiting for CP treatment on patient outcomes is limited.  Instead, 
research has typically focussed on treatment efficacy and different populations (e.g. surgical waitlists 
or community samples).  It is also unclear whether participants were informed of wait-times when 
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referred for treatment.  Waits for CP services are difficult to predict because waitlists are continually 
updated, based on clinical information and triage demands: thus, many patients lack definite 
timelines.  This uncertainty has been linked with increased distress, impaired concentration and 
reduced life-engagement (Fogarty & Cronin, 2008).  Lengthy indefinite waitlists are almost 
universally condemned, but exactly when long becomes too long is unclear. 
Long-term data is needed because waits for public multidisciplinary CP treatment often 
exceed six months.  This project prospectively examined the long-term psychological adjustment and 
health care utilisation (HCU) of individuals’ waitlisted for a public outpatient CP service. 
4.4 Materials and Method 
Participants 
Participants were adults referred to the Pain Management Unit (PMU) of Royal Adelaide 
Hospital (November 2011-2013), which – as one of two public multidisciplinary CP services in South 
Australia – assesses, treats and manages adults with CP across a large Australian region.  Referrals 
are triaged and prioritized on the basis of clinical need (see Supplementary Table 4.A).  Individuals 
triaged for an urgent/semi-urgent (<6 months) appointment (triage codes 1-2) were excluded 
because we examined the impact of waiting >6 months.  Participants needed basic English fluency 
(determined from referral information) to provide informed consent and complete the questionnaire.  
All eligible new referrals were invited to participate (see Burke, Denson, & Mathias, 2016 for further 
details). 
Measures 
Newly-referred patients routinely complete a screening battery (Patient Screening 
Questionnaire; PSQ) before being placed on the PMU waitlist; this measure was used to minimise 
participant-burden.  The PSQ collects demographic, health and pain-related information, HCU and 
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medication use, and includes measures of pain-related interference and pain severity (BPI: Cleeland 
& Ryan, 1994) and psychological distress (Kessler Distress Scale [K-10]: Kessler, et al., 2003).  In 
addition, the Chronic Pain Acceptance Questionnaire (CPAQ: McCracken, et al., 2004) measured 
pain willingness (willingness to experience pain in order to perform activities), activity engagement 
(engagement with meaningful activity) and overall pain acceptance.  Lastly, the World Health 
Organisation QOL-Brief Scale (WHOQOL-BREF: Murphy, Herrman, Hawthorne, Pinzone, & Evert, 
2000) assessed QOL using four subscales (physical health, psychological health, social 
relationships, environment), but the ‘overall’ and ‘health-related’ QOL scores were ultimately 
excluded due to their poor psychometric properties. 
Changes in pain-related HCU and medication were also examined in terms of: (1) HCU 
frequency (mean number of health-related appointments in the previous three months), treatment 
types (medical, psychological, alternative, physical), and uptake of new treatments since the last 
survey; and (2) amount of relief that participants reported receiving from their pain medication(s) and 
changes in medication dose/strength since the previous survey. 
Finally, the Social Desirability Response Set Scale (SDRS-5: Hays, Hayashi, & Stewart, 
1989) was included to gauge whether participants were responding (intentionally or not) in socially-
desirable ways in order to expedite appointment allocation (see Burke, Denson, et al., 2016 for more 
information). 
Procedure 
Following triage (T1), all eligible individuals were mailed the PSQ (standard clinic practice) 
and an invitation to participate (information sheet, consent form, research questionnaires, pre-paid 
envelope).  They were advised that the study would explore the impact of waiting for services on 
individuals with CP and that their wait-time/treatment would not be affected by their research (non-) 
participation.  Participants were followed-up two months after referral (T2) — coinciding with an 
optional pre-clinic education session being trialled at the time (see Burke, Denson, et al., 2016) — 
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and then at six-monthly intervals until their first PMU appointment (T3-T7: six months-2.5 years).  
Reminder packs were sent to participants who did not return questionnaires within one month.  
Participants were deemed to have opted-out of the study if they did not return two successive mail-
outs. 
PMU appointments were offered on the basis of chronological referral and clinical 
need/urgency (assessment with: doctor/doctor & allied health/multidisciplinary panel), but were 
modified if updated information was received indicating greater urgency.  Thus, individuals were not 
advised of an anticipated wait-time at the point of referral.  Study follow-ups ceased when 
participants received their initial PMU appointment (no longer waitlisted); accounting for some 
attrition from T1-T7 (see Supplementary Figure 4.A).  Those who declined/withdrew study 
participation remained on the PMU waitlist and received equivalent waitlist management.  Staff who 
scheduled PMU appointments were blinded to study participation status. 
CP and waiting for treatment are both associated with distress (Burke, Mathias, et al., 2015); 
therefore the mail-out included information about how to access external psychological assistance 
(services, telephone numbers) while waiting for their PMU appointment.  The study was approved by 
the Research Ethics Committees of Royal Adelaide Hospital (Protocol #111004) and University of 
Adelaide. 
Analyses 
Study power was estimated using G*Power and deemed satisfactory (effect size f = 0.25, 
αerror probability = 0.05; power = 0.95) (Faul, Erdfelder, Lang, & Buchner, 2007).  The potential impact of 
sex, age, marital status, country of birth, primary pain location and pain duration on outcome was 
assessed to determine whether they should be entered as covariates into the mixed-model analyses.  
Backwards elimination indicated that sex was the only variable to contribute to outcomes and thus, 
was the only covariate. 
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Next, repeated measures mixed-model analyses examined the impact of Time (T1-T7) on: 
pain impact (BPI: pain-related interference, pain severity), psychological distress (K-10), pain 
acceptance (CPAQ), QOL (WHOQOL-BREF), HCU (frequency, type, new treatments) and 
medication usage (pain relief, change in dose/strength).  Significant effects were explored via post-
hoc t-tests with Sidak corrections.  Cohen’s d was calculated to assess the standardized difference 
between means across study time-points and interpreted using Cohen’s (1988) guidelines (d = 0.2, 
0.5, 0.8 indicating small, medium, large effects respectively).  Finally, ordinal logistic generalized 
estimating equation (GEE) model analyses examined the impact of Time (T1-T7) on reported uptake 
of new treatments and changes in medication use (Homish, Edwards, Eiden, & Leonard, 2010). 
4.5 Results 
Sample Characteristics 
In total, 678 referrals were screened for eligibility and 664 invited to participate (see 
Supplementary Figure 4.A).  Almost half either did not respond (31%, n = 209) or opted for a PMU 
appointment, but declined research participation (17%, n = 116).  Independent samples t-test and 
2-square statistics confirmed that there were no significant differences between the age or sex of 
those who agreed to participate (Mage = 44.1, SDage = 10.4; Nfemales = 197, 58%) and those who 
declined (Mage = 44.1, SDage = 11.2; Nfemales = 71, 61%) (age: t(453) = 0.01, p = 0.99; sex: 2(1, N = 
466) = 0.34, p = 0.56), indicating demographic comparability. 
The final sample comprised 339 adults aged 17-83 years; mostly referred by general 
medical practitioners.  Participants were predominantly female, unemployed, un-partnered and 
Australian-born (see Table 4.1).  Pain was usually long-standing (56% had pain for >5 years), 
experienced in multiple sites and of unknown aetiology.  Consistent with referral to public clinics, 
most had no private health insurance and were not involved in pain-related litigation; effectively 
precluding access to private services.  Few had previously attended a pain clinic.  
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Table 4.1: Summary demographic information of the sample 
 
Females 
N  (%) 
Males 
N  (%) 
Full Sample 
N  (%) 
GENERAL INFORMATION 
Nparticipants 
Age (Mean, SD) 
Relationship status 
 Single 
 Married/de facto 
 Divorced/separated 
 Widowed 
 Not reported 
Employment status 
 Unemployed (due to pain) 
 Unemployed (other) 
 Part-time 
 Full-time 
 Home duties 
 Retired 
 Disability Pension 
 Student 




 Not reported 






 South America 
 North America 
 Not reported 
Private Health Insurance 
 No 
 Yes 
 Not reported 
 
197  (58) 
44.8  (11.0) 
 
77  (39) 
86  (43.5) 
29  (14.5) 
1  (0.5) 
5  (2.5) 
 
62  (31) 
23  (12) 
25  (13) 
18  (9) 
28  (14.5) 
12  (6) 
6  (3) 
9  (4.5) 
3  (1.5) 
- 
2  (1) 
1  (0.5) 
8  (4) 
 
151  (77) 
27  (14) 
9  (5) 
3  (1) 
1  (0.5) 
1  (0.5) 
- 
5  (2) 
 
142  (72) 
50  (25) 
5  (3) 
 
142  (42) 
43.2  (9.5) 
 
70  (49) 
43  (30) 
15  (11) 
- 
14  (10) 
 
62  (43.5) 
34  (24) 
8  (5) 
15  (10) 
4  (3) 
4  (3) 
5  (4) 
2  (1.5) 
1  (1) 
3  (2) 
- 
- 
4  (3) 
 
100  (70) 
22  (15) 
8  (6) 
3  (2) 
4  (3) 
- 
1  (1) 
4  (3) 
 
113  (80) 
23  (16) 
6  (4) 
 
339 
44.1  (10.4) 
 
147  (43) 
129  (38) 
44  (13) 
1  (0.5) 
19  (5.5) 
 
124  (36.5) 
57  (17) 
33  (10) 
33  (10) 
32  (9) 
16  (5) 
11  (3) 
11  (3) 
4  (1) 
3  (1) 
2  (0.5) 
1  (0.5) 
12  (3.5) 
 
251  (74) 
49  (14) 
17  (5) 
6  (1.5) 
5  (1.5) 
1  (0.5) 
1  (0.5) 
9  (3) 
 
255  (75) 
73  (22) 
11  (3) 
PAIN / HEALTH INFORMATION 
Pain in More Than One Site 
 Yes 
 No 
 Not reported 
Pain Duration 
 Greater than 10 years 
 5 – 10 years 
 3 - 5 years 
 12mths – 3 years 
 6 - 12 months 
 Less than 6 months 
 Not reported 
 
 
189  (96) 
7  (3.5) 
1  (0.5) 
 
63  (32) 
43  (21.5) 
27  (14) 
45  (23) 
16  (8) 
2  (1) 
1  (0.5) 
 
 
129  (91) 
13  (9) 
- 
 
54  (38) 
30  (21) 
29  (20) 
18  (12.5) 
4  (3) 
2  (1.5) 
5  (4) 
 
 
318  (93.5) 
20  (6) 
1  (0.5) 
 
117  (35) 
73  (21) 
56  (17) 
63  (18.5) 
20  (6) 
4  (1) 
6  (1.5) 
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Table 4.1 Summary demographic information of the sample cont. 
 
Females 
N  (%) 
Males 
N  (%) 
Full Sample 
N  (%) 
PAIN / HEALTH INFORMATION cont. 
Primary Pain Site 
 Total / Almost total body 
 Lower Back / Buttocks 
 Legs / Feet 
 Neck / Head / Face / Mouth 
 Upper Back / Shoulders 
 Hip / Abdominal 
 Arms / Hands 
 Anal / Genital / Pelvic / Groin 
 Not reported 
Reason for Pain Onset 
 No clear reason 
 Illness related 
 Work / Home accident 
 Motor vehicle accident 
 Post-surgical 
 Other 
 Not reported 
Seen a Pain Clinic Before 
 No 
 Yes, multidisciplinary clinic 
 Pain doctor only 








32  (16) 
69  (35) 
25  (13) 
17  (8.5) 
18  (9) 
19  (9.5) 
5  (3) 
4  (2) 
8  (4) 
 
51  (26) 
45  (22.5) 
33  (17) 
17  (9) 
7  (3.5) 
38  (19) 
6  (3) 
 
168  (85) 
20  (10) 
4  (2) 
5  (3) 
 
183  (93) 
8  (4) 




14  (10) 
65  (45) 
14  (10) 
16  (11) 
5  (1) 
9  (7) 
2  (1.5) 
6  (4.5) 
11  (7) 
 
33  (23) 
14  (10) 
31  (22) 
18  (12.5) 
7  (5) 
35  (24.5) 
4  (3) 
 
114  (80) 
21  (15) 
3  (2) 
4  (3) 
 
132  (93) 
6  (4) 




46  (14) 
134  (40) 
39  (12) 
33  (9.5) 
23  (7) 
28  (7.5) 
7  (2) 
10  (2.5) 
19  (5.5) 
 
84  (25) 
59  (17.5) 
64  (19) 
35  (10) 
14  (4) 
73  (21.5) 
10  (3) 
 
282  (83) 
41  (12) 
7  (2) 
9  (3) 
 
315  (93) 
14  (4) 
8  (3) 
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Participants experienced significant pain-related interference in their ability to perform daily 
activities and significant psychological distress at intake (T1); with 70% (n = 238) reporting 
‘moderate’ or ‘severe’ (≥25) distress (K-10).  QOL (WHOQOL-BREF) was also markedly below 
Australian norms (Murphy, et al., 2000) and there was a high degree of HCU, with an average of 10 
health-related appointments/person every three months and many (n = 120, 35%) having >1 weekly 
appointment(s) (see Table 4.2). 
Throughout the study, 54 people were removed from the waitlist without appointment (34 
were self-removed/declined to wait/sought services elsewhere, 17 were cancelled by clinic/duplicate 
referral/redirection to more appropriate service and 3 of them died).  Appointment wait-times varied 
because referrals were triaged on the basis of clinical information; the mean wait-time was 21 
months (n = 273; SD = 10.9; range = 2-53 months). 
Sample Attrition 
Sample attrition was of concern (see Supplementary Figure 4.A), with individuals exiting the 
study because they either received a PMU appointment (no longer waiting), opted-out (declined to 
complete further measures while waiting), or cancelled their referral (removed themselves from the 
waitlist).  Regression analyses were conducted to determine whether the four groups (still 
in/received appointment/opted-out/cancelled appointment) differed in terms of key 
demographic/outcome variables as a function of overall study participation time.  These analyses 
confirmed that the groups were comparable across age (R2 = 0.01, F(2, 452) = 1.67, p = 0.19), sex 
(R2 = 0.001, F(2, 452) = 2.41, p = 0.79) pain-related interference (R2 = 0.01, F(2, 446) = 1.92, p = 
0.15), pain severity (R2 = 0.004, F(2, 444) = 0.79, p = 0.46) and psychological distress (R2 = 0.01, 





Table 4.2: Estimated means for outcome domains, by Time and Sex (first 12 months of waiting) 
Outcome Domain T1 (intake) T2 (2 months) T3 (6 months) T4 (12 months) SEX 
Female Male Total Female Male Total Female Male Total Female Male Total Female Male 
N 197 142 339 117 78 195 84 67 151 54 37 91 197 142 
Pain impact (BPI) 
 Pain-related interference 











































Psychological distress (K-10) 29.9 (0.6) 30.3 (0.7) 30.1 (0.5) 31.0 (0.8) 30.3 (0.9) 30.7 (0.6) 30.2 (0.9) 32.1 (1.0) 31.1 (0.7) 30.4 (1.2) 31.3 (1.4) 30.8 (0.9) 29.7 (9.2) 30.3 (9.1) 
Pain acceptance (CPAQ) 
 Pain willingness 
 Activity engagement 

























































Quality of life(WHOQOL-BREF) 
 Physical health 
 Psychological health 








































































Health care utilisation 
 Frequency 
 Treatment types 
      Medical 
      Psychological 
      Alternative 
      Physical 
 N (%) tried new treatment 































































































































Note: N = number of participants; BPI = Brief Pain Inventory; K-10 = Kessler Distress Scale; CPAQ = Chronic Pain Acceptance Questionnaire; WHOQOL-BREF = World Health Organisation Quality of Life – Brief 












Table 4.2: Estimated means for outcome domains, by Time and Sex (first 12 months of waiting) cont. 
Outcome Domain T1 (intake) T2 (2 months) T3 (6 months) T4 (12 months) SEX 
Female Male Total Female Male Total Female Male Total Female Male Total Female Male 
Medication usage 
 % relief received 
 Change since last (N, %) 
      Taking stronger / more 
      Nil, taking same 
      Taking weaker / less 
      Ceased all medication 

















































































































Note: N = number of participants; BPI = Brief Pain Inventory; K-10 = Kessler Distress Scale; CPAQ = Chronic Pain Acceptance Questionnaire; WHOQOL-BREF = World Health Organisation Quality of Life – Brief Scale.   
Scores represent estimated mean (standard error) unless indicated otherwise to be N (%). 
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Next, we compared the key outcomes at each follow-up (T2-T6) of groups defined by their 
participation status at the following time-point (T3-T7), to determine whether those who continued in 
the study differed from those who did not (received appointment/opted-out/cancelled appointment).  
All group differences were non-significant at each time-point, with one exception: individuals who 
received a PMU appointment at T3 reported more psychological distress at T2 (M = 33.7, SD = 8.3) 
than those who opted-out of the study (M = 25.4, SD = 7.6) at T3 (F(3,191) = 30.94, p = 0.028) (see 
Supplementary Table 4.B).  This aligns with PMU triage practices (those reporting greater 
psychological distress received earlier appointments).  Overall, these analyses suggest that those 
who continued were comparable to those who opted-out. 
Finally, levels of socially-desirable responding were compared at each follow-up to evaluate 
any variance in response validity.  The tendency toward socially-desirable responding did not differ 
over time or between sexes (Time: F(6, 540) = 1.36, p = 0.230; Sex: F(1, 675) = 0.1.03, p = 0.310), 
nor was there an interaction effect (Time x Sex: F(6, 540) = 0.61, p = 0.720).  Scores fell well below 
normative standards across all time-points (see Supplementary Table 4.B), suggesting that 
participants were not consciously or unconsciously distorting their responses. 
Although the preceding analyses indicated that continuing participants were not a biased 
sample, ongoing attrition (due to participants receiving PMU appointments or opting-out of the study) 
meant that the T5-T7 samples were small; reducing statistical power and certainty in the conclusions 
drawn from these data.  Hence, the data for the first 12 months (T1-T4), when the samples were 
large, were examined first.  In the absence of research examining very long waits, we also examined 
T1-T7 in order to determine whether there were any noteworthy preliminary findings.  Given the 
reduced statistical power of these T1-T7 analyses, there is a risk that some changes/findings may go 
undetected; consequently they provide a conservative estimate of the impact of long wait-times. 
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Pain Impact (BPI) 
First year (T1-T4).  Pain-related interference changed significantly over the first year of 
waiting (Time: F(3, 135) = 3.70, p = 0.013), with post-hoc analyses indicating that participants 
reported steadily decreasing amounts of pain-related interference, such that T4 scores were 
significantly less than at intake (T1) (Mdifference = 0.55, p = 0.008, d = 0.18).  Sex differences were not 
evident (F(1, 252) = 2.61, p = 0.108).  Pain severity did not change over Time (F(3, 134) = 0.70, p = 
0.554), but there was a small sex difference (F(1, 249) = 5.40, p = 0.021); with females reporting 
more severe pain (see Tables 4.2 and 4.3).  No interaction effects were found (F(3, 135) = 2.33, p = 
0.077; and F(3, 134) = 0.24, p = 0.871, respectively). 
Longer-term trends (T1-T7).  Although males reported decreasing pain-related interference 
in the longer-term, females experienced relatively stable levels until T6, followed by a significant 
increase, with a marked sex difference at T7 (interaction: F(6, 24) = 10.98, p < 0.001).  Notably, the 
T3-T6 findings equated to medium to large and significant effects, with the three-point difference in 
BPI scores at T7 being clinically meaningful (see Supplementary Tables 4.C and 4.D).  The sex 
differences in pain severity were maintained in the longer-term (F(1, 141) = 4.77,  p = 0.031), but 
time-related changes also became apparent (F(6, 30) = 3.20, p = 0.015): pain severity was higher at 
T7 than all other times, except T2.  The T5 and T6 findings equated to medium and large effects, 
respectively (see Supplementary Tables 4.C and 4.E). 
Psychological Distress (K-10) 
First year (T1-T4).  Psychological distress did not differ across Time (F(3, 137) = 1.18, p = 
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Quality of life (WHOQOL-BREF) 
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Note: BPI=Brief Pain Inventory; CPAQ=Chronic Pain Acceptance Questionnaire; WHOQOL-BREF=World Health Organisation Quality of Life – 
Brief Scale.  Scores represent M (SD) unless indicated otherwise to be N (%). 




















LL UL LL UL 
Health care utilization cont. 
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Note: BPI=Brief Pain Inventory; CPAQ=Chronic Pain Acceptance Questionnaire; WHOQOL-BREF=World Health Organisation Quality of Life – 
Brief Scale.  Scores represent M (SD) unless indicated otherwise to be N (%). 
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Longer-term trends (T1-T7).  Despite comparable early levels of distress (T1-T2), females 
reported less distress than males in the medium-term (T3-T4) and more distress in the longer-term 
(T5-T7) (interaction: F(6, 34) = 41.27, p < 0.001) (see Supplementary Tables 4.C and 4.D).  Those 
differences were greatest at T4 and T6 (large effects).  Interestingly, these findings largely reflected 
fluctuating levels of distress in males: females reported a steady increase in distress over time – 
most noticeably from T4 on – while males reported oscillating levels; peaking at T6 and markedly 
reducing by T7.  Notably, at T7, the distress reported by males (M = 18.8, SD = 7.7) was lower than 
intake; the only time when scores were within the healthy range (“likely to be well”). 
Pain Acceptance (CPAQ) 
First year (T1-T4).  Pain willingness was impacted by both Time (F(3, 136) = 16.46, p < 
0.001) and Sex (F(1, 243) = 7.87, p = 0.005), with post-hoc analyses indicating that the levels of pain 
willingness at T2-T4 were all significantly greater than at intake (T1) (T2: Mdifference = 3.53, p < 
0.0001, d = 0.36; T3: Mdifference = 2.96, p < 0.001, d = 0.24; T4: Mdifference = 3.50, p < 0.001, d = 0.26) 
and, overall, women reported more willingness than men (Mdifference = 32.52, p = 0.005, d = 0.16) (see 
Tables 4.2 and 4.3).  Activity engagement, however, did not differ across either domain (Time: F(3, 
137) = 1.29, p = 0.281; Sex: F(1, 272) = 0.66, p = 0.417).  Finally, although overall pain acceptance 
was unaffected by Sex (F(1, 273) = 3.88, p=0.050), it was impacted by Time (F(3, 131) = 10.10, 
p<0.001); with acceptance increasing significantly at T2 and T3, compared to intake (T1) (T2: 
Mdifference = 4.90, p < 0.001, d = 0.30; T3: Mdifference = 3.94, p = 0.001, d = 0.21), before decreasing, 
albeit not significantly, by T4 (12 months) (see Tables 4.2 and 4.3).  There were no significant Time x 
Sex interactions for pain acceptance (pain willingness: F(3, 136) = 0.62, p = 0.604; activity 
engagement: F(3, 137) = 0.33, p = 0.806; overall pain acceptance: F(3, 131) = 0.39, p = 0.760). 
Longer-term trends (T1-T7).  Over time, pain willingness increased for women until T6, 
after which it returned to T1 levels.  Men reported a different pattern, showing greater variability over 
time, but improving at T7 compared to intake (T1) (interaction: F(6, 29) = 9.54, p < 0.001) (see 
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Supplementary Tables 4.C and 4.D).  T6 was particularly notable because it equated to a medium 
effect.  Although activity engagement was stable during the first year (T4), a significant Time x Sex 
interaction effect was evident at T7 (F(6, 33) = 40.21, p < 0.001): whereas females reported 
reasonably stable activity levels up to T4, followed by a gradual reduction, males reported oscillating 
levels (lowest at T4 and highest at T6).  These sex differences represented small to medium effects 
(see Supplementary Tables 4.C and 4.D).  The findings for overall pain acceptance confirmed those 
in the first year, with acceptance continuing to increase over time (Time: F(6, 27) = 5.11, p = 0.001). 
Quality of Life (WHOQOL-BREF) 
First year (T1-T4).  Physical health changed over Time (F(3, 139) = 3.09,  p = 0.029), with 
post-hoc analyses indicating that the physical aspects of QOL increased significantly at T2 
compared to T1 (Mdifference = 0.73, p = 0.019, d = 0.17), but was then stable.  Social relationships 
showed a small sex difference (F(1, 252) = 9.58, p = 0.002), with females reporting higher social 
QOL (see Tables 4.2 and 4.3).  All other domains were unaffected by Time (psychological health: 
F(3, 133) = 1.52, p = 0.213; social relationships: F(3, 157) = 1.33, p = 0.268; environment: F(3, 134) 
= 0.34, p = 0.794), Sex (physical health: F(1, 266) = 2.84, p = 0.093; psychological health: F(1, 303) 
= 0.11, p = 0.737; environment: F(1, 288) = 3.87, p = 0.050), or an interaction between the two 
(physical health: F(3, 139) = 0.23, p = 0.877; psychological health: F(3, 133) = 0.29, p = 0.834; social 
relationships: F(3, 157) = 0.38, p = 0.767; environment: F(3, 134) = 0.44, p = 0.727). 
Longer-term trends (T1-T7).  Although physical health changed over Time (F(6, 532) = 
2.25, p = 0.038), model estimates and post-hoc analyses were non-significant; suggesting that any 
changes were minimal (see Supplementary Tables 4.C and 4.E).  Although there was a small main 
effect of Sex for social relationships at T4, this was not significant by T7 (F(1, 686) = 3.27, p = 
0.071).  In contrast, despite scores being comparable throughout the first year, women reported 
significantly higher environmental aspects of QOL than males in the longer-term (F(1, 614) = 3.90, p 
= 0.049) (see Supplementary Tables 4.C and 4.E). 
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Health Care Utilisation (HCU) 
First year (T1-T4).  Frequency of HCU changed significantly during the first year (Time: F(3, 
137) = 5.42, p = 0.001), with post-hoc analyses indicating that participants attended fewer health 
care appointments at T2 and T3 than they did at T1 (T2: Mdifference = 1.17, p = 0.010, d = 0.18; T3: 
Mdifference = 1.81, p = 0.003, d = 0.20) (see Tables 4.2 and 4.3).  There were no Sex (F(1, 241) = 0.37, 
p = 0.546) or interaction (F(3, 137) = 0.12, p = 0.948) effects. 
For treatment type, there was a significant Time x Sex interaction in the use of physical 
treatments in the first 12 months (F(3, 131) = 2.85, p = 0.040): although both reported comparable 
use at T1, females decreased their use at T2, but increased at T3-T4.  Males were stable across T1-
T2, then increased their use at T3-T4; resulting in a marked Sex difference in the use of physical 
treatments at T2 (Estimate = 0.69, p = 0.014, d = 0.19).  No interaction effects were found for any 
other treatment type (medical: F(3, 136) = 0.06, p = 0.983; psychological: F(3, 131) = 1.00, p = 
0.396; alternative: F(3, 134) = 0.57, p = 0.633) and there were no main effects for Sex (medical: F(1, 
251) = 0.46, p = 0.496; psychological: F(1, 218) = 3.04, p = 0.083; alternative: F(1, 263) = 3.26, p = 
0.072).  With the exception of alternative treatments, all were impacted by Time (medical: F(3, 136) = 
8.86, p < 0.001; psychological: F(3, 131) = 17.00, p < 0.001; alternative: F(3, 134) = 2.25,   p = 
0.086) (see Tables 4.2 and 4.3).  Specifically, fewer medical treatments were used at T2 than at T4, 
with post hoc analyses indicating that T2 levels were lower than all other time-points (T1: Mdifference = 
0.42, p < 0.001, d = 0.28; T3: Mdifference = 0.40, p = 0.001, d = 0.28; T4: Mdifference = 0.40, p = 0.011, d 
= 0.23).  Similarly, psychological treatments were used least at T2 (T1: Mdifference = 0.30, p < 0.001,    
d = 0.30; T3: Mdifference = 0.56, p < 0.001, d = 0.49; T4: Mdifference = 0.43, p = 0.003, d = 0.28) and most 
at T3 (Mdifference = 0.25, p = 0.014, d = 0.17), suggesting a spike in uptake while waiting.  Overall it 
appears that the use of treatments decreased immediately following referral, but increased over time 
while waiting for an appointment; in several instances equating to meaningful changes (medium 
effects). 
Chapter 4: Waiting to access CP treatment 
89 
 
GEE modelling of the number of new treatments tried during the first 12 months indicated 
that it was related to Time (2(2, N = 221) = 12.82, p = 0.002), with individuals being more than twice 
as likely to try a new treatment at T2 (OR = 2.85; 95% CI = 1.61, 5.05; p < 0.001) and T3 (OR = 
2.20; 95% CI = 1.24, 3.91; p = 0.007), than at T4.  The Sex (2(1, N = 221) = 2.30, p = 0.129) and 
Time x Sex interaction (2(2, N = 221) = 0.54, p = 0.764) effects were both non-significant.  For 
those who tried new treatment(s), mixed-model analyses revealed that the number varied over time 
(F(2, 43) = 8.30, p = 0.001), such that individuals tried more new treatments at T2 and T3, than at T4 
(medium and small-to-medium effects) (see Tables 4.2 and 4.3).  There were also significant sex 
differences (F(1, 56) = 6.17, p = 0.016); males tried more new treatments than females (Mdifference = 
0.56, p = 0.016, d = 0.28).  The interaction effect was not significant (F(2, 43) = 0.47, p = 0.629). 
Longer-term trends (T1-T7).  As per the first year, HCU frequency continued to decrease 
over Time (F(6, 10) = 17.62, p < 0.001), with fewer health-related appointments attended at T5 and 
T6, than T7.  T6 was particularly notable (large effect), with four fewer appointments every three 
months than at T7 (see Supplementary Tables 4.C and 4.E).  For treatment type, there was again a 
significant Time x Sex interaction for physical treatments (F(6, 560) = 2.47, p = 0.023), but model 
estimates and post-hoc analyses indicated that any longer-term differences were small (p < 0.05).  
However, significantly fewer physical treatments were used at both T1 and T2, than at T7 (Time: F(6, 
560) = 2.47, p = 0.023).  Whereas use of alternative treatments was reasonably stable during the 
first year (T1-T4), it was less so in the longer-term (Time: F(6, 539) = 3.06, p = 0.006): post-hoc 
analyses indicated that after a small non-significant reduction at T2, the use of alternative treatments 
increased significantly by T6 (compared to T2) (Mdifference = 0.31, p = 0.035, d = 0.23).  The findings 
for medical treatments were consistent with T1-T4, with use being lowest immediately following 
referral (T2) than at all other times (T1: Mdifference = 0.45, p < 0.001, d = 0.27; T3: Mdifference = 0.42, p = 
0.001, d = 0.30; T5: Mdifference = 0.0.66, p = 0.001, d = 0.29; T6: Mdifference = 0.82, p = 0.002, d = 0.29) 
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(Time: F(6, 549) = 7.35, p < 0.001).  Thus, treatment use decreased immediately following referral, 
but frequently increased with continued waiting. 
With respect to new treatments, the data indicate new treatment uptake continued to 
change over Time (2(5, N = 221) = 25.27, p < 0.001), with the interaction between Time and Sex 
also significant (2(1, N = 221) = 4.17, p = 0.041): over the longer-term, males were 38% less likely 
to try new treatment(s) (OR = 0.62; 95% CI = 0.40, 0.98; p = 0.041).  For those who tried new 
treatment(s), the T1-T4 sex difference in the number of treatments was lost by T7 (F(1, 76) = 2.81, p 
= 0.098).  Although the effect of Time was significant (F(5, 116) = 2.63, p = 0.027), the differences 
were small (model estimates and post-hoc analyses both non-significant). 
Medication Usage 
First year (T1-T4).  Time (F(3, 137) = 0.47, p = 0.705) and Sex (F(1, 228) = 2.92, p = 0.089) 
did not impact on the amount of medication-related relief and there was no significant interaction 
(F(3, 137) = 0.24, p = 0.867).  Changes in dose/strength, were unaffected by Time (2(2, N = 188) = 
1.89, p = 0.390) but GEE analysis revealed a significant Sex difference (2(1, N = 188) = 5.15, p = 
0.023), such that females were almost twice as likely to report an increase in their medication 
dose/strength (OR = 1.93; 95% CI = 0.84, 4.46; p = 0.12).  Indeed, 36%-45% of the sample reported 
taking more/stronger medication than they had previously at each time-point (see Table 4.2).  There 
was no Time x Sex interaction (2(2, N = 188) = 0.38, p = 0.829). 
Longer-term trends (T1-T7).  The results concerning medication use were supported in 
the longer-term (see Supplementary Tables 4.C and 4.E), with females being more likely to report an 
increase in the dose/strength of their medication throughout the study. 




We examined the psychological adjustment and HCU of adults while waiting for up to 2.5 
years for a first appointment at an Australian multidisciplinary CP service.  Waits were non-standard 
because referrals were triaged, based on clinical need.  Thus, participants exited the study (received 
an appointment) at different times which, when combined with those who opted-out or whose referral 
was cancelled, meant that there were fewer people in the longer-term follow-ups (T5-T7) than the 
first year (T1-T4).  Although participants who completed the study were comparable to those did not, 
smaller samples impact statistical power.  Although tentative, our longer-term findings (T1-T7) are 
the only published data exploring the long waits experienced by many people with CP.  Sample 
attrition is an inherent difficulty in longitudinal studies of clinically-triaged waitlists, possibly explaining 
the dearth of research examining long waits. 
The impact of waiting on psychological adjustment and HCU was mixed.  Some domains 
showed deterioration: more commonly for women than men and usually after one or more years 
(≥T4).  Although the one-year data indicated decreasing pain interference and stable psychological 
distress, there may be longer-term sex differences.  Whereas males reported that pain interfered 
less in their daily activities after six months (T3) (improvement), females were stable for the first two-
years, followed by a large increase (T7) (decline).  Similarly, women reported increasing distress 
over time (rapidly escalating at one-year post-referral; T4), but men fluctuated with no clear pattern, 
ending (T7) with below-intake (T1) levels.  Similarly, pain acceptance was stable (activity 
engagement) or improved (pain willingness, overall pain acceptance) in the first year, but women 
deteriorated after 18 months (T5, activity engagement) and 2.5 years (T7, pain willingness), while 
men oscillated before improving.  Although tentative, these longer-term findings highlight the 
changing impact of waiting for treatment over prolonged periods. 
The types of HCU sought also changed following referral to the PMU; overall HCU 
decreased immediately following referral (T2, T3), followed by significant increases in the use of 
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psychological therapies at six months (T3), alternative therapies at two-years (T6) and physical 
therapies at 2.5 years (T7).  This contrasted with a reduction in overall HCU frequency during the 
same period (18-24 months), suggesting that health care became more focussed.  However, it is 
unclear whether this decrease occurred because participants did not attend appointments — due to 
better self-management or reduced hope about benefits — or whether appointments decreased for 
other reasons (e.g. awaiting PMU appointment).  Although the underlying cause(s) are unclear, 
these changes have implications for health planning. 
Perhaps surprisingly, some domains appeared largely unaffected by the long indefinite wait.  
Despite females reporting more severe pain (consistent with research by Bartley & Fillingim, 2013), 
pain severity was relatively stable for everyone in the first year, with longer-term findings suggesting 
this continued before spiking at 2.5 years (T7).  This is consistent with the reports of stable 
medication-related pain relief.  Nevertheless, over a third of the sample, and twice as many women, 
reported an increase in the dose/strength of their medication at each survey.  This accords with 
recent research suggesting that women frequently obtain equal or greater access to 
pharmacotherapy than men, including polypharmacy, which may defy best-practice guidelines (Oliva 
et al., 2015).  Unfortunately, sex differences in medication use at baseline could not be examined 
because this information was not collected.  Males may have entered the waitlist on more optimal 
doses, whereas females may have started at suboptimal doses, thus requiring increased pain relief.  
Indeed, the relatively stable ratings of pain severity and medication relief may have been achieved 
because medication dose/strength increased.  Prescribing may also have been influenced by other 
factors (e.g., greater longer-term distress/pain-related interference in females), although dosage 
changes did not correlate with ratings of pain severity or relief, implying that medication increased 
without benefit. 
QOL was similarly unchanged over time.  Males generally reported less satisfaction with 
their social relationships (first year) and environmental supports/opportunities (longer-term) than 
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females.  Although consistent with literature asserting that males experience significantly greater 
erosion of QOL when in pain (McNamee & Mendolia, 2014), other aspects of QOL were not similarly 
impaired.  However, given baseline QOL was well-below Australian norms, further deterioration may 
have been unlikely. 
In terms of intervention, no critical time or endpoint was highlighted by the data.  However, 
pain acceptance — an important precursor for change — peaked between two and six months post-
referral, suggesting that therapeutic change may be optimized if interventions are delivered during 
that period.  Moreover, although the overall stability in numerous domains in the six months (T3) 
after referral (T1) challenges reports of participant deterioration during that period (Lynch, et al., 
2008), our preliminary findings suggest that longer waits (>12 months) were associated with 
increasing distress and decreasing function, especially in women; supporting the view that earlier 
intervention is important. 
In combination, the findings appear conclusive for women, but clear guidelines for men 
could not be established because their coping was more variable.  Although men reported 
comparatively greater psychological distress than women in the medium-term, the reverse occurred 
in the longer-term.  Moreover, although new treatment uptake was greater for females, women also 
reported patterns of stable or declining adjustment, suggesting limited benefit.  Together, these 
findings suggest that despite being more variable, men tended to fare comparatively better than 
women during long and indefinite waits, implying a possible trend towards improved coping with, if 
not adaptation to, pain. 
Study Limitations 
First, almost half of those who were invited declined participation.  Despite being 
demographically comparable (age, sex) to the study sample, they may have differed in other 
important ways.  For example, non-participation may have reflected greater psychological distress 
or, conversely, participation may have been motivated by the desire for assistance, with more 
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distressed people enrolling.  Nevertheless, the final sample resembled others recruited from public 
multidisciplinary CP services, across multiple dimensions (e.g. demographics, pain duration, 
distress, pain-related interference, pain severity) (e.g., Smith, et al., 2016) and was therefore likely to 
be broadly representative.  Second, only self-report data were collected; with obvious implications for 
response validity in the current context.  The question exploring HCU treatment types asked about 
treatments tried (ever), rather than treatments currently using.  Scores on this variable should not 
decrease, but did, possibly influenced by pain-levels at the time of responding, resulting in impaired 
recall.  However, estimates of pain severity were either stable (females) or decreased (males) from 
intake to two years, suggesting this is unlikely.  Similarly, participants’ responses did not appear to 
have been influenced by social desirability.  It is therefore likely that, in general, responses were 
reliable (within limitations of self-report) and that some responses to the ‘treatment types’ question 
reflected current, not historical, use.  Third, although prospective and repeated assessments were 
completed, there was no comparison group (randomised access to treatment is ethically 
unacceptable) making it difficult to dismantle any confounding influences of initial triage and other 
factors (e.g. hospital admissions, advocacy) on the timing of the PMU appointments.  Fourth, sample 
attrition from T1-T7 reduced the power of our analyses, possibly underestimating the extent of the 
impact of waiting.  Finally, as noted elsewhere (Burke, Denson, et al., 2016), the follow-up 
assessments may have had some intrinsic benefit (e.g., participants feeling attended to), potentially 
ameliorating some impact of waiting to access treatment, particularly indefinite waiting.  Similarly, 
providing participants with information about other sources of psychological assistance (duty-of-
care/ethical requirement), may have also had benefits.  Qualitative research exploring patient 
perceptions of waiting would be a useful future addition. 
Overall, this study suggests that an indefinite wait of 12 months-2.5 years to access 
multidisciplinary CP treatment may be associated with deterioration across important functions (pain-
related interference, psychological distress, pain willingness, activity engagement).  Females 
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typically reported the greatest levels of impairment, whereas males fluctuated, often improving by the 
end of the waiting period.  There were also meaningful changes in a range of variables (e.g., 
medication usage, treatment uptake) that require further exploration.  Importantly, our data suggest 
that, for women at least, intervening within six months of referral to a CP service may help optimise 
outcomes; a recommendation that needs evaluation. 
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Chapter 5 : Staffing in Australian Tertiary Chronic Pain Clinics 
5.1 Preamble 
Having established the psychological impact of living with CP and of lengthy indefinite waits 
for treatment, this project then addressed its secondary aim, which was to explore service-related 
factors that may impact access to CP treatment.  The first target for this examination was staff 
resources in Australian tertiary CP services. 
Although there are evidence-based guidelines for the treatment of CP, there does not 
appear to be any research establishing the amount and mix of staff resources that are necessary to 
effectively enact evidence-based care in this clinical population.  This creates problems when 
(re)designing health care services because it is unclear whether long wait-times primarily reflect 
insufficient resourcing or an inefficient use of the available resources.  Therefore, this third paper 
surveyed and critically examined multidisciplinary staffing profiles in tertiary CP centres across 
Australia.  Importantly, staffing was considered in terms of specific disciplines (medical, psychiatry, 
nursing, physiotherapy, clinical psychology, occupational therapy, administrative) and numbers, and 
as a function of clinical activity (staff per patient), thus facilitating the calculation of individualised 
clinical profiles. 
The published article for this chapter (Appendix 3.2) referred to persistent rather than 
chronic pain because that was the preferred term of the fourth author (MNH).  It has been changed 
to CP in the body of the chapter so that consistent terminology is used throughout this larger thesis 
document. 
Tables and Figures are inserted within the text and online supplementary information is 
presented in Appendix 3: 
 Survey questions (Appendix 3.1), and  
 A copy of the published article (reproduced with permission) (Appendix 3.2). 
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Objective: To document staffing (medical, nursing, allied health (AH), administrative) in Australian 
multidisciplinary chronic pain services and relate them to clinical activity levels. 
Methods: Of the 68 adult outpatient chronic pain services approached (Dec 2008 – Jan 2010), 45 
agreed to participate, received over 100 referrals/year, and met the contemporaneous IASP criteria 
for Level 1 or 2 multidisciplinary services.  Structured interviews with Clinical Directors collected 
quantitative data regarding staff resources (disciplines, amount), services provided, funding models 
and activity levels. 
Results: Compared to Level 2 clinics, Level 1 centres reported higher annual demand (referrals), 
clinical activity (patient numbers), and absolute numbers of medical, nursing and administrative staff, 
but comparable numbers of AH staff. When staffing was assessed against activity levels, medical 
and nursing resources were consistent across services, but Level 1 clinics had relatively fewer AH 
and administrative staff. Metropolitan and rural services reported comparable activity levels and 
discipline-specific staff ratios (except occupational therapy).  The mean annual AH staffing for pain 
management group programs was 0.03 full-time equivalent (FTE) staff per patient. 
Conclusions: Reasonable consistency was demonstrated in the range and mix of most disciplines 
employed, suggesting they represented workable clinical structures.  The greater number of medical 
and nursing staff within Level 1 clinics may indicate a lower multidisciplinary focus, but this needs 
further exploration.  As the first multidisciplinary staffing data for chronic pain clinics, this provides 
critical information for designing and implementing clinical services.  Mapping against clinical 
outcomes to demonstrate the impact of staffing patterns on safe and efficacious treatment delivery is 
required. 
  




Chronic Pain (CP) costs Australia $AUD34.3 billion annually (Access Economics, 2007).  
With a point-prevalence of approximately 20% (Blyth, et al., 2001), around 3.2 million Australians 
were living with this condition in 2007.  Population aging estimates suggests this figure will reach 5.0 
million by 2050 (National Pain Summit Initiative, 2011).  Despite the high incidence of CP and its 
associated disease-burden, timely access to appropriate treatment is out of reach for many 
Australians.  Indeed, approximately 80% of people fail to receive an intervention that could improve 
their functioning and quality of life (National Pain Summit Initiative, 2011), while those who do 
receive treatment endure wait-times of six-18 months or longer (Hogg, et al., 2012), during which 
time their health and well-being often deteriorate (Lynch, et al., 2008). 
Although the day-to-day care of people with CP occurs in primary care settings, a significant 
proportion of patient consultation and advice regarding complex case management is provided by 
tertiary pain units.  As outlined by the International Association for the Study of Pain (IASP) (IASP, 
2009), these units are multidisciplinary in nature, offering an integrated range of services spanning 
assessment and treatment of physical and mental health, pharmacotherapy, medical procedures 
(e.g., nerve blocks), physical therapies, psychosocial interventions (e.g., cognitive behavioural 
therapy, acceptance and commitment therapy), group programs and education.  Many of these 
clinical teams are also heavily involved in training and research activities – developing the evidence-
base and workforce of the future.  Recommendations are available regarding the disciplines that 
should be represented in these clinics and the types of services that should be provided (Gatchel & 
Okifuji, 2006; National Pain Summit Initiative, 2011), but in the absence of a clear formulae for clinic 
structure, the exact types and amounts of services offered may vary greatly. 
As outlined by Health Workforce Australia (HWA), significant innovations are needed in both 
health care delivery and training, for the Australian health care system to be sustainable (Health 
Workforce Australia, 2012).  In the midst of major health care reforms (Council of Australian 
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Governments, 2011), the health system is under increasing pressure to enhance patient outcomes 
by facilitating timely access to services. The current wait-times associated with accessing tertiary 
pain services demonstrate that the present model of care is inappropriate to address clinical need 
and/or that units are inadequately staffed. 
From a model of care perspective, considerable evidence is available to inform 
multidisciplinary therapeutic guidelines for CP (Chan, et al., 2011; Eccleston, et al., 2009; Hassett & 
Williams, 2011; Louw, et al., 2011; Morley, et al., 2008; Morlion, 2011) and Australian pain clinicians 
are actively moving beyond established methods of service delivery to trial novel initiatives, such as 
pre-clinic education sessions (Davies, et al., 2011), on-line treatments (Dear et al., 2013) and 
enhanced links with primary care (C. Hayes & Hodson, 2011).  There has also been a strong 
national endeavour across CP services to actively monitor patient outcomes, in order to ensure that 
the treatments provided actually result in improved function and quality of life for patients (refer NSW 
Department of Health).  Despite these initiatives, however, there are currently no empirical data 
regarding the staffing resources that are required to effectively assess and treat CP in tertiary clinical 
settings, or the impact of different staffing levels and patterns on patient outcomes. 
Careful resource allocation is crucial to patient care.  For inpatients, at least, the impact of 
nursing and medical staffing levels on service delivery is well-documented.  Suboptimal staffing is 
associated with problems in assessment and treatment delivery, longer admissions, and higher 
complication rates and medical costs (Cho, Ketefian, Barkauskas, & Smith, 2003; Holmes, 
Handrinos, Theologus, & Salzberg, 2011).  While tertiary pain services employ doctors and nurses, 
they also employ significant numbers of allied health (AH) professionals; most commonly 
psychologists, physiotherapists and occupational therapists (National Pain Summit Initiative, 2011).  
The impact of AH staffing is less well understood, due to factors such as inadequate systems for 
capturing workforce information (Harris, Gavel, & Conn, 2002); smaller and more fragmented 
professional structures for AH (Campbell, Smedts, Lowe, Keane, & Smith, 2010); less directly 
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established relationships between specific AH interventions and clinical outcomes; and unclear 
service tracking due to variable funding models, not all of which are attributable to specific disciplines 
(National Health Workforce Planning and Research Collaboration, 2010; Schoo, Boyce, Ridoutt, & 
Santos, 2008).  Because this gap in the data involves a significant proportion of the multidisciplinary 
pain management workforce, it creates problems for evidence-based health care design in tertiary 
CP services. 
The ‘Standards for Adult Inpatient Medical Rehabilitation Services’ produced by the 
Australian Faculty of Rehabilitation Medicine (AFRM) (Australasian Faculty of Rehabilitation 
Medicine, 2005) currently provide the most comprehensive guidelines for multidisciplinary staffing.  
Detailing numerous aspects of service delivery, including staffing, equipment requirements and 
treatment guidelines, this document has identified and quantified many of the major service needs 
for medical rehabilitation providers.  These Standards can, and do, inform tertiary outpatient CP 
services, but they do not specify optimal or minimum staffing establishments for such pain clinics, or 
provide an evidence-base for resource allocation.  In order to make informed choices about service 
design and delivery, service directors first need to understand the current staffing configurations of 
multidisciplinary pain clinics, after which they can evaluate these models in terms of patient 
outcomes and thereby work to maximise service efficiencies — a major consideration for sustainable 
health care.  The first stage of this process was undertaken by the ‘Waiting in Pain’ (WIP) project of 
the Australian Pain Society (a chapter of IASP).  Primary outcome data from the WIP project has 
been reported previously; detailing clinic structure, funding models and activity, as well as wait-times 
to access services (Hogg, et al., 2012).  This paper extends the findings of the WIP project by 
offering the first detailed analysis of the staffing associated with Australian tertiary outpatient 
services for adults with CP, thereby providing valuable information that can inform service design 
and delivery. 




Sample and Data Collection 
As stated above, the study data were collected as part of the WIP project of the Australian 
Pain Society (APS), which explored the provision of outpatient CP services in Australia (Hogg, et al., 
2012).  After an exhaustive search — spanning a pre-existing APS facility directory, internet 
searches and consultation with local experts — 68 adult CP services were identified and contacted, 
57 (84%) of which agreed and were eligible to participate in the WIP study (three did not respond; six 
declined; two were excluded due to low referrals: <100 per/year) (see Hogg, et al. (2012) for a more 
detailed account of the recruitment method).  Because the focus of the current analysis was on the 
structure and function of multidisciplinary clinics, we excluded an additional nine clinics that operated 
under a limited pain clinic model (not offering multi- or inter-disciplinary care) and three with a single-
discipline model, resulting in a final sample of 45 publicly and/or privately funded multidisciplinary 
pain clinics. 
Outcome Measures 
CP Service Directors (medical, nursing, AH) completed structured interviews (see Appendix 
3.1), either face-to-face or by telephone, between December 2008 and January 2010.  Interviews 
were conducted by M.N.H and/or a research officer.  Where necessary, responses were later 
clarified by telephone/email. 
Participants were provided in advance with the interview questions, which covered: the 
various disciplines that they employed (medical, nursing, psychiatry, psychology, physiotherapy, 
occupational therapy, administrative); staffing levels (i.e. full-time equivalent (FTE) staffing — total 
number of hours worked by paid staff (part-time, full-time and casual/sessional employees) divided 
by the number of hours worked by a full-time staff member); types of outpatient service provided; 
funding models; annual referral numbers; and patient activity levels.  The provision of Pain 
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Management Group Programmes (PMGP) was specifically explored because this was deemed to be 
a key indicator of services that offered co-ordinated interdisciplinary care, compared with those who 
facilitated multidisciplinary input in a non-integrated fashion (e.g., referred to independent allied 
health services as required).  In addition, qualitative information was sought regarding the evolution 
of services, barriers to optimal care and service development plans, however, data was reported in 
insufficient levels to permit meaningful analysis of this information.  The data sources used by 
respondents were also documented, with most basing their estimates on electronic systems or 
paper-based records (see Table 5.1).  Although somewhat less reliable than the more objective data 
sources, informed estimates were deemed acceptable as the research method (i.e., providing 
respondents with the structured interview questions in advance) facilitated the collection of relevant 
data/information prior to the interview, thereby maximising data accuracy.  Full-time equivalent (FTE) 
figures for psychiatry were recorded separately to general medical FTE because psychiatry was not 
consistently provided by all services and, where available, represented a secondary consultancy role 
that was distinct from the initial medical assessment. 
Using the IASP classification system for multidisciplinary pain treatment services available at 
the time of data collection (IASP, 2009), each clinic was coded as Level 1 (i.e., multidisciplinary pain 
[MDP] management centre offering coordinated interdisciplinary patient care, research and training) 
or Level 2 (MDP management clinic operating as for Level 1, but without regular research and 
teaching activities). 
Data Analysis 
Quantitative data were analysed using IBM SPSS Statistics 20 (SPSS Inc, 2011).  
Descriptive statistics explored clinic characteristics, funding models, service locations and data 
sources. Homogeneity of variance was checked using Levene’s test for equality of variance. 
Analysis of variance and t-tests were used to explore differences in staffing numbers across clinic 
and discipline type, clinical activity, location of service delivery (rural vs. metro, Australian states),   




Table 5.1: Source of data and general service information 
 n % 
Source of data   
    Electronic system 20 44.4 
    Clinic lists 18 40.0 
    Informed estimates 7 15.6 
Service location   
    Rural 8 17.8 
    Metropolitan 37 82.2 
FTE employed 
  
    Rural * 4.9 3.3 
    Metropolitan * 8.0 4.6 
    Total * 7.4 4.5 
Funding Source 
  
    Public (>90%) 25 55.6 
    Private (>90%) 11 24.4 
    Mixed 9 20 
Links with acute pain service (APS) 
  
    No connection  19 42.2 
    Independent but connected to APS 21 46.7 
    Located within APS 5 11.1 
Note. FTE = full time equivalent; APS = acute pain service.  Data reported is n (%) 





and PMGP factors (e.g., programme intensity, location).  Cohen’s d measured the magnitude of the 
effects (d = .3, .5, .8 equate to small, medium, large effects, respectively (Cohen, 1988)). Confidence 
intervals (CI) were also calculated for d to examine the significance of the observed effects: CIs that 
span zero are not statistically significant. 
Ethics Approval 
The study was approved by the Human Research Ethics Committee of Royal Melbourne 
Hospital (HREC 2008.119). 




Most of the 45 services included in this study were based in capital cities, connected to an 
acute pain service and partly, or mostly, publicly-funded (see Table 5.1). Clinic sizes ranged from 0.9 
FTE (Victoria, rural) to 20.9 FTE (Queensland, metropolitan). 
Clinic Type 
Using IASP criteria (IASP, 2009), 26 services were classified as Level 1 and 19 as Level 2.  
Mean FTEs by discipline and clinic type are summarised in Table 5.2.  Overall, Level 1 centres 
employed significantly more staff than did Level 2 clinics (t(43) = 2.91, p = 0.006, d = 0.09): 
specifically, more medical (t(39.0) = 6.70, p < 0.001, d = 1.8), psychiatry (t(30.74) = 3.38, p = 0.002, 
d = 1.1), nursing (t(37) = 2.61, p = 0.013, d = 0.9), and administrative (t(38) = 2.29, p = 0.028, d = 
0.7) staff.  However, the service types were comparable regarding the number of AH staff they 
employed. 
Clinic Activity 
Consistent with the finding that Level 1 centres employed more staff in all disciplines, except 
AH, they reported receiving significantly more referrals (t(43) = 3.37, p = 0.002, d = 1.1) and seeing 
more new patients (t(43) = 3.09, p = 0.004, d = 0.09) each year than Level 2 clinics.  Nationally, 
Level 1 centres saw around 65% (range: 43% SA to 90% ACT) of their annual new referrals, 
whereas Level 2 clinics saw approximately 73% (range: 52% QLD to 100% SA).  Despite there being 
no differences in overall AH staffing between Level 1 and 2 clinics, there were significant differences 
between Australian states in the employment of occupational therapists within both Level 1 and 2 
services (Level 1: F(5, 11) = 3.23, p = 0.049; Level 2: F(6, 9) = 6.75, p = 0.006), and in the 





Table 5.2: Staff numbers: mean FTE (standard deviation) by discipline and clinic type 
 TOTAL FTE Medical Psychiatry Nursing Physiotherapy Psychology Occupational 
Therapy 
Administrative Annual # New 
Referrals  
























LEVEL 1 MDP CENTRE          
Total 9.0 (4.6) ** 
N=26 
3.0 (1.3) *** 
N=26 
0.3 (0.2) ** 
N=22 








2.1 (1.3) * 
N=22 
988 (494) ** 
N=26 
645 (239) ** 
N=26 
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Note. FTE = full time equivalent; MDP = multidisciplinary pain; SA = South Australia; VIC = Victoria; Tas = Tasmania; NSW = New South Wales; ACT = Australian Capital Territory; QLD = 
Queensland; NT = Northern Territory; WA = Western Australia; Effect Size=Cohen’s d.  SD and confidence intervals are shown in parentheses for means and effect sizes (Cohen’s d) respectively. 










Table 5.2: Staff numbers: mean FTE (standard deviation) by discipline and clinic type cont. 
 TOTAL FTE Medical Psychiatry Nursing Physiotherapy Psychology Occupational 
Therapy 
Administrative Annual # New 
Referrals  
Annual # New 
Patients Seen 
LEVEL 2 MDP CLINIC cont.         
























































           
Tas - - - - - - - - - - 


















































           
           
Effect size 0.9 (0.3, 1.5) 1.8 (1.1 2.5) 1.1 (0.4, 1.9) 0.9 (0.2, 1.5) 0.0 (-0.6, 0.6) 0.5 (-0.2, 1.1) 0.0 (-0.7, 0.7) 0.7 (0.1, 1.4) 1.1 (0.6, 1.5) 0.9 (0.3, 1.6) 
Note. FTE = full time equivalent; MDP = multidisciplinary pain; SA = South Australia; VIC = Victoria; Tas = Tasmania; NSW = New South Wales; ACT = Australian Capital Territory; QLD = 
Queensland; NT = Northern Territory; WA = Western Australia; Effect Size=Cohen’s d.  SD and confidence intervals are shown in parentheses for means and effect sizes (Cohen’s d) respectively. 
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An examination of staff resources is more meaningful when evaluated against clinical 
activity.  Detailed information regarding the range of specific clinical activities was not collected, but 
Table 5.3 displays the national mean average staffing levels (FTE) for each discipline/procedure 
type, per hundred new patients.  Despite lower referral and activity rates, Level 2 clinics had 
significantly more administrative and AH (all types) staff resources per patient than Level 1.  The fact 
that Level 1 and 2 clinics employed comparable numbers of medical and nursing staff (when 
assessed against their activity levels) suggests that they were providing similar amounts of medical 
care.  Level 1 and 2 clinics also provided similar rates of medical procedures, both minor (e.g., 
epidural steroids and nerve blocks) (t(42) = 0.36, p = 0.719, d = 0.29) and major (e.g., spinal cord 
stimulation and intrathecal pumps) (t(41) = 0.94, p = 0.352, d = 0.11).  Of note, medical procedure 
rates were calculated on the basis of number of ‘new patients’ seen and therefore do not reflect 
overall caseload (new + existing patients) rates. Irrespective, while there was no significant 
difference between the clinic types overall, the range within both clinic categories indicates 
significant variability across individual clinics in their use of these types of medical procedures (see 
Table 5.3). 
Location of Service 
Sixty-two percent (n = 23) of the metropolitan based services were classified as Level 1 
centres (n = 23), compared with 38% (n = 3) of rural services. Overall, as summarised in Table 5.4, 
metropolitan and rural based services reported employing comparable numbers of staff across most 
disciplines (t(43) = 1.79, p = 0.081, d = 0.7); the exception being doctors, who were employed in 
greater numbers in metropolitan based services (t(43) = 2.34, p = 0.024, d = 0.9).  Metropolitan and 
rural services also reported receiving comparable numbers of new referrals (t(43) = 1.71, p = 0.095, 
d = 0.7) and seeing similar numbers of new patients (t(43) = 1.31, p = 0.197, d = 0.5) each year.  
When staffing was considered as a function of clinical activity (number of new patients seen each 









Table 5.3: National average staffing levels (FTE) and provision of interventional procedures per 100 new patients seen 
 National Total Level 1 MDP centre Level 2 MDP clinic Effect 
 M (SD) Range n M (SD) Range n M (SD) Range n Size 
/100 new pts 5.1 (3.6) 0.9-20.0 45 6.5 (2.4) ** 3.0-11.0 26 3.4 (4.3) 0.9-20.0 19 0.9 (0.3, 0.1) 
Total service FTE 1.9 (1.5) 0.2-7.8 45 1.4 (0.6) 0.3-3.1 26 2.6 (2.1) * 0..2-7.8 19 -0.8 (-1.5, -0.2) 
   Medical 0.5 (0.3) 0.1-1.3 45 0.5 (0.2) 0.1-0.9 26 0.4 (0.3) 0.1-1.3 19 0.4 (-0.2, 1.0) 
   Psychiatry 0.0 (0.1) 0.0-0.2 33 0.0 (0.0) 0.0-0.1 22 0.0 (0.1) 0.0-0.2 11 0.0 (-0.8, 0.8) 
   Nursing 0.4 (0.6) 0.0-3.0 39 0.3 (0.2) 0.0-0.9 24 0.6 (0.9) 0.0-3.0 15 -0.5 (-1.2, 0.1) 
Total Allied Health FTE 0.7 (0.6) 0.0-2.5 45 0.4 (0.3) 0.0-0.9 26 1.1 (0.7) *** 0.0-2.5 19 0.6 (0.0, 1.2) 
   Physiotherapy 0.3 (0.3) 0.0-1.0 41 0.2 (0.1) 0.0-0.4 23 0.5 (0.3) *** 0.0-1.0 18 -1.4 (-2.1, -0.7) 
   Clinical Psychology 0.3 (0.2) 0.0-1.0 41 0.2 (0.1) 0.0-0.5 23 0.4 (0.3) *** 0.0-1.0 18 -0.9 (-1.6, -0.3) 
   Occupational Therapy 0.2 (0.2) 0.0-0.8 33 0.1 (0.1) 0.0-0.3 17 0.3 (0.2) ** 0.0-0.8 16 -1.3 (-2.0, -0.5) 
   Administrative 0.4 (0.3) 0.0-1.3 40 0.3 (0.1) 0.1-0.7 22 0.5 (0.4) * 0.0-1.3 18 -0.7 (-1.4, -0.1) 
Procedures           
    Minor 62.4 (75.4) 0.0-400.0 44 66.0 (60.1) 5.7-283.3 25 57.6 (93.4) 0.0-400.0 19 0.1 (-0.5, 0.7) 
    Major  1.9 (3.7) 0.0-22.0 43 2.4 (4.5) 0.0-22.0 25 1.3 (2.2) 0.0-6.7 18 0.3 (-0.3, 0.9) 
Note. FTE = full time equivalent; /100 new pts = mean number per 100 new patients seen each year; MDP = multidisciplinary pain; minor procedures = procedures such as 
epidural steroids or nerve blocks; major procedures = procedures such as intrathecal pumps or spinal cord stimulation; effect Size=Cohen’s d.  SD and confidence intervals 
are shown in parentheses for means and effect sizes (Cohen’s d) respectively. 








Table 5.4: Staff numbers: Mean FTE (standard deviation) by discipline and per 100 new patients seen for metropolitan and rural based services 
 Metro Rural Effect Metro /100 new pts Rural /100 new pts Effect 
 M (SD) N M (SD) N Size M (SD) Range N M (SD) Range N Size 
TOTAL FTE 8.0 (4.6) 37 4.9 (3.3) 8 0.7 (-0.1,1.5) 1.9 (1.4) 0.2-7.8 37 2.2 (2.1) 0.3-6.3 8 -0.2 (-0.9, 0.6) 
    Medical 2.3 (1.5) * 37 1.1 (0.8) 8 0.9 (0.1, 1.6) 0.5 (0.3) 0.1-1.3 37 0.4 (0.3) 0.2-1.1 8 0.3 (-0.4, 1.1) 
    Psychiatry 0.2 (0.2) 29 0.1 (0.1) 4 0.5 (-0.5, 1.6) 0.04 (0.05) 0.0-0.2 29 0.01 (0.01) 0.0-0.03 4 0.6 (-0.4, 1.7) 
    Nursing 1.6 (1.3) 33 1.2 (1.0) 6 0.3 (-0.6, 1.2) 0.4 (0.6) 0.0-3.0 33 0.6 (0.8) 0.0-2.2 6 -0.3 (-1.2, 0.6) 
    Physiotherapy 1.1 (1.0) 34 0.9 (0.4) 7 0.2 (-0.6, 1.0) 0.3 (0.3) 0.0-1.0 34 0.5 (0.3) 0.2-0.8 7 -0.7 (-1.5, 0.2) 
    Clinical 
       Psychology 
1.1 (0.7) 34 0.6 (0.4) 7 0.8 (-0.1, 1.6) 0.3 (0.2) 0.0-1.0 34 0.4 (0.3) 0.0-0.8 7 -0.5 (-1.3, 0.4) 
   Occupational   
      Therapy 
0.5 (0.6) 29 0.6 (0.3) 4 -0.2 (-1.2, 0.9) 0.1 (0.2) ** 0.0-0.6 29 0.4 (0.3) 0.2-0.8 4 -1.4 (-2.5, -0.3) 
    Administration 1.8 (1.3) 33 1.4 (1.3) 7 0.3 (-0.5, 1.1) 0.4 (0.3) 0.3-1.3 33 0.5 (0.4) 0.1-1.0 7 -0.3 (-1.1, 0.5) 
Annual # new referrals 832 (602) 37 458 (286) 8 0.7 (-0.1, 1.4)        
Annual # new patients 
seen 
547 (366) 37 362 (329) 8 0.5 (-0.3, 1.3)        
/100 new patients 5.5 (3.7) 37 3.6 (3.29) 8         
Note. FTE = full time equivalent; Metro = metropolitan; /100 new pts = mean number per 100 new patients seen each year.  Effect Size=Cohen’s d.  SD and confidence intervals are shown in 
parentheses for means and effect sizes (Cohen’s d) respectively. 
** p<0.01; * p<0.05 
 
 




in greater proportions by rural than metropolitan services (t(31) = -3.28, p = 0.003, d = -1.4) — 
metropolitan and rural clinics employed comparable amounts of staff across the disciplines for the 
numbers of patients that were seen. 
Pain Management Group Programmes 
Pain Management Group Programmes (PMGPs) are a common model of care in tertiary 
pain units and were offered by most clinics (Level 1: n = 24, 92%; Level 2: n = 15, 79%).  PMGPs 
are primarily staffed by AH - most often psychologists and physiotherapists.  Medical and/or nursing 
team members commonly provide input to PMGP sessions but unfortunately these data were not 
captured in the WIP survey, precluding an analysis of this aspect of staffing. 
Similar numbers of new patients were seen each year by clinics who offered a PMGP and 
those who did not (t(43) = -0.48, p = 0.631, d = 0.21). Of these new patients, a greater percentage 
participated in a group programme in Level 2 clinics (M = 40.4%, SD = 55.7), than in Level 1 (M = 
11.1%, SD = 6.5) (t(37) = -2.57, p = 0.014, d = 0.81).  For AH, there was no significant difference in 
overall FTE between services with a PMGP (M = 2.3, SD = 1.6) and those without (M = 1.7, SD = 
2.8) (t(43) = -0.82, p = 0.416, d = 0.34). 
For clinics that provided specific PMGP data, there was marked variation in the duration 
(total therapy hours) of group programmes (M = 68.6 hours, SD = 30.1, range: 5-120, n = 39) and 
the associated AH FTE (M = 1.60, SD = 1.3, range: 0.3-4.0 FTE, n = 24).  However, because PMGP 
duration did not differ significantly across service models (t(37) = 0.48, p = 0.633, d = 0.16) or 
location (F(7, 31) = 0.69, p = 0.683), these categories (clinic level, metropolitan vs rural) were 
collapsed for the remaining analyses.  PMGP staffing and activity data are presented in Table 5.5. 
Given the variability in duration, frequency of contact and therapy hours, PMGPs were 
categorised based on their intensity (defined as total number of therapy hours for each patient) into: 
low: <30 hours (n = 2, 5.13%); medium: 30-50 hours (n = 11, 28.2%); moderate: 51-90 hours (n = 




Table 5.5: Group programme activity levels and allied health FTE 
 AH FTE Hours / PMGP Patients Seen AH FTE / PMGP Patient 
 M (SD) Range n M (SD) Range n M (SD) Range n M (SD) Range n 
National Total 1.6 (1.3) 0.3-4.0 24 68.6 (30.1) 5-120 39 72.4 (60.7) 1-300 39 0.03 (0.02) 0.01-0.07 24 
   NSW 1.2 (1.3) 0.3-3.8 9 67.4 (33.5) 5-105 14 55.4 (42.7) 1-150 14 0.02 (0.02) 0.01-0.05 9 
   VIC 1.6 (1.3) 0.4-3.6 7 80.4 (32.7) 32-120 9 87.4 (72.4) 26-250 9 0.02 (0.01) 0.01-0.03 7 
   QLD 3.4 (-) - 1 62.8 (26.6) 39-100 5 126.0 (106.7) 40-300 5 0.03 (-) - 1 
   WA 4. (-) - 1 82.5 (20.6) 60-100 4 62.5 (5.0) 60-70 4 0.07 (-) - 1 
   SA 1.7 (1.8) 0.4-3.0 2 62.5 (46.) 30-95 2 78.0 (31.1) 56-100 2 0.02 (0.02) 0.01-0.03 2 
   Tas - - - 40.0 (-) - 1 50.0 (-) - 1 - - - 
   ACT 1.5 (0.8) 1.0-2.4 3 49.7 (14.6) 36-65 3 55.0 (30.4) 35-90 3 0.04 (0.03) 0.01-0.07 3 
   NT 0.4 (-) - 1 48.0 (-) - 1 12.0 (-) - 1 0.03 (-) - 1 
Program Intensity            
   (a) <30 hrs 0.3 (-) - 1 12.5 (10.6) 5-20 2 10.5 (13.4) 1-20 2 0.02 (-) - 1 
   (b) 30-50 hrs 0.8 (0.3) 0.4-1.2 6 39.6 (6.9) 30-50 11 70.4 (78.3) 12-300 11 0.02 (0.00) 0.01-0.03 6 
   (c) 51-90 hrs 1.1 (1.2) 0.3-3.4 7 63.6 (10.5) 51-80 11 56.8 (40.4) 12-140 11 0.03 (0.02) 0.01-0.07 7 
   (d) >90 hrs 2.5 (1.2) * 0.8-4.0 10 101.0 (8.9) 90-120 15 93.7 (56.6) 35-250 15 0.03 (0.02) 0.01-0.07 10 
Level 1 MDP Centre            
   Total 1.8 (1.3) 0.3-3.8 14 70.4 (33.2) 5-120 24 69.1 (41.5) 1-150 24 0.03 (0.02) 0.01-0.07 14 
   NSW 1.5 (1.5) 0.3-1.8 6 62.4 (36.0) 5-105 11 59.4 (46.4) 1-150 11 0.02 (0.02) 0.01-0.05 6 
Note. AH FTE = allied health full-time equivalent; hours / PMGP = total treatment hours per Pain Management Group Program; patients seen = total number of new patients 
seen per annum; FTE/PMGP patient = mean average FTE per Pain Management Group Program patient. 








Table 5.5: Group programme activity levels and allied health FTE cont. 
 AH FTE Hours / PMGP Patients Seen AH FTE / PMGP Patient 
 M (SD) Range n M (SD) Range n M (SD) Range n M (SD) Range n 
Level 1 MDP Centre cont            
   VIC 2.2 (1.3) 1.0-3.6 3 110.3 (11.8) 96-120 4 86.3 (50.2) 35-150 4 0.03 (0.00) 0.02-0.03 3 
   QLD 3.4 (-) - 1 55 (-) - 1 140 (-) - 1 0.02 (-) - 1 
   WA - - - 76.7 (20.8) 60-100 3 63.3 (5.8) 60-70 3 - - - 
   SA 1.7 (1.8) 0.4-2.2 2 62.5 (46.0) 30-95 2 78.0 (31.1) 56-100 2 0.02 (0.02) 0.01-0.03 2 
   Tas - - - 40.0 (-) - 1 50.0 (-) - 1 - - - 
   ACT 1.8 (0.8) 1.2-2.4 2 56.5 (12.0) 48-65 2 62.5 (38.9) 35-90 2 0.04 (0.04) 0.01-0.07 2 
Level 2 MDP Clinic            
   Total 1.3 (1.2) 0.4-4.0 10 65.6 (25.1) 32-100 15 77.7 (84.4) 12-300 15 0.03 (0.02) 0.01-0.07 10 
   NSW 0.8 (0.2) 0.6-1.0 3 86.0 (12.5) 72-96 3 40.7 (25.3) 12-60 3 0.03 (0.02) 0.02-0.05 3 
   VIC 1.2 (1.2) 0.4-3.0 4 56.6 (21.0) 32-90 5 88.4 (92.6) 26-250 5 0.02 (0.00) 0.01-0.02 4 
   QLD - - - 64.8 (30.3) 39-100 4 122.5 (122.8) 40-300 4 - - - 
   WA 4.0 (-) - 1 100 (-) - 1 60 (-) - 1 0.07 (-) - 1 
   ACT 1.0 (-) - 1 36.0 (-) - 1 40 (-) - 1 0.03 (-) - 1 
   NT  0.4 (-) - 1 48.0 (-) - 1 12 (-) - 1 0.03 (-) - 1 
Note. AH FTE = allied health full-time equivalent; hours / PMGP = total treatment hours per Pain Management Group Program; patients seen = total number of new patients 
seen per annum; FTE/PMGP patient = mean average FTE per Pain Management Group Program patient. 
* p<0.05 




significant differences (F(3, 23) = 4.33, p = 0.017).  Specifically, medium and moderate intensity 
PMGPs had significantly fewer AH staff dedicated to their groups than did the most intensive model 
(t(14) = -3.26, p = 0.006, d = -1.34; t(15) = -2.27, p = 0.039, d = -0.89, respectively).  When 
programme intensity was mapped against clinical activity, results indicated that groups saw a similar 
number of patients each year irrespective of the format of the programme (F(3, 35) = 1.63, p = 0.20).  
As noted above, it is important to evaluate the adequacy of staffing by additionally examining the 
clinical activity to which those resources are allocated.  An examination of PMGP staffing as a 
function of the number of patients treated annually indicated no significant difference between the 
models (F(3, 20) = 0.64, p = 0.596), suggesting that, regardless of programme intensity, the staff-to-
patient ratio was consistent; with 0.03FTE of AH staff required per patient treated. 
5.6 Discussion 
The ‘Waiting in Pain’ (WIP) project of the Australian Pain Society previously reported poor 
access to multidisciplinary care for Australians living with CP; and longer wait-times for publicly-
funded services than within the private sector (Hogg, et al., 2012).  This project sought to describe 
and systematically examine staffing in Australian tertiary CP services in terms of the associated 
clinical activity levels, in order to better understand and predict clinical resource needs and inform 
future developments in this sector of Australian health care. 
In summary, across Australia, Level 1 centres consistently employ more medical, nursing 
and administrative staff, and annually receive more new referrals and see more new patients than 
their Level 2 counterparts.  Despite this higher clinical activity, the amount of AH staffing is 
comparable: thus patients at Level 2 clinics are likely to have greater access to AH resources, both 
individually and group-based, than patients seen at Level 1 centres.  This is consistent with the 
finding that a greater percentage of patients in Level 2 clinics completed a PMGP than in Level 1 
centres.  Moreover, because offering a PMGP was not associated with higher AH staffing, it is likely 




that in clinics without a PMGP, AH provide other services, probably individual assessment and 
treatment sessions.  The same is true for administrative staffing: as a function of clinical activity 
levels, resources in Level 1 centres are stretched significantly further than they are in Level 2 clinics.  
It is acknowledged, however, that although larger clinics have comparatively fewer staff than their 
smaller counterparts, this may partly reflect increased efficiencies due to larger size (i.e. economies 
of scale). Thus, adequate or necessary staffing may not always be directly proportional to clinical 
activity or patient numbers.  It is not possible to draw firmer conclusions here because some other 
variables relevant to issues of workload and throughput — such as staff expertise and/or length of 
relevant experience, staff stress, retention rates, incident reports and efficiency modelling — were 
beyond the scope of the WIP data set. 
Our findings suggest that the additional clinical activity in Level 1 centres is largely 
undertaken by medical and/or nursing staff.  This may imply that Level 1 centres deliver a more 
medical, rather than multidisciplinary, approach to CP: a suggestion that is consistent with the finding 
of increased patient participation in PMGP’s in Level 2, compared with Level 1, clinics.  However, the 
major distinction between IASP Level 1 and 2 classifications is the provision of teaching and training 
— part of which includes medical training via junior medical staff rotations and, more specifically, the 
Faculty of Pain Medicine (FPM) fellowship program (1-2 years).  Typically, trainees undertaking this 
fellowship are paid employees of the unit and provide clinical services to patients; as such, they are 
included in recorded staff establishments.  Therefore, although a component of the medical FTE 
found in Level 1 centres may reflect their additional teaching/training/trainee roles, the higher levels 
of patient activity and nursing FTE in Level 1 clinics suggest that these trainees’ duties were largely 
clinical in nature and, therefore, could still be considered to reflect a medical focus.  Of note, 
potentially similar AH training activities were not captured in this study because, unlike their medical 
counterparts, AH trainees are unpaid and consequently not recorded within staffing establishments.  
Moreover, as specific information regarding the clinical activities of AH outside of PMGP’s was not 




captured, it is not possible to accurately assess the amount of multidisciplinary activity provided 
across services.  Until detailed information about the full range of clinical, training and research 
activities are systematically collected for all disciplines, the suggestion that Level 1 centres have a 
more medical focus remains to be confirmed.  However, despite the availability of a large amount of 
information to inform models of care for CP, the variability in PMGP intensity levels and rates of 
patient participation, as well as in the use of medical procedures (both minor and major) suggests 
that there is not yet agreement regarding an optimal care configuration for multidisciplinary pain 
services. 
With the exception of medical staff, metropolitan and rural based services were reasonably 
comparable in terms of the staffing models (disciplines and amounts) that they employed, the level of 
clinical demand they experienced and the number of new patients they saw each year.  It is 
interesting to note that the higher numbers of medical FTE in metropolitan services did not translate 
to increased clinical activity (number of new patients seen).  One possible explanation for this might 
be that rural clinics see a different case-mix of patients; with metropolitan clinics receiving more 
complex referrals, possibly from other city-based medical specialists.  Such cases may require 
longer and/or more frequent consultations, effectively reducing the number of appointment times 
available for new patients.  Alternatively, it is possible that rural services are better connected with 
their primary care colleagues and thus more able to support and co-ordinate care that is provided 
primarily in the community.  Clinical activity was operationalised here as the number of new patients 
seen per annum: thereby capturing patient intake data but not data regarding patients that were then 
seen in an ongoing or recurrent way (i.e. return appointments rather than new appointments).  
Indeed, differences in case-mix and availability of/links with community services (both impacting on 
need for ongoing management by a pain service) may contribute to the differences in national 
median wait-times for CP services reported previously (Level 1: 150 days, Level 2: 90 days) (Hogg, 
et al., 2012).  As such, more detailed examination of case-mix and service information is needed to 




better understand this finding and indeed, to fully understand the rates of medical intervention 
reported. 
Overall, the reasonable consistency demonstrated in the range and mix of disciplines 
employed by CP services across Australia (apart from the variation in occupational therapy staffing) 
suggests that current clinic configurations represent workable clinical structures. Accordingly, our 
study provides some empirical support for use of these configurations as initial guidelines when 
designing CP clinics. An important limitation, however, is that we are not able to comment on service 
quality or patient outcomes.  Thus, we cannot say whether these employment and activity levels 
necessarily translate to effective or efficient services.  Indeed, it is clear from long waiting lists and 
annual unmet clinical needs (Hogg, et al., 2012) that current arrangements are inadequate. 
Another limitation of this study is that it did not fully explore or document the complete range 
of treatments and/or activities provided by clinics, hampering our ability to fully appreciate nuances 
of staff utilisation.  As stated above, this is particularly relevant for AH whose activity outside of 
PMGPs was not explored at all. It remains unclear whether lower levels of AH staffing equate to a 
less multidisciplinary focus or whether, in fact, AH were engaged in other multidisciplinary activities.  
Similarly, the survey failed to capture the contributions of doctors and nurses to PMGPs, leaving this 
aspect of staffing unexamined.  Although considerable efforts were made to maximise the accuracy 
of the data, it did not all come from electronic systems. Finally, almost 20% of the clinics approached 
declined to participate.  Thus, the degree to which our results can be generalised to those clinics, or 
indeed to international equivalents, is not clear. 
This report represents one step toward maximising treatment efficiencies and outcomes in 
the area of CP: documenting the first Australian data on multidisciplinary staff resources (Table 5.2), 
the discipline-specific staff cost per/100 patients of providing this service in ISAP defined Level 1 and 
2 clinics (Table 5.3); and the AH cost of PMGPs (Table 5.5).  Future research needs to explore: the 
relationship between staffing levels and patient outcomes, medical/nursing input to PMGPs, and the 




clinical activity of AH staff outside PMGPs.  This would help to clarify whether Level 1 centres use 
resources more effectively or whether Level 2 clinics, in fact, have more available resources and are 
more truly multidisciplinary in nature.  Further, the contribution of occupational therapy to CP 
services needs to be clarified to address the variable involvement of this discipline across current 
service models.  It is only by systematically gathering this information that we will be able to provide 
a detailed understanding of the impact of staffing resources and patterns on treatment outcomes for 




Chapter 6 : Does Pre-Clinic Intervention Help Reduce the Negative Impact of 
Waiting to Access Treatment for Chronic Pain? 
6.1 Preamble 
Multidisciplinary care is considered best-practice for CP treatment, but many services 
struggle to cope with the growing demand, resulting in lengthy waits for patients.  Thus far, this 
thesis has demonstrated that these waiting periods have a significant negative impact on waitlisted 
individuals; more so for women than men and from 12 months on (Study 2, Chapter 4).  An 
intervention delivered within the first six months following referral therefore appears to be important, 
but there is no information regarding the best way to achieve this within the existing funding and 
staffing constraints.  The relative consistency that was observed in the range and mix of disciplines 
employed by CP services across Australia suggests that clinics have developed workable staffing 
structures (Study 3, Chapter 5).  Consequently, earlier interventions are likely to require increased 
staffing levels, rather than a change in mix of disciplines that are employed. 
In the absence of any increased funding to better resource these services, clinicians have 
recently focussed on devising novel approaches to service delivery — including the provision of a 
brief intervention during the pre-clinic (waitlist) period.  However, the best model of care for this type 
of intervention has yet to be determined; with the programs that are being utilised across clinics 
differing in both their intensity and frequency.  Brief single interventions are particularly attractive 
because they are more readily supported using existing resources than are more intensive models 
that require more clinical input; a critical consideration in the context of constrained funding for health 
services. 
This fourth study therefore sought to examine whether a single brief pre-clinic education 
session improved the well-being and QOL of individuals entering the waitlist for a tertiary CP service.  
Of note, this paper was published before Study 2 and so additionally includes an exploration of the 




impact of the first six months of waiting to access CP treatment; data that was expanded upon in the 
2.5 year longitudinal study. 
Tables and Figures have been inserted within the text to make it easier to read and a copy 
of the published article (reproduced with permission) is presented as supplementary information in 
Appendix 4.  As per previous chapters, all references have been compiled into a complete 
references list which is presented at the end of this thesis. 
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Objectives: To examine (1) whether a single brief pre-clinic educational session improved the well-
being and quality of life of individuals entering the waitlist for a tertiary chronic pain (CP) service, and 
(2) the impact of waiting for services on these outcomes. 
Methods: Participants were 346 adults, with basic English skills and non-urgent triage codes, who 
were recruited on referral to a tertiary Australian metropolitan CP unit.  Participants were randomised 
across two conditions: ‘treatment as usual’ (normal waitlist) and ‘experimental’ (normal waitlist plus a 
three-hour CP educational session).  The educational session encouraged self-management and life 
engagement despite pain.  Multiple outcomes (pain acceptance, pain-related interference, 
psychological distress, health care utilisation [frequency, types], quality of life, health 
knowledge/beliefs), as well as pain severity and symptom exaggeration, were assessed at intake 
and again at two weeks and six months post-educational session (or equivalent for the waitlist 
group). 
Results: Satisfaction with the educational session was moderate-to-high, but attendance was not 
associated with improved outcomes.  At two weeks, all study participants reported significant 
improvements in pain acceptance (willingness, overall acceptance), health care utilisation 
(frequency) and quality of life (physical); which were maintained/enhanced at six months.  Use of 
psychological and physical therapies increased significantly by six months.  There was no functional 
deterioration while waitlisted. 
Conclusions:  Attending a brief pre-clinic education session did not improve function.  There was no 
deterioration in waitlisted participants who agreed to be involved in research and who completed 
study measures at two and six months, but referral was associated with short-term functional 
improvements.  This is the first study to link positive change with referral to, rather than treatment by, 
a tertiary CP service. 
  





Chronic pain (CP) is a major contributor to the global burden of disease; with one in ten 
people being newly diagnosed each year (IASP & EFIC).  Not surprisingly, CP has been linked with 
significant impairment across a range of psychological domains, including anxiety, depression and 
quality of life (QOL) (Burke, Mathias, et al., 2015).  It is also associated with physical and 
occupational restrictions (Douglas, et al., 2004; W. F. Stewart, et al., 2010), withdrawal from valued 
life activities (Haythornthwaite & Benrud-Larson, 2000), and increased health care utilization (HCU) 
(Blyth, et al., 2004).  Despite its high prevalence and associated costs, CP is often poorly 
represented in the diagnostic data collected by health agencies (Commonwealth Department of 
Health and Aged Care, 1998; Tian, Zlateva, & Anderson, 2013), resulting in limited public funding for 
CP services. 
Research supports multidisciplinary care as best practice for CP (Hassett & Williams, 2011), 
leading to improved physical and psychological adjustment for patients (National Pain Summit 
Initiative, 2011).  Typically, this involves contributions from medical, nursing, psychological, 
physiotherapy and psychiatric professionals (Burke, Denson, Mathias, & Hogg, 2015).  However, 
many multidisciplinary CP services struggle to meet increasing demand, resulting in significant wait-
times for assessment and treatment (Hogg, et al., 2012; Peng, et al., 2007), during which patients’ 
health and well-being may deteriorate (Lynch, et al., 2008).  Accordingly, CP clinicians are 
developing alternative ways to address clinical needs, including brief interventions in the pre-clinic 
(waitlist) period. One exemplar is the Self-Training Educative Pain Sessions (STEPS) model 
(Davies, et al., 2011), which involves a two-day (or six-session) pre-clinic group program that 
educates patients about pain processes and promotes active self-management.  Three-month 
follow-up data indicated that, although STEPS did not impact on anxiety or depression, the two-day 
program afforded numerous other benefits to patients (i.e., improved self-efficacy, reduced disability, 
impression of change, greater strategy use) and service delivery (i.e., reduced wait-time, costs and 




need for individual follow-up appointments, greater attendance rates and patient satisfaction with 
treatment).  Moreover, the incorporation of STEPS into the clinic’s core intake process resulted in a 
significant reduction in demand for individual clinic appointments, with just over half of all patients 
opting not to pursue additional input beyond the STEPS program (Davies, et al., 2011). 
Given the lengthy wait for services experienced by many, the idea of a brief session at 
referral is compelling.  Despite considerable debate in the CP literature, optimal group program 
intensity has yet to be determined for either clinic or pre-clinic interventions (British Pain Society, 
2013; NSW Agency for Clinical Innovation, 2013).  It has however, been suggested that intensity 
should be directly proportional to the degree of disability (physical and psychological) experienced by 
individuals, with the most disabled persons requiring the most intensive programs (NSW Agency for 
Clinical Innovation, 2013).  In addition, other research has supported the potential impact of single 
brief educational sessions on the pain catastrophizing and fear (de Jong, et al., 2005), physical 
performance (Moseley, et al., 2004), and return to work rates of individuals living with CP (Engers, et 
al., 2008). 
The current project therefore sought to evaluate whether a single brief multidisciplinary CP 
educational session of three hours duration — adopting a low-intensity model, conducive to 
implementation using existing clinical resources — could yield positive benefits, both in the short- 
(two weeks) and intermediate-term (six months), for individuals waiting to access a tertiary CP 
service.  A secondary aim was to document any changes in participants’ well-being during the first 
six months on a waitlist for CP services in order to explore the independent effects of waiting for 
treatment. 






Participants were adults who were newly referred to the Pain Management Unit (PMU) of 
the Royal Adelaide Hospital between November 2011 and November 2013.  The PMU is a 
‘Multidisciplinary Pain Centre’ (IASP, 2009) situated in the largest accredited teaching hospital in the 
state of South Australia.  It provides a range of coordinated multidisciplinary services to adults living 
with CP.  Referrals are actively triaged, based on a range of clinical factors, and wait-times are 
typically long; often exceeding two years.  Individuals referred for cancer/palliative care, early 
intervention (e.g. for Complex Regional Pain Syndrome) or intervention within six months were 
excluded from this study because initial appointments were likely to occur before completion of the 
proposed educational session and/or follow-up time-points (two weeks, six months).  Individuals 
referred prior to November 2011 were excluded because all recruitment occurred at the time of 
referral.  Finally, basic English fluency and literacy skills were required in order to complete the study 
components (session presentation, handouts, outcome measures).  All eligible patients (screened on 
the basis of referral information and PMU triage processes) newly referred to the PMU during the 
recruitment period were approached to participate in the study. 
Study Design 
A randomised research design was employed, whereby a random number allocation list was 
produced using an online generator (http://graphpad.com/quickcalcs/randomize1.cfm) to guide the 
allocation of potential study participants (ordered on the basis of sequential referral date) to one of 
two conditions — standard waitlist management (‘treatment as usual’: TAU) or standard waitlist 
management plus educational session (‘experimental’: EXP).  Once randomised, individuals were 
sent the associated paperwork (standard PMU questionnaires plus study information for the TAU or 
EXP conditions, respectively) inviting them to participate in the study.  Participants were told that the 




research was designed to investigate the impact of waiting for services on individuals living with CP 
and to determine whether changes to waitlist management could improve outcomes.  An ‘opt-out’ 
model was utilised for the educational session in order to maximize attendance (Treweek et al., 
2010), thus each EXP group participant was notified of the date and time of the session to which 
they had been allocated and advised that they were welcome to reschedule to another session if 
desired.  Allocation was initially randomised equally (1:1) between the EXP and TAU groups.  
However, unequal randomisation (2 EXP : 1 TAU) was subsequently adopted to more evenly 
balance group numbers and maximize statistical power for the between-groups analyses (Dumville , 
Hahn, Miles, & Torgerson, 2006) because lower uptake and greater drop-out rates were observed in 
the EXP condition. 
Intervention 
Each educational session was facilitated by a multidisciplinary panel of PMU staff — a pain 
consultant physician, psychologist and physiotherapist — all with significant experience in CP.  The 
length of the session (three hours) was based on the recommendations of a meta-analytic review 
(Engers, et al., 2008), which suggested that a minimum of 2.5 - three hours duration was required for 
an educational session to be beneficial.  Session content was standardized via a PowerPoint 
presentation to ensure consistency across presentations and included information about: CP 
processes, the clinical unit and what to expect from treatment, the role of psychological factors in 
pain and ways to manage pain (e.g., relaxation, mindfulness, challenging thinking etc.), goal setting, 
sleep hygiene, distraction/attention focus, self-care, exercise, activity pacing and medication.  
Consistent with the literature on the self-management of CP, the session was designed to encourage 
participants to critically review their approach to pain management by (1) providing basic education 
about pain processes, including neurobiological conceptualisations (Moseley, et al., 2004); (2) 
exploring the limitations of medications in CP management; and (3) exploring ways of enhancing 
QOL, despite experiencing ongoing pain (Davies, et al., 2011; National Pain Summit Initiative, 2011).  




In doing so, we communicated that the role of the pain management team was to support effective 
CP management, rather than to provide better analgesia or a cure for CP.  Thus, the central goal of 
the session was to inform and encourage a psychological shift from the often fruitless quest for pain 
cessation or control, to a stance of acceptance and life engagement in the face of pain.  Printed 
handouts were produced to support and supplement the session information (distributed at the 
commencement of each session), because group outcomes are thought to be enhanced by the 
provision of written literature (Bennett, Bagnall, & Closs, 2009). 
Measures 
Consistent with contemporaneous clinic practice, at the point of referral, individuals were 
required to complete and return an intake screening measure prior to being placed on the clinic 
booking queue.  This measure — the Patient Screening Questionnaire (PSQ) — was based on a 
triage questionnaire sourced from Hunter Integrated Pain Service (New South Wales Department of 
Health).  The PSQ explores information related to pain (onset, duration, pattern, site(s), 
compensation status), HCU (frequency, treatment types) and demographic information (sex, age, 
marital and work status).  The PSQ also includes validated measures of pain severity (four items of 
the Brief Pain Inventory: BPI-PS (Cleeland & Ryan, 1994)), pain-related interference (seven items of 
the Brief Pain Inventory: BPI-PI (Cleeland & Ryan, 1994)) and psychological distress (Kessler 
Distress Scale: K-10 (Kessler, et al., 2003)); all of which were used in the current study to minimize 
respondent burden (see Table 6.1 for details of the study measures). 
A range of other outcome measures were additionally utilised in order to more fully explore 
the multifaceted experience of living with CP: measures of pain acceptance (Chronic Pain 
Acceptance Questionnaire: CPAQ (McCracken, et al., 2004)), QOL (World Health Organisation 
QOL-Brief Scale: WHOQOL-BREF (Murphy, et al., 2000)), pain-related health knowledge and 







Table 6.1: Overview of measures used in the study 
Domain Assessed Measure Number of Items Time Period assessed Possible Score Range Reference 
Pain acceptance CPAQ 20   (McCracken, et al., 2004) 
 Pain willingness  9 “as it applies to you” 0-54  
 Activity engagement  11 “as it applies to you” 0-66  
 Overall acceptance  20 “as it applies to you” 0-120  
Pain-related interference BPI-PI 7 previous 24 hours 0-10 (Cleeland & Ryan, 1994) 
Psychological distress K-10 10 previous 4 weeks 10-50 (Kessler, et al., 2003) 
Health care utilisation (HCU) PSQ 18    
 Frequency  5 previous 3 months 0-40  
 Treatment types  13 - 0-13  
Quality of life (QOL) AWHOQOL-BREF 26   (Murphy, et al., 2000) 
 Physical health  7 previous 4 weeks 7-35  
 Psychological health  6 previous 4 weeks 6-30  
 Social relationships  3 previous 4 weeks 3-15  
 Environment  8 previous 4 weeks 8-40  
 Overall  1 previous 4 weeks 1-5  
 Overall Health  1 previous 4 weeks 1-5  
Health knowledge/beliefs (HKB) Study specific 5 - 5-25  
Pain Severity BPI-PS 4   (Cleeland & Ryan, 1994) 
 Worst pain  1 previous 24 hours 0-10  
 Least pain  1 previous 24 hours 0-10  
 Average pain  1 on average 0-10  
 Current pain  1 right now 0-10  
Symptom exaggeration SDRS-5 5 - 0-5  
Note: BPI-PI = Brief Pain Inventory, Pain Interference subscale; K-10 = Kessler Distress Scale; PSQ = Patient Screening Questionnaire; CPAQ = Chronic Pain Acceptance Questionnaire; 
AWHOQOL-BREF = Australian World Health Organisation Quality of Life Brief Scale; BPI-PS = Brief Pain Inventory, Pain Severity subscale; SDRS-5 = Social Desirability Response Set 
Scale. 
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influence on psychological distress, engagement with physical activity and QOL (Mason, Mathias, & 
Skevington, 2008).  The QOL measure was chosen because it explores QOL more broadly than 
many other measures and was therefore more inclusive of the range of ways that CP may impact on 
this domain.  The study-specific health knowledge/beliefs measure was devised to explore 
participants’ understanding of CP and its management, and, specifically, awareness of concepts 
presented within the educational session (EXP group).  Although not an outcome measure, pain 
severity (‘current’ pain) was included because it was an important consideration when assessing the 
impact of waiting to access a CP service.  This was particularly salient because it had the potential to 
influence responses on other questionnaires; with higher pain at the time of responding possibly 
being associated with greater reported distress and impaired recall.  However, it is important to note 
that pain reduction was not a core goal of the educational session; consequently we did not expect 
ratings of pain severity to be influenced by session attendance.  Likewise, symptom exaggeration 
was included because we recognized that a desire to expedite appointment allocation may 
potentially influence responses; either deliberately or unintentionally.  Accordingly, a measure of 
symptom exaggeration (Social Desirability Response Set Scale: SDRS-5) (Hays, et al., 1989) was 
included at the end of the health knowledge/beliefs measure, following two study-specific linking 
items (i.e. “my pain impacts on the way that I respond to others” and “I find that I am more 
understanding of the difficulties of others”) devised specifically to prevent the symptom exaggeration 
items from appearing discordant with preceding questions. 
Finally, a study-specific measure was developed to assess participant satisfaction with the 
pre-clinic educational session.  Attendees were asked to rate five items on a five-point scale, ranging 
from ‘1’ (not at all) to ‘5’ (completely).  Specifically, they rated: satisfaction with the overall 
presentation, usefulness of the presentation and printed materials, whether the individual’s thinking 
had changed as a result of attending the session and, if it had, the degree of perceived usefulness of 
that change.  Participants were also asked whether they would have liked more information about 
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anything in particular and, if so, what.  Space was then offered for participants to provide 
unstructured feedback. 
Procedure 
Following referral and initial medical triage, potential participants were randomised and sent 
the intake screening measure (PSQ), as well as the appropriate study information sheet (EXP or 
TAU), consent form and intake research questionnaire pack.  The study documents outlined the 
aims of the project and invited research participation, while emphasizing that individuals were free to 
decline or discontinue participation at any time without affecting wait-times or later treatment.  
Following questionnaire completion and study consent, participants in the TAU group were placed on 
a booking queue, pending notification of an available appointment (standard PMU practice at that 
time).  EXP participants were placed on the same booking queue and details of their educational 
sessions (date, time, location, description) were provided in their information sheets. 
Because the initial questionnaire pack was sent out with the PSQ (Time 1: T1), a condensed 
version was generated for follow-up to avoid unnecessary duplication (e.g., birthplace).  EXP 
participants were followed-up at two weeks (Time 2: T2) and six months (Time 3: T3) after their pre-
clinic session.  Feedback on the session was sought from attendees at T2.  The TAU group was sent 
the same questionnaires (excluding the session feedback form) at equivalent times.  By T3, 7% of 
participants (n = 24) had attended, or been offered, an initial clinic appointment.  Individuals who did 
not return a pack within one month were sent a reminder pack, with a note encouraging them to 
return the completed measures.  Reply paid self-addressed envelopes accompanied all packs. 
Although it was not anticipated that completion of the study measures would cause undue 
discomfort, it is well documented that CP is frequently associated with significant levels of 
psychological distress (Burke, Mathias, et al., 2015).  Hence, each mail-out included information 
outlining options for gaining assistance with distress, whether resulting from participation in this 
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project or other causes.  Finally, as a means of thanking participants for their involvement, every 
mail-out included a thank-you note encouraging them to “relax and enjoy a cuppa”.  Taped to each 
note was an individually sealed tea bag. 
The study was approved by the Research Ethics Committee of Royal Adelaide Hospital 
(Protocol #111004).  Participant randomisation, mail-outs, questionnaire scoring and data entry were 
all completed by the ALJB.  Moreover, ALJB attended the start of each session to introduce the 
presenters to the attendees, explain the research aims and answer any research-related questions.  
The researcher then handed the session over to the clinical team and left the room. 
Statistical Analyses 
Independent samples t-tests and chi-square statistics were calculated to assess differences 
between those EXP participants who ‘failed to attend’ the pre-clinic educational session (without 
notice) and those who ‘declined to attend’ (contacted the unit in advance to advise of non-
attendance).  These analyses indicated that there was no significant difference between the two 
groups on any of the demographic/background variables (age: t(152) = -0.34, p = 0.73; sex: 2(1, 
N=154) = 0.04, p = 0.84; relationship status: 2(3, N=148) = 2.22, p = 0.53; employment: 2(11, 
N=149) = 15.93, p = 0.14; born in Australia: 2(1, N=150) = 0.04, p = 0.83; non-Australian location of 
birth: 2(3, N=35) = 2.51, p = 0.47; previous contact with pain clinic: 2(2, N=151) = 1.27, p = 0.53; 
private health insurance: 2(1, N=148) = 0.12, p = 0.73; pain duration: 2(5, N=150) = 4.69, p = 0.46; 
compensation: 2(1, N=149) = 1.27, p = 0.26; pain in more than 1 site: 2(1, N=154) = 2.19, p = 
0.14; primary pain site: 2(11, N=144) = 10.61, p = 0.48; reason for pain onset: 2(7, N=148) = 2.80, 
p = 0.90).  Thus, they were combined to form a third group - ‘did not attend’ (DNA) - for all 
subsequent analyses. 
Power calculations conducted via G*Power (Faul, et al., 2007) indicated that the study was 
adequately powered (effect size f = 0.25, αerror probability = 0.05; power = 0.95).  As recommended by 
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Armijo-Olivo and colleagues (2009), data was analyzed using an ‘as treated’ rather than ‘intention to 
treat’ protocol because the large number of participants in the DNA group did not receive any 
treatment at all.  One-way analyses of variance were used to check for differences between the 
groups on the independent variables at T1 in order to ensure that they were comparable at intake.  
Repeated measures mixed-model analyses then explored the impact of Time (T1, T2, T3) and 
Group (EXP, DNA, TAU) on the dependent variables (outcome measures: pain acceptance, pain-
related interference, psychological distress, HCU, QOL, health knowledge/beliefs) (Armijo-Olivo, et 
al., 2009).  Where main effects were found, post-hoc analyses using t-tests with Bonferroni 
corrections explored the differences.  In accordance with current recommendations regarding 
calculation of effect size for this type of analysis, d was calculated to provide a measure of the 
standardized difference between the means for the three groups (Dunlap, Cortina, Vaslow, & Burke, 
1996; Feingold, 2013) and was interpreted using Cohen’s (Cohen, 1988) guidelines: with d = 0.2, 0.5 
and 0.8 indicating small, medium and large effects, respectively. 
6.5 Results 
Participant Characteristics at Intake 
As Figure 6.1 depicts, 712 people were invited to participate in the research.  Six declined 
referral to the PMU, one could not be contacted, four had consulted another clinic and three did not 
meet the English language requirements.  Of the remaining 698 individuals, 33% (n = 232) did not 
respond and 17% (n = 120) only returned the PSQ, thereby securing their position on the clinic 
booking queue, but declining to participate in the study.  This resulted in a final research sample of 
346 people, ranging in age from 22 to 83 years, the majority of whom were female, not partnered, 
unemployed as a result of their pain and Australian-born (see Table 6.2).  An independent samples t-
test and chi-square statistic indicated that there was no significant difference in age or sex mix 
between those individuals who agreed to participate in the study and those who declined to do so   




























Figure 6.1: Flow of participants through the study  
Referrals randomised to treatment condition 
(N=712) 
Experimental (EXP) Condition 
(N=485) 




Unable to contact 
(N=1) 




EXP sent invitation to participate 
(N=475) 




EXP total recruited 
(N=220) 
EXP - Attended 
session 
(N=66) 
DNA - Did not 
attend session 
(N=154) 
Failed to attend 
(N=130) 




TAU sent invitation to participate 
(N=223) 
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Table 6.2: Summary demographic information of the sample 
 
EXP 
N  (%) 
DNA 
N  (%) 
TAU 
N  (%) 
Full Sample 
N  (%) 
GENERAL INFORMATION 
Nparticipants 






 Married/de facto 
 Divorced/separated 
 Widowed 
 Not reported 
Employment status 
 Unemployed (due to pain) 
 Unemployed (other reasons) 
 Part-time 
 Full-time 
 Home duties 
 Retired 
 Disability Support Pension 
 Student 




 Not reported 






 South America 
 North America 
 Not reported 
 
 
66  (19) 
46.2  (9.9) 
 
44  (67) 
22  (33) 
 
20  (30) 
29  (44) 
14  (21) 
- 
3  (5) 
 
27  (41) 
10  (15) 
5  (7.5) 
5  (7.5) 
11  (17) 
3  (4.5) 
2  (3) 





1  (1.5) 
 
48  (73) 
9  (14) 
5  (8) 
- 
1  (1) 
1  (1) 
- 
2  (3) 
 
154  (45) 
45.0  (10.2) 
 
87  (56) 
67  (44) 
 
67  (43) 
60  (39) 
20  (13) 
1  (1) 
6  (4) 
 
60  (39) 
19  (12) 
14  (9) 
15  (10) 
13  (8.5) 
11  (7) 
4  (2.5) 
4  (2.5) 
3  (2) 
3  (2) 
2  (1.5) 
1  (1) 
5  (3) 
 
115  (75) 
26  (17) 
3  (2) 
4  (2.5) 
2  (1) 
- 
- 
4  (2.5) 
 
126  (36) 
41.8  (10.3) 
 
67  (53) 
59  (47) 
 
63  (50) 
42  (33) 
12  (10) 
- 
9  (7) 
 
41  (33) 
29  (23) 
14  (11) 
12  (10) 
8  (6) 
2  (2) 
7  (5) 
5  (4) 
1  (1) 
1  (1) 
- 
- 
6  (4) 
 
95  (75) 
15  (12) 
9  (7) 
1  (1) 
2  (2) 
- 
1  (1) 
3  (2) 
 
346 
44.1  (10.3) 
 
198  (57) 
148  (43) 
 
150  (43) 
131  (38) 
46  (13) 
1  (0.5) 
18  (5.5) 
 
128  (37) 
58  (17) 
33  (9.5) 
32  (9) 
32  (9) 
16  (5) 
13  (4) 
11  (3) 
4  (1) 
4  (1) 
2  (0.5) 
1  (0.5) 
12  (3.5) 
 
258  (72) 
50  (14) 
17  (5) 
5  (2) 
5  (2) 
1  (1) 
1  (1) 
9  (3) 
PAIN / HEALTH INFORMATION 
Pain in More Than One Site 
 Yes 
 No 
 Not reported 
Pain Duration 
 Greater than 10 years 
 5 – 10 years 
 12mths – 3 years 
 3 - 5 years 
 6 - 12 months 
 
 
63  (95.5) 
3  (4.5) 
- 
 
24  (36) 
10  (15) 
11  (17) 
16  (24) 
5  (8) 
 
 
143  (93) 
11  (7) 
- 
 
60  (39) 
34  (22) 
28  (18) 
18  (12) 
9  (5.5) 
 
 
118  (94) 
7  (5) 
1  (1) 
 
37  (29) 
30  (24) 
24  (19.5) 
24  (19.5) 
6  (4) 
 
 
324  (93.5) 
21  (6) 
1  (0.5) 
 
121  (35) 
74  (21) 
63  (18) 
58  (17) 
20  (6) 
Note: EXP = Experimental Group (attend pre-clinic educational session); DNA = Did Not Attend Group (did not 
attend pre-clinic session); TAU = Treatment As Usual Group (waitlist). 
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Table 6.2: Summary demographic information of the sample cont. 
 
EXP 
N  (%) 
DNA 
N  (%) 
TAU 
N  (%) 
Full Sample 
N  (%) 
PAIN / HEALTH INFORMATION cont. 
Pain Duration cont. 
 Less than 6 months 
 Not reported 
Primary Pain Site 
 Lower Back / Buttocks 
 Total / Almost total body 
 Legs / Feet 
 Neck 
 Head / Face / Mouth 




 Arms / Hands 




 Not reported 
Reason for Pain Onset 
 No clear reason 
 Other 
 Other illness related 
 Work accident 
 Motor vehicle accident 
 Post-surgical 
 Home accident 
 Cancer 
 Not reported 
Seen a Pain Clinic Before 
 No 
 Yes, multidisciplinary clinic 
 Pain doctor (single discipline only) 




 Not reported 
Private Health Insurance 
 No 
 Yes 






21  (32) 
11  (17) 
8  (12) 
3  (4.5) 
3  (4.5) 
5  (7.5) 
3  (4.5) 
2  (3) 
2  (3) 
2  (3) 
- 
1  (1.5) 
1  (1.5) 
- 
4  (6) 
 
16  (24) 
15  (23) 
12  (18) 
8  (12) 
7  (11) 
4  (6) 
3  (4.5) 
- 
1  (1.5) 
 
54  (82) 
10  (15) 
1  (1.5) 
1  (1.5) 
 
64  (97) 
1  (1.5) 
1  (1.5) 
 
47  (71) 




1  (1) 
4  (2.5) 
 
67  (44) 
16  (10) 
15  (9.5) 
11  (7) 
8  (5) 
7  (4.5) 
6  (4) 
7  (4.5) 
2  (1.5) 
2  (1.5) 
- 
2  (1.5) 
1  (1) 
- 
10  (6) 
 
36  (23) 
33  (21) 
23  (15) 
29  (19) 
16  (10) 
6  (4) 
4  (3) 
1  (1) 
6  (4) 
 
124  (80) 
23  (15) 
4  (3) 
3  (2) 
 
142  (92) 
7  (5) 
5  (3) 
 
117  (76) 
31  (20) 
6  (4) 
 
 
3  (2) 
2  (2) 
 
49  (39) 
19  (15) 
16  (13) 
5  (4) 
5  (4) 
3  (2) 
4  (3) 
4  (3) 
5  (4) 
3  (2) 
4  (3) 
1  (1) 
- 
2  (2) 
6  (5) 
 
33  (26.5) 
26  (21) 
23  (18) 
18  (14) 
15  (12) 
4  (3) 
4  (3) 
- 
3  (2.5) 
 
107  (85) 
11  (9) 
3  (2) 
5  (4) 
 
114  (91) 
8  (6) 
4  (3) 
 
98  (78) 
23  (18) 
5  (4) 
 
 
4  (1) 
6  (2) 
 
137  (39.5) 
46  (13) 
39  (11) 
19  (5.5) 
16  (5) 
15  (4.5) 
13  (4) 
13  (4) 
9  (3) 
7  (2) 
4  (1) 
4  (1) 
2  (0.5) 
2  (0.5) 
20  (5.5) 
 
85  (24) 
74  (21) 
58  (17) 
55  (16) 
38  (11) 
14  (4) 
11  (3) 
1  (1) 
10  (3) 
 
285  (82) 
44  (13) 
8  (2) 
9  (3) 
 
320  (92) 
16  (5) 
10  (3) 
 
262  (76) 
73  (21) 
11  (3) 
Note: EXP = Experimental Group (attend pre-clinic educational session); DNA = Did Not Attend Group (did not 
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(i.e. ‘opt out’ group: Mage = 44.3, SDage = 11.6, range = 17-79 years; Nfemales = 73, 61%) (age: t(464) = 
0.21, p = 0.84; sex: 2(3, N=466) = 3.78, p = 0.29). 
Most participants indicated that they experienced pain in more than one site and just over 
half of the sample (n = 195, 56%) said that their pain had persisted for five or more years, often in 
the absence of a clear cause.  Consistent with referral to a public health service with lengthy wait-
times, most participants had not previously consulted a multidisciplinary pain service, were not 
involved in pain-related litigation and did not have private health insurance (see Table 6.2).  As can 
be seen in Table 6.3, scores on the Pain Interference subscale of the Brief Pain Inventory (BPI-PI) 
(Cleeland & Ryan, 1994) at T1 indicated that participants experienced a high level of pain-related 
interference in their ability to undertake daily activities.  Psychological distress was also prevalent at 
T1, with the majority of respondents (N = 245, 71%) reporting symptoms in the “moderate” or 
“severe” range (≥ 25) of the Kessler Distress Scale (K-10) (Kessler, et al., 2003).  These phenomena 
were also reflected in the measure of HCU, with participants reporting an average of 10 health-
related appointments every three months (M = 10.4, SD = 6.5) and weekly appointments being 
reported by a third of participants (N = 127, 37%).  As might be expected, scores on the Australian 
World Health Organisation QOL Brief Scale (AWHOQOL-BREF) (Murphy, et al., 2000) indicated 
marked impairment across all QOL domains for the present sample when compared with Australian 
normative data (Murphy, et al., 2000).  Finally, scores for ‘current pain’ on the Pain Severity subscale 
of the BPI (BPI-PS) revealed that the sample as a whole reported experiencing a significant amount 
of physical pain at T1. 
As indicated, one-way analyses of variance were performed to check whether the three 
Groups (EXP, DNA, TAU) were comparable prior to the intervention.  These analyses showed that 
there were no significant differences between the Groups at T1 on any of the measures, indicating 
that they were comparable prior to the study intervention in terms of: pain acceptance (CPAQ – pain 




Table 6.3: Mean (SD) scores on the outcome measures, by assessment times and group 
 
Full Sample at 
Intake (T1) 
T1 T2 T3 
 EXP DNA TAU EXP DNA TAU EXP DNA TAU 
CPAQ 
 Pain Willingness 
 Activity Engagement 









































BPI-PI 7.4 (1.7) 7.3 (1.5) 7.3 (1.7) 7.5 (1.6) 7.2 (1.7) 7.2 (1.8) 7.6 (2.1) 6.9 (1.8) 7.2 (1.8) 7.2 (2.5) 
K-10 30.0 (8.7) 30.0 (9.2) 29.8 (8.6) 30.3 (8.6) 31.3 (8.4) 29.5 (8.8) 31.9 (9.7) 28.5 (8.0) 31.1 (9.0) 30.0 (11.0) 
HCU 
       Frequency 
      Treatment Types 
  Medical 
  Psychological 
  Alternative 
  Physical 


















































































 Physical Health 
 Psychological Health 
 Social Relationships 
 Environment 
 Overall QOL 







































































HKB 14.4 (2.8) 14.1 (2.9) 14.6 (2.7) 14.5 (3.0) 14.9 (3.0) 15.0 (2.7) 14.3 (2.8) 14.4 (2.2) 14.9 (2.4) 14.5 (2.7) 
BPI-PS 6.9 (1.9) 7.1 (1.8) 6.8 (2.0) 7.0 (1.8) 6.7 (2.3) 7.0 (1.8) 6.8 (2.6) 7.3 (1.8) 6.5 (2.3) 6.7 (2.7) 
SDRS-5 1.8 (1.5) 1.8 (1.5) 1.9 (1.5) 1.8 (1.4) 2.1 (1.7) 1.7 (1.5) 1.8 (1.5) 2.1 (1.6) 1.8 (1.5) 1.7 (1.4) 
Note: T1 = Time 1 (intake); T2 = Time 2 (2-week post-session follow-up); T3 = Time 3 (6-month follow-up); EXP = Experimental Group (attended pre-clinic session); DNA = Did Not Attend 
Group (did not attend pre-clinic session); TAU = Treatment As Usual Group (waitlist); CPAQ = Chronic Pain Acceptance Questionnaire; BPI-PI = Brief Pain Inventory, Pain Interference 
subscale; K-10 = Kessler Distress Scale; HCU = Health care utilisation; AWHOQOL-BREF = Australian World Health Organisation Quality of Life Brief Scale; HKB = Health Knowledge/Beliefs; 
BPI-PS = Brief Pain Inventory, Pain Severity subscale – current pain; SDRS-5 = Social Desirability Response Set Scale. 
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acceptance: F(2,322) = 0.89, p = 0.41), pain-related interference (BPI-PI: F(2,344) = 0.62, p = 0.54), 
psychological distress (K-10: F(2,340) = 0.10, p = 0.90), HCU (F(2,337) = 0.67, p = 0.51), treatments 
tried (medical: F(2,336) = 2.51, p = 0.08, psychological: F(2,336) = 0.68, p = 0.51, alternative: 
F(2,336) = 1.67, p = 0.19, physical: F(2,336) = 0.76, p = 0.47), quality of life (AWHOQOL-BREF - 
physical health: F(2,329) = 0.05, p = 0.95, psychological health: F(2,329) = 0.31, p = 0.74, social 
relationships: F(2,329) = 0.02, p = 0.98, environment: F(2,329) = 0.96, p = 0.38, overall QOL: 
F(2,331) = 0.07, p = 0.93, overall health: F(2,331) = 0.87, p = 0.42), health knowledge/beliefs (HKB: 
F(2,329) = 0.59, p = 0.55); current pain severity (BPI-PS: F(2,341) = 0.53, p = 0.59); and symptom 
exaggeration (SDRS-5: F(2,328) = 0.03, p = 0.97). 
Pre-Clinic Session: Participant Evaluation 
Of the 66 people who attended an educational session, 39 (59%) returned a partially- or 
fully-completed evaluation form, providing feedback about the session and indicating their 
satisfaction with the content and style of presentation.  Overall, the feedback indicated a reasonable 
level of acceptance, with most participants (n = 30, 77%) reporting that they were at least 
‘moderately’ satisfied with the session and many being ‘mostly’ (n = 13, 33%) or ‘completely’ (n = 10, 
26%) satisfied.  Similarly, the majority of participants reported having found the information 
presented in the session to be at least ‘moderately’ useful (n = 27, 69%), with many rating it as 
‘mostly’ (n = 13, 33%) or ‘completely’ (n = 10, 26%) useful.  There was however, a mixed response 
to the printed materials, with comparable numbers of participants describing them as either ‘not at 
all’/’a little’ helpful (n = 17, 44%) or ‘mostly’/’completely’ helpful (n = 15, 38%).  Despite these 
generally positive responses, most respondents stated at T2 that the session had influenced their 
thinking about the pain ‘moderately’ or less (n = 35, 90%), with many saying ‘not at all’ (n = 15, 38%).  
Thus, although respondents reported being satisfied with session content and delivery, and asserted 
that the information had been helpful, they did not believe that it had influenced the way that they 
interpreted or responded to their pain. 
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Next, mixed-model analyses of variance were performed to examine the impact of Group 
(EXP, DNA, TAU) and Time (T1, T2, T3) on outcome measures.  There were no significant Group by 
Time interactions; consequently interaction effects are not discussed below.  Similarly, results were 
not impacted by age, sex, pain severity, primary pain location or pain duration, thus covariate 
analyses are also not discussed. 
Pain Acceptance (CPAQ) 
Results indicated that Group did not impact significantly an any of the areas of pain 
acceptance (pain willingness: F(2, 270) = 1.19, p = 0.31; activity engagement: F(2, 303) = 0.28, p = 
0.75; overall pain acceptance: F(2, 302) = 0.73, p = 0.48), indicating that attendance at the 
educational session did not influence these measures.  The level of activity engagement was 
similarly unaffected by Time (F(2, 167) = 1.83, p = 0.16).  However, there was a main effect for Time 
across two aspects of pain acceptance: pain willingness (F(2, 181) = 26.05, p < 0.001, d = 0.44) and 
overall pain acceptance (F(2, 169) = 16.31, p < 0.001, d = 0.30).  Post-hoc analyses indicated that, 
for the sample as a whole, pain willingness and overall pain acceptance increased over time, with 
participants reporting improved levels at T2 and T3, compared to T1 (see Table 6.4).  The fact that 
the changes in pain willingness were associated with a medium effect, suggests that this particular 
finding reflects clinically meaningful change. 
Pain-Related Interference (BPI-PI) 
Consistent with the findings for activity engagement, the level of pain-related interference in 
daily activities did not differ significantly between Groups (F(2, 227) = 0.64, p = 0.53) or across Time 







Table 6.4: Mean (SD) scores on the outcome measures for the full sample at each time-point, and for each group overall (across times) 
 Time of Assessment Group 
 T1 T2 T3 EXP DNA TAU 
CPAQ 
 Pain Willingness 
 Activity Engagement 






18.5 (7.9) a*** 
24.4 (12.1) 
43.0 (16.3) a*** 
 
18.1 (8.9) a*** 
24.7 (13.2) 













BPI-PI 7.4 (1.7) 7.3 (1.9) 7.1 (2.0) 7.2 (1.6) 7.3 (1.8) 7.5 (1.9) 
K-10 30.0 (8.7) 30.8 (9.1) 30.2 (9.5) 30.0 (8.7) 30.0 (8.7) 30.7 (9.4) 
HCU 
     Frequency 
     Treatment Types 
  Medical 
  Psychological 
  Alternative 
  Physical 










9.1 (6.2) a* 
 
0.5 (0.7) a*** 
0.7(0.7) a*** 
0.2 (0.4) a* 
1.1 (0.9) a* 
2.5 (1.5) 
 
8.3 (6.5) a*** 
 
1.2 (1.1) b*** 
1.4 (1.1) b*** 
0.4 (0.6) b*** 



























 Physical Health 
 Psychological Health 
 Social Relationships 
 Environment 





































HKB 14.4 (2.8) 14.7 (2.8) 14.6 (2.5) 14.4 (2.8) 14.7 (2.6) 14.4 (2.9) 
BPI-PS 6.9 (1.9) 6.9 (2.2) 6.8 (2.3) 7.1 (1.9) 6.8 (2.0) 6.9 (2.1) 
SDRS-5 1.8 (1.5) 1.8 (1.5) 1.8 (1.4) 1.9 (1.6) 1.8 (1.5) 1.8 (1.4) 
Note: T1 = Time 1 (intake); T2 = Time 2 (2-week post-session follow-up); T3 = Time 3 (6-month follow-up); EXP = Experimental Group (attended pre-clinic session); DNA = Did Not 
Attend Group (did not attend pre-clinic session); TAU = Treatment As Usual Group (waitlist); CPAQ = Chronic Pain Acceptance Questionnaire; BPI-PI = Brief Pain Inventory, Pain 
Interference subscale; K-10 = Kessler Distress Scale; HCU = Health care utilisation; AWHOQOL-BREF = Australian World Health Organisation Quality of Life Brief Scale; HKB = 
Health Knowledge/ Beliefs; BPI-PS = Brief Pain Inventory, Pain Severity subscale – current pain; SDRS-5 = Social Desirability Response Set Scale. 
*** = p<0.001; ** p<0.01; * p<0.05 
a = significant difference compared to T1; b = significant difference compared to T2 




Psychological Distress (K-10) 
Psychological distress was also not significantly impacted by Group (F(2, 313) = 0.29, p = 
0.75) or Time (F(2, 180) = 1.24, p = 0.29), indicating that distress was not altered by session 
attendance or time spent waiting to access CP treatment (see Table 6.4). 
Health Care Utilisation (HCU) 
Frequency.  The results concerning frequency of HCU showed that the Groups did not differ 
significantly on this measure (F(2, 298) = 0.66, p = 0.52), meaning that session attendance did not 
impact frequency of health care access.  There was, however, a small main effect for Time (F(2, 
180) = 8.26, p < 0.001, d = 0.16), with participants reporting lower levels of HCU at T2 and T3, 
compared with intake (see Table 6.4).  Thus, participants attended significantly fewer health-related 
appointments after having been referred to the pain service than they did prior to referral.  Of note, 
although not statistically significant, the rates of HCU for the EXP and TAU groups continued to 
decrease further between T2 and T3, whereas HCU rates for the DNA group did not (see Table 6.3). 
Treatment types.  The types of treatments that participants reported having tried did not 
vary significantly between the Groups: medical (F(2, 248) = 0.55, p = 0.58); psychological (F(2, 219) 
= 0.38, p = 0.68); alternative (F(2, 218) = 0.96, p = 0.39); physical (F(2, 215) = 0.40, p = 0.67).  
However, all aspects of this domain did change significantly across Time: medical (F(2, 204) = 
29.64, p < 0.001, d = 0.63); psychological (F(2, 127) = 33.78, p < 0.001, d = 0.46); alternative (F(2, 
164) = 7.32, p = 0.001, d = 0.27); physical (F(2, 165) = 58.41, p < 0.001, d = 0.31).  Specifically, 
post-hoc analyses indicated that participants reported having tried markedly fewer treatments at T2 
than they did at either T1 or T3 (see Table 6.4).  Moreover, although the levels of use reported for 
medical and alternative treatments were reasonably stable between T1 and T3, the reported levels 
for psychological and physical treatments were higher at T3 than at T1, indicating an increased 
uptake of these types of treatment six months after being referred to the PMU.  The small to 




medium-large effect sizes associated with the use of treatments over time suggest that the majority 
of these changes represent clinically observable differences — especially with respect to medical 
and psychological treatments.  In terms of new treatments tried/retried, there was no significant 
difference between the groups at either T2 or T3 (F(2, 80) = 0.14, p = 0.87; and F(2, 53) = 0.04, p = 
0.96 respectively) (see Table 6.3). 
Quality of Life (AWHOQOL-BREF) 
QOL was assessed in terms of multiple domains, none of which differed significantly 
between Groups: physical (F(2, 301) = 0.22, p = 0.81); psychological (F(2, 323) = 0.02, p = 0.98); 
social (F(2, 221) = 0.61, p = 0.54); environmental (F(2, 307) = 1.12, p = 0.33); overall QOL (F(2, 293) 
= 0.20, p = 0.82).  Similarly, most aspects of QOL assessed did not vary over Time: psychological 
(F(2, 173) = 0.37, p = 0.69); social (F(2, 177) = 0.92, p = 0.40); environmental QOL (F(2, 173) = 
0.10, p = 0.90); overall QOL (F(2, 177) = 1.15, p = 0.32).  The exception to this was physical QOL, 
for which there a small positive main effect (F(2, 176) = 4.45, p = 0.013, d = 0.17); with post-hoc 
analysis indicating significant improvements at T2 and T3, compared with T1 (see Table 6.4). 
Health Knowledge/Beliefs (HKB) 
Consistent with other findings, results for health knowledge/beliefs were non-significant for 
Group (F(2, 274) = 1.14, p = 0.32) and Time (F(2, 193) = 0.99, p = 0.37), indicating that neither 
attendance at the educational session nor time spent waiting to access CP treatment impacted 
significantly on the level of pain-related knowledge reported by participants (see Table 6.4). 
Pain Severity (BPI-PS) 
Consistent with the previous domains, ratings of ‘current’ pain severity did not differ 
significantly across Group (F(2, 249) = 0.36, p = 0.70) or Time (F(2, 135) = 0.11, p = 0.90), 




suggesting that the study results were not unduly influenced by pain fluctuations at the time of 
responding (see Table 6.4). 
Symptom Exaggeration (SDRS-5) 
With respect to symptom exaggeration, the between-groups comparison was non-significant 
(F(2, 291) = 0.32, p = 0.73) as was the comparison across Time (F(2, 174) = 0.08, p = 0.93) (see 
Table 6.4).  Notably, the level of bias in responding was below the normative median for the 
measure on all three occasions.  As such, responses were unlikely to have been excessively 
influenced by a desire to respond in socially desirable ways and were therefore deemed to provide 
reasonably accurate representations (within the limitations of self-report measurements). 
6.6 Discussion 
Chronic pain (CP) is a common condition, which negatively impacts on a range of important 
life domains.  Many CP services struggle to meet patient demands, frequently resulting in long wait-
times.  The need to improve access to appropriate treatments for individuals living with CP has led 
clinicians to explore therapeutic opportunities in the pre-clinic (waitlist) period.  Given the 
accumulating evidence for pre-clinic and brief interventions, this study explored whether therapeutic 
benefits could be achieved from a single brief intervention — a three-hour pre-clinic educational 
session — for patients newly referred to the waitlist of a tertiary CP service.  More specifically, we 
examined whether this single educational session had an impact on pain acceptance (CPAQ), pain-
related interference in daily activities (BPI-PI), psychological distress (K-10), HCU (frequency, type), 
quality of life (AWHOQOL-BREF) and health knowledge/beliefs.  We also explored the impact of 
waiting six months for CP treatment. 
In terms of the pre-clinic education session, the results indicated that this was a negative 
trial: although participants reported reasonable satisfaction with the session itself, there was no 
significant benefit associated with session attendance in any of the areas we assessed.  On 




reflection, this is probably not surprising given that, despite its longer duration and significant positive 
impacts, the STEPS program was also unable to reduce psychological distress (anxiety, depression, 
mental health composite scores) (Davies, et al., 2011). 
In addition, we experienced a large self-selected exclusion rate, with 33% of referrals 
declining to engage with the PMU at all and 17% opting to engage with the unit but not participate in 
the research.  Little is known about how these individuals compare, demographically or 
psychologically, with the included sample.  Moreover, 70% of the respondents who were offered a 
pre-clinic session did not attend (DNA group).  Again, little is known about their reasons for non-
attendance.  It is possible that individuals ‘voted with their feet’, deliberately choosing not to engage 
with an intervention that they did not perceive to be valuable.  Equally plausible is that invitees felt 
unable to attend due to factors such as pain/disability, emotional difficulties, life demands, physical 
access issues etc.  In hindsight, follow-up telephone calls may have proven informative. 
Many public CP services struggle with high rates of non-response and non-attendance.  
Inclusion of a pre-clinic educational session (such as that trialed here) as a mandatory portion of the 
intake process is becoming increasingly common.  Based on data regarding pre-clinic session 
uptake rates, completion rates and reported demand for individual follow-up after pre-clinic session 
completion (Davies, et al., 2011), it is easy to see how service efficiencies (i.e. decreased wait-
time/occasions of service/clinic costs) could accumulate by adopting this model.  If, however, the 
primary driver in service delivery is therapeutic outcomes — rather than economic gains — then 
more detailed consideration of a range of patient factors is required in order to better understand 
these findings.  For instance, it is interesting to note that those individuals who chose not to engage 
early with the service — the DNA group who were offered, but did not attend, an educational session 
— were the only ones to report increased psychological distress and decreased engagement in 
valued activities six months after being referred to the PMU (T3), despite initial improvements post-
referral (T2) (see Table 6.3).  Moreover, they were the only group whose level of HCU remained 




stable during this period (T2 - T3) — the other two groups attended pain-related health care 
appointments less frequently following referral to the tertiary service.  Although these differences did 
not reach significance, this same trend was not observed in the other two groups.  This suggests that 
there may be individual patient variables associated with low treatment engagement that may 
perpetuate unhelpful pain cycles, thereby increasing distress, fostering help-seeking behaviors 
including attendance at health care appointments (possibly as a mechanism via which to gain 
reassurance) and entrenching patterns of avoidance and withdrawal.  However, as the groups were 
comparable on all of the areas assessed at the time of referral, we are unable to determine whether 
the DNA group’s lack of engagement with treatment at the tertiary service was due to 
premorbid/individual factors or other processes.  Moreover, it is not possible to say whether session 
effects may have been different if a motivational approach to the follow-up of non-attenders had 
been employed – an activity that was not possible given existing staffing resources.  As outlined by 
Williams and colleagues (Williams, et al., 2012), matching patients to treatments, based on 
diagnostic groupings (i.e. unresolved CP), rather than individual factors, can lead to poor treatment 
alliances, resulting in reduced treatment adherence post-intervention.  This erodes potential 
outcomes that might be achieved by selecting more effectively aligned patient groups.  Therefore, 
more information is needed about who might benefit from a brief pre-clinic education session and 
who might not; the latter needing alternative management. 
With respect to the impact of waiting six months for CP services, the numerous main effects 
found for Time across the sample as whole suggest that, where change occurred, this change was 
positive.  Shortly after referral (T2), study participants reported a significant decrease in the 
frequency of health care use (all types) and significantly improved pain acceptance (pain willingness 
and overall pain acceptance) and QOL (physical); all of which were maintained, or improved, at six-
month follow-up (T3).  Further, there was a change in the types of health care sought by participants 
over time, with significant increases in the use of psychological and physical therapies at six months 




(T3) compared with intake (T1).  These findings are important for two reasons.  The overall stability 
demonstrated in numerous areas from referral (T1) to the six month follow-up (T3) challenges 
previous reports that waiting up to six months is associated with declines in patient functioning 
(Lynch, et al., 2008) — at least for individuals who voluntarily participate in research involving 
intermittent follow-up surveys.  Second, and perhaps more importantly, this is the first time that 
functional benefits have been linked with referral to — rather than treatment by — a tertiary CP 
service; suggesting that there may be something about being referred to, and intermittently followed-
up by, a tertiary pain clinic that may be beneficial to patients, thereby highlighting what may be an 
important time-point for intervention. 
With new referrals reporting an average of 10 pain-related health care appointments every 
three months, and 37% reporting weekly appointments, it is evident that CP is one of the most 
expensive health conditions of developed countries around the world (Gaskin & Richard, 2013; 
National Pain Summit Initiative, 2011).  It is therefore interesting that, following referral to a tertiary 
CP service, many individuals changed the way that they approached, or engaged with, their health 
care.  Specifically, many individuals reported attending progressively fewer health care appointments 
following referral to a tertiary pain service than they did before.  For the sample as a whole, this 
decrease in health care appointments occurred despite an increase in the use of psychological and 
physical CP treatments.  Following referral to a tertiary CP service, it is possible that health care 
became more targeted than it had been before, specifically focusing on physical or psychological 
strategies.  That is, referral may have marked a shift in the way that patients (and perhaps their 
health care providers) viewed their condition: defining the problem as a CP issue, rather than 
another acute condition (i.e. an unresolved medical/surgical issue) and deciding that it should now 
be treated by a tertiary CP service instead of other active treatments.  This shift may represent the 
creation of essentially a new diagnosis for the patient — potentially carrying renewed hope for 
effective treatments by the specialist service and also changing, or reducing, engagement with other 




clinicians.  Alternatively it is possible that referral was triggered by a period of acute distress and, 
accordingly, participants experienced a natural subsidence of symptoms following referral as the 
acute distress resolved.  In the absence of a non-referred control group to explore this in more detail, 
it is not possible to draw definite conclusions. 
The current study is not without limitations; most notably the reliance on self-report 
measures which, despite assurances to the contrary, may have been perceived by participants as 
potentially influencing their wait-time.  In particular, it must be acknowledged that T2 was associated 
with a significant reduction across all domains in the number of treatments individuals reported 
having tried.  This question explored the number of treatments that had been tried (ever), not 
treatments that were currently being used; consequently domain scores should not have decreased.  
Hence, the findings for this variable should be viewed with caution.  It is possible that individuals 
misunderstood the question — reporting strategies/treatments that they were currently using, rather 
than a tally of all treatments that they had ever tried.  Alternatively, reports may have been affected 
by unreliable memory.  It is also possible that, at T2, individuals felt somewhat more compelled to 
respond in socially desirable ways, as they became aware that wait-times could be lengthy.  
Although we concluded that the study data had not been unduly influenced by symptom 
exaggeration (because scores were below the normative median at all three time-points), the 
potential for biased responding was greater at T2 than at either of the other assessment points.  
Intermittent follow-up may also have resulted in participants feeling supported, or attended to, by the 
tertiary service — thereby mediating the level of distress/deterioration experienced.  Similarly, 
cognitive shifts may have resulted from repeated administration of survey items — particularly the 
CPAQ, completion of which may encourage patients to rethink their approach to life engagement 
despite ongoing pain — rather than other factors.  Moreover, randomisation, data collection and 
analyses were conducted by the primary author and therefore were not blinded.  Finally, our data 
were all derived from newly-referred patients who volunteered for the study and completed 




intermittent follow-up questionnaires.  We are unable to comment on wait-times of more than six 
months duration, or on the experiences of those newly-referred individuals who either did not return 
the PSQ (thereby failing to engage at all with the PMU service) or who returned the PSQ and 
entered the clinic booking queue, but declined to participate in this research. 
Future researchers could usefully expand on this study in numerous ways.  Exploration of a 
range of pre-clinic intervention lengths (e.g., three hours, half day, full day) would greatly assist in 
identifying optimal program intensity.  Seeking feedback from, and providing motivational 
interventions to, individuals who were invited to, but did not attend, sessions may also be productive.  
Qualitative exploration of patient and general practitioner conceptualisations of pain pre- and post-
referral to a tertiary CP service may better inform our understanding about referral decisions and 
how they influence engagement with health care.  Comparison of individuals referred to a tertiary CP 
service with non-referred individuals would also better inform our understanding of the impact of the 
referral process on individuals living with CP.  Low treatment engagement is costly for both patients 
and agencies.  Therefore a more detailed consideration of individuals who fail (or decline) to engage 
with CP treatment may help clarify whether poor engagement with clinical services is better 
predicted by pre-disposing/individual factors, or aspects of the referral process itself: information that 
may meaningfully assist clinics to engage with these patients.  Similarly, more detailed monitoring of 
patient progress while waiting for services — including comparison with a non-referred group — 
would assist in clarifying the existence and scope of any critical intervention period, thereby 
facilitating more targeted service delivery.  Such research would be aided by a randomised 
controlled trial comparing the impact of early clinical intervention (rather than an educational session) 
with standard appointment scheduling. 
Overall, we were unable to demonstrate any significant improvements for newly-referred 
people on a waitlist as a result of a brief single pre-clinic educational session.  Future research could 
usefully conduct further examination of referral and pre-clinic experiences, individual engagement 




factors and options to inform matching of interventions with participants.  Interestingly, unlike 
previous research (Lynch, et al., 2008), in waitlisted participants who agreed to be involved in 
research and who completed study measures at two and six months follow-up, a wait of six months 
to access an appointment at a tertiary CP service was not associated with significant deterioration in 
patient well-being.  Instead, referral was associated with short-term functional improvements — in 
the first one to two months after referral to the tertiary pain service, participants reported 
improvements in a range of areas, including pain acceptance (willingness and overall acceptance), 
frequency of health care appointments and QOL (physical).  This is the first time that functional 
benefits have been linked with referral to, rather than treatment by, a tertiary pain service; 




Chapter 7 : Discussion 
Chronic pain (CP) is a prevalent and costly condition, for which most Australians cannot 
access multidisciplinary care without first enduring a very long wait.  What happens to people during 
this period is not well understood, nor is the solution for this clinical challenge clear.  This thesis was 
motivated by a clinician’s desire to examine the impact that current approaches to service delivery 
were having on the people who were referred for treatment, and to assess some of the available 
options that may facilitate more timely access to evidence-based care; the ultimate goal being to 
improve the quality of life of people living with CP. 
The broad aims of this project were; (a) to investigate the psychological impact of CP and of 
waiting to access CP treatment, and (b) to examine two factors that are related to service 
design/delivery which impact on health care access, namely staff resourcing and a specific model of 
care (pre-clinic education).  This involved conducting a meta-analysis, a large-scale randomised 
controlled trial with prospective longitudinal follow-up, and a survey of Australian CP clinics.  The 
focus throughout was on public tertiary services because this is where the majority of Australians 
with CP access multidisciplinary care for their condition.  This final chapter summarises the findings 
from each study, then explores the implications that they pose for CP-related practice, policy and 
research, before discussing the main limitations of the overall research project. 
7.1 Summary of the Findings 
Study 1: Meta-Analysis Examining Psychological Functioning 
Study 1 (Chapter 3) synthesised a large literature exploring the relationship between CP and 
psychological distress, deliberately taking a broad perspective in order to account for the complexity 
of the CP experience.  Data from 110 studies were meta-analysed and those aspects of 
psychological functioning that had been most commonly explored in people with CP were identified.  
Specifically, these were depression, anxiety, pain anxiety/concern, somatisation, anger/hostility, self-




efficacy, self-esteem and general emotional functioning — all of which were found to be significantly 
impaired in people with CP.  However, contrary to previous assertions that depression is the leading 
psychological issue in this population (Access Economics, 2007; Von Korff, et al., 2005), this meta-
analysis indicated that the more physically-focussed aspects were, in fact, the most profoundly 
affected; namely, pain anxiety/concern and somatisation.  This suggests that the psychological 
distress associated with CP may lead to a heightened focus on, and therefore lower threshold for, 
physical symptoms; increasing the chance that physical symptoms are noticed and interpreted as 
threatening, thus heightening distress and discomfort, and perpetuating the cycle.  This cycle of pain, 
distress and disability is discussed in detail in the CP literature (e.g., Vlaeyen & Linton, 2000; 
Vlaeyen & Linton, 2012) and the current data suggest that, in order to break it, therapeutic 
intervention should prioritise these physically-focussed aspects of psychological function. 
A core challenge for this meta-analysis proved to be the inconsistent ways in which the 
psychological domains were conceptualised and assessed in the literature; with the same domains 
often being assessed using a variety of different measures, each documenting slightly different 
aspects.  For example, the pain anxiety/concern domain was examined using 15 different measures, 
most of which explicitly focussed on pain that was directly related to the CP experience (e.g., it will 
make my back pain worse), some that focussed on health but not specifically CP (e.g., I am 
sometimes afraid that I have a serious illness), and one that focussed on general painful experiences 
that were not at all related to CP (e.g., gulping a hot drink before it has cooled).  Although the 
measures varied, most discriminated between CP and healthy controls.  The one exception to this 
was anger/hostility, where the different measures yielded inconsistent findings, suggesting that the 
definition and/or measurement of this construct requires careful consideration in any future research 
that assesses this domain.  Similarly, the term somatisation was used inconsistently; being 
conceptualised as physical symptoms which exceeded the level that would be predicted by 
pathology, or as emotional distress that is experienced in physical ways.  The first explanation is 




unsurprising given the poor relationship between CP and physical pathology (Sharp, 2001), but the 
second suggests that individuals with CP are more likely to experience emotional distress in physical 
ways, possibly due to an increased vigilance towards physical, especially CP-related, sensations.  
This project could not distinguish between these two competing conceptualisations and so further 
examination is required because they have different implications for research and clinical practice.  
Balanced against this, the use of different measures to explore the same domain also highlighted 
some interesting findings.  Specifically, fear of pain was found to be greater for CP-related scenarios 
than it was for general pain scenarios, suggesting that this fear is explicitly tied to the CP experience 
and that there is a level of discrimination within pain-related fear that had not previously been 
highlighted. 
Study 2: Waiting for Chronic Pain Treatment 
Study 2 (Chapter 4) built on these findings by investigating how the psychological 
functioning of individuals with CP was impacted by lengthy indefinite waits for treatment.  The 
previous meta-analysis was not able to examine this issue because it was often unclear in the 
literature where individuals were in their treatment cycle.  Study 2 also examined the impact of 
waiting for treatment on the health care utilisation of individuals referred for management at a tertiary 
CP service and the role of sex in moderating these outcomes; the latter having been highlighted as 
an important variable in exploratory data analyses.  Accordingly, this study followed 339 participants 
for 2.5 years after they entered an indefinite, clinically-triaged waitlist for treatment at a tertiary CP 
service (Mwait-time = 21 months).  Individuals were assessed at the point of intake (T1), at two months 
after referral (T2) and then at six-monthly intervals (T3-T7) until they received their first appointment 
with the pain service. 
Sample attrition over the course of the follow-up period was of concern, with people exiting 
the study for several reasons: they received their first appointment with the clinic (no longer waiting), 
they opted-out of the study (declined to complete further measures while waiting for an appointment) 




or they cancelled their referral (removed themselves from the waitlist).  Thus, the data were 
examined to ensure that the final included sample was representative of the larger pool of referred 
individuals.  These checks indicated that the people who completed the study were comparable to 
those who did not (did not respond, opted-out, withdrew from study) in terms of age and sex at the 
point of intake (T1).  Moreover, when study participation status (still in study, received appointment, 
opted-out, cancelled appointment) was considered, the groups were shown to be comparable across 
a number of key domains, including age, sex, pain-related interference in the performance of daily 
activities, pain severity and psychological distress.  That said, sample sizes were smaller for the 
longer-term follow-up time-points than they were for the first 12 months of waiting, consequently 
those findings were interpreted more cautiously.  Importantly, unlike previous research that has 
typically used surgical waitlists or community samples, this study recruited individuals from a waitlist 
at a CP service.  It also undertook a much longer follow-up than is generally seen in CP studies of 
this type, therefore providing critical and directly relevant, albeit tentative, information which can 
guide service planning and health-related policy. 
At the point of referral (T1), participants reported significant pain-related interference in their 
ability to perform daily activities, high levels of psychological distress, frequent health-related 
appointments and pronounced dissatisfaction with their quality of life (QOL).  This did not change 
markedly over the first 12 months of waiting, with pain severity, psychological distress and 
engagement in meaningful activities all remaining stable throughout the first year.  Where change 
occurred during this time period, it was typically positive; with pain-related interference, pain 
acceptance (overall and pain willingness), physical aspects of QOL and frequency of health care use 
all improving.  This relative stability continued in the longer-term for some domains.  For example, 
pain severity remained stable for the first two years (T1-T6); although females reported more severe 
pain, overall, than males.  The amount of relief that participants reported receiving from their 
medication also remained stable throughout (T1-T7), despite the fact that 36-45% of the sample 




reported an increase in the dose/strength of their medication each time that they were surveyed.  
Again, this was more common amongst females than males.  QOL was similarly unchanged across 
the period of waiting (T1-T7), with participants consistently reporting marked impairment at each 
time-point, although males reported less overall satisfaction with their social relationships (first year) 
and environmental supports/opportunities (longer-term) than females. 
Other domains were significantly impacted by the lengthy treatment waits, albeit differently 
for each sex.  Pain-related interference steadily declined for males over time, but females remained 
stable for the first two years before experiencing a sharp increase (T7).  Females also reported 
increasing levels of psychological distress, especially from 12 months of waiting (T4) onwards, but 
males fluctuated before ending with less distress (T7) than they reported when they were first 
referred (T1).  Similar patterns were seen for pain acceptance, where females deteriorated over time 
(T5: activity engagement, T7: pain willingness), but males oscillated before improving.  There were 
also changes in the types of health care sought, with an overall decrease in the use of health 
services immediately following referral (T2, T3), followed by significant increases in the use of 
psychological (T3), alternative (T6) and physical therapies (T7).  The frequency of pain-related 
health care appointments, on the other hand, decreased.  In short, although this study did not 
identify a critical time-point for intervention, longer waits (>12 months) were associated with 
increasing distress and decreasing function, especially in females. 
Last, a finding that was not reported in the published article, but was of considerable 
interest, was a shift in self-reported work status that occurred in the early period following referral to 
the tertiary service.  Specifically, there was a seven-fold increase in the number of people who 
reported receiving a government disability pension during the first few months of being waitlisted for 
treatment.  Although this may have represented a significant increase in the uptake of government-
supported pensions, most people reported that this was not a change in status; meaning that nearly 
half (41%) of those who were receiving the disability pension at T2 answered differently on the intake 




questionnaire.  Given that levels of social-desirability in responding did not exceed normative 
standards or change significantly over time, it appears unlikely that this was a deliberate shift in self-
representation.  Thus, it may reflect a change in the way that individual’s perceived their potential for 
future workforce participation.  As indicated, this information was removed from the final manuscript 
at the direction of the publishing journal because of word count limits. 
Study 3: Staff Resourcing 
Having addressed the first aim, this research sought to examine the second aim — to 
explore two important service-related factors (staffing, model of care) that are associated with health 
care access.  Accordingly, Study 3 (Chapter 5) explored the staff resources (amount, type) that were 
employed in Australian tertiary CP services (N = 45), in case staffing was tied to waitlist length.  
Importantly, staffing was considered in terms of both the absolute numbers of staff that were 
employed by a clinic and as a function of the number of new patients that were seen by those clinics 
each year.  Clinics were classified using the IASP criteria (IASP, 2009) for Levels 1 and 2 
multidisciplinary pain (MDP) services; with both providing interdisciplinary care, but Level 1 
additionally undertaking research and teaching activities. 
The staffing profiles were consistent for most disciplines; the exceptions being occupational 
therapy (Level 1 and 2 services) and psychiatry (Level 1), which were employed in varying numbers 
by these services, suggesting that their role in tertiary CP services needs to be elucidated.  When 
compared to Level 2 clinics, Level 1 centres received more new referrals, saw more new patients, 
and employed more medical, nursing and administrative staff, but comparable numbers of allied 
health staff.  Service location (rural vs. metropolitan) did not impact on clinical demand (number of 
new referrals) or activity (number of new patients seen), but medical staff were employed in greater 
absolute numbers in metropolitan-based services and patients had comparatively greater access to 
occupational therapy in rural clinics. 




Pain Management Group Programmes (PMGPs) were offered by most services but in very 
different formats, with the frequency and duration of programmes varying considerably (range: 5-120 
hours).  Although PMGPs are largely run by allied health staff, the services that offered group 
programmes didn’t employ more allied health staff than those that did not.  Overall, the most 
intensive programs (>90 hours) employed more allied health staff than did those using less intensive 
models (51-90 hours, 30-50 hours), but they also saw more patients each year.  Consequently, a 
consistent amount of allied health staff were employed to deliver a PMGP, irrespective of the 
intensity/format of the programme: 0.03FTE of allied health staff for each patient who participated in 
a group. 
These results provide much needed data that can be used to inform workforce planning for 
tertiary CP services.  However, although waitlist lengths and wait-times were not examined in this 
study, this information had been examined and reported elsewhere (Hogg, et al., 2012).  When this 
was considered along with the current findings, it was clear that staffing was consistent across clinics 
that had different waitlist lengths.  In combination, the findings from this and the Hogg et al. (2012) 
study therefore suggest that improving access to tertiary CP treatment will require more than just 
additional staff resources.  It may require a change to the way that services are provided within 
clinics. 
Study 4: Pre-Clinic Education  
Accordingly, Study 4 (Chapter 6) explored whether changing the way that referrals were 
managed by a tertiary CP service improved the psychological adjustment of individuals who were 
waitlisted for treatment.  This involved conducting a large-scale randomised controlled trial in order 
to examine whether attending a three-hour educational session, shortly after referral and prior to 
being seen at a tertiary pain clinic, promoted better outcomes for individuals than treatment as usual 
(waitlisted without intervention).  This study was embedded within the larger longitudinal follow-up 




that was reported in Study 2 (Chapter 4), consequently participants were assessed when they were 
first waitlisted (T1), two months after they had attended the pre-clinic session (T2) and six months 
later (T3).  Individuals were sent an appointment for the educational session once they returned the 
clinic’s intake measure (PSQ: Patient Screening Questionnaire) and provided they additionally 
consented to participate in the study.  These appointments were rescheduled if people requested a 
change in date however, this altered the follow-up interval for those individuals because the T2 
assessment was tied to attendance at the educational session. 
Overall, individuals reported being reasonably satisfied with the content and delivery of the 
educational session, but attendance was not associated with significant change in any of the 
domains that were assessed; namely, people’s pain acceptance (pain willingness, activity 
engagement, overall pain acceptance), pain impact (pain-related interference, pain severity), 
psychological distress, health care use (frequency, treatment type), QOL, and understanding of CP 
and its management (health knowledge/beliefs).  Accordingly, both models of care — waitlisted 
without intervention and pre-clinic education then waitlisted — proved to be comparable in terms of 
patient outcomes.  Notably however, participation in the pre-clinic education session was low for 
multiple reasons including the fact that 33% of all referrals to the pain clinic declined to engage with 
the service at all and another 17% declined to participate in the study.  In addition, 70% of those who 
were offered a pre-clinic session failed to attend.  This lack of engagement with clinical services that 
are provided on an optional basis has implications for treatment access; with lower engagement 
resulting in fewer people needing appointments, thus expediting the allocation of appointments to 
those who are waitlisted. 
This study also examined the impact of the first six months of waiting for treatment and 
found that individuals did not deteriorate in a number of important psychological domains during this 
time.  Instead, the QOL (physical) of participants improved and individuals reported being more 
willing to experience pain in order to do things that they valued (pain willingness, overall pain 




acceptance).  Their health care usage also changed, with the frequency of appointments and uptake 
of new treatments decreasing after being referred to the tertiary service (T2).  Although their uptake 
of psychological and physical treatments had increased again by six months (T3), the overall 
frequency of appointments did not. 
The impact of this early period of waiting for treatment appeared to be moderated by how 
effectively, or otherwise, an individual engaged with the tertiary service.  Specifically, those people 
who were offered but did not attend an educational session (the DNA group) were the only ones who 
reported a worsening of psychological distress and decreased engagement in valued activities six 
months after being waitlisted, despite initially improving shortly after referral (T2).  Moreover, they 
were the only people whose level of health care use remained stable during this period (T2 - T3); 
while others (EXP and TAU groups) attended appointments less frequently.  As with Study 2, those 
who did and did not attend the educational session were comparable in terms of the domains that 
were assessed prior to the study (pain acceptance, pain impact, psychological distress, health care 
use, QOL, and understanding of CP and its management), but it is possible that other variables 
moderated the extent to which people engaged with the clinical service. 
Together, these findings suggest that referral to a tertiary CP service was associated with 
improvements across a range of domains for individuals with CP, highlighting what may be an 
important time-point for intervention.  This finding contrasts with that of an earlier systematic review, 
which found that waiting up to six months for treatment at a CP service was associated with 
worsening health-related quality of life and depression (Lynch, et al., 2008).  Although that review 
was focussed on individuals seeking care at a CP service, it was not clear within the study whether 
individuals were on a definite or indefinite waitlist list, and analyses were hampered by the variable 
use of measures to assess certain domains and differing CP populations across studies (e.g., 
fibromyalgia, chronic low back pain, tension headache, CP).  Thus, it may not fully reflect the impact 




of the long and indefinite waitlists that are experienced by many of the people who are referred to 
tertiary CP services in Australia, and elsewhere.  
7.2 Clinical Implications and Directions for Future Research 
Psychological Functioning 
The psychological well-being of individuals living with CP was examined via a meta-analysis 
(Chapter 3) and a large-scale clinical study with longitudinal follow-up (Chapters 4 and 6).  The 
findings from these studies indicated that psychological functioning was consistently impaired in the 
presence of CP.  Although depression has been most commonly linked with CP in the literature 
(Access Economics, 2007; Von Korff, et al., 2005), the current research suggests that individuals 
with CP were comparatively more anxious than they were depressed.  This is not the first time that 
anxiety has been highlighted as a primary consideration in this cohort (McWilliams, et al., 2004) and 
the findings are consistent with models that describe the perception of threat as a key factor in 
determining how individuals interpret and respond to pain sensations (Eccleston, 2012).  However, 
despite this, the relative emphasis on depression in people with CP has largely gone unchallenged 
(e.g., Woo, 2010).  The current findings suggest that this should be revisited.  Although depression 
and anxiety are frequently comorbid in people with CP, research designed to specifically compare 
and contrast the experiences of anxiety and depression in CP samples is needed in order to 
elucidate their relative contribution to the CP-disability cycle and thus better inform treatment. 
In the interim, these findings suggest that anxiety is an important therapeutic consideration 
for clinicians who are working with this cohort.  Despite a well-established link between anxiety and 
CP (e.g., Keefe, et al., 2004; Vlaeyen & Linton, 2000), current treatments vary in the extent to which 
they effectively address anxiety.  For instance, graded in vivo exposure and acceptance and 
commitment therapy have been shown to reduce fear-avoidance more effectively in people with CP 
than mixed cognitive behavioural approaches and graded activity (Bailey, Carleton, Vlaeyen, & 




Asmundson, 2009).  Moreover, the choice of therapeutic intervention and subsequent outcomes are 
heavily influenced by clinician training and expertise (Stein & Lambert, 1995) but, despite its 
prevalence, CP is often not well-covered in post-graduate training programs (Darnall, et al., 2016; 
Fishman, et al., 2013), leaving many clinicians poorly-equipped to work effectively in this area.  This 
research confirms that anxiety, particularly anxiety about CP-related scenarios, is an important 
component of the overall experience of CP and suggests that clinicians who are working with this 
patient group should ensure they are well versed in how to effectively treat this aspect of the CP-
disability cycle. 
This research also highlights the need for clinicians to be mindful of the different ways that 
psychological functioning can be impacted by CP.  For example, the understanding that anxiety is 
explicitly tied to the CP experience in this patient cohort may lead clinicians to direct the focus of 
behavioural interventions and cognitive work towards specific aspects of CP-related 
experiences/activities.  Similarly, clinicians should be encouraged to actively explore differences 
between chronic and general pain scenarios to assist them identify strengths and strategies that may 
facilitate improved coping in the presence of CP. 
Defining and Measuring Aspects of Psychological Function 
As stated, the meta-analysis (Chapter 3) highlighted considerable variation in the ways that 
psychological functioning was defined and assessed in the literature.  Indeed, psychological distress 
was assessed in the current research (clinical study and longitudinal follow-up; Chapters 4 and 6) 
using a general measure of distress (K10), whereas the findings of the meta-analysis would 
recommend a more detailed examination.  However, it was not possible for the design of the clinical 
study to be fully informed by the findings of the meta-analysis because of the longitudinal nature and 
timing requirements of the project.  Nevertheless, these inconsistencies pose a number of 
challenges for clinicians and researchers when the same terms are used to refer to different things 




within the literature.  For instance, it is difficult to select appropriate search terms when conducting 
systematic reviews and meta-analyses, or to compare findings from different studies when domains 
are inconsistently operationalised. 
Notwithstanding these caveats, most outcomes were not unduly impacted by the variability 
in measures that were used to assess different constructs; with most yielding similar results and 
consistently discriminating between individuals with CP and healthy controls.  Moreover, within a 
domain, the findings from measures that had a small amount of somatic content did not differ 
significantly from those that much more somatic content.  This was unexpected because persons 
with CP are likely to endorse more physical symptoms on scales that have a high somatic content.  
This is particularly true for depression, where the overlap of symptoms between CP and depression 
is high (Wong, et al., 2011) and could therefore be expected to lead to larger differences between 
the groups.  However, in this research, the measures equally discriminated between people with CP 
and those without, regardless of the extent to which they contained somatic content. 
Although this appears true for the between-group comparisons that researchers explore, 
clinicians use measures on an individual basis to inform assessments of outcomes that have been 
achieved by therapeutic intervention.  That is, not only do they want to know if an individual is 
psychologically impaired, compared to a healthy population, they also want to know how impaired 
that person is, so that they can examine changes in the level of impairment before and after an 
intervention.  An assessment of therapeutic change relies on the availability of relevant normative 
data, but this is often not available for CP samples, particularly for measures that have a greater 
somatic focus.  If clinicians choose to use these measures for individual assessment purposes, they 
must source published normative information that is appropriate for use with CP populations (e.g., 
Lopez, Pierce, Gardner, & Hanson, 2013; Nicholas, Asghari, & Blyth, 2008) or employ statistical 
methods, such as minimal clinically important difference, which determine the amount of change 
required in order to indicate that a person has benefitted from the intervention (Crosby, Kolotkinc, & 




Williams, 2003; Frahm Olsen et al., 2018).  Thus, clinicians may choose measures on a different 
basis than researchers do. 
Consequences of Waiting for Chronic Pain Treatment 
Despite previous reports to the contrary (Fogarty & Cronin, 2008; Lynch, et al., 2008), the 
current data indicate that indefinite waits of six months or less for treatment at a tertiary CP service 
did not lead to deterioration.  After that time, if deterioration occurred, it was typically more 
pronounced in females than males.  In fact, although males frequently fluctuated in their responses 
on individual measures, they oftentimes experienced some improvement by the end of the waiting 
period; possibly indicating improved coping with, if not adaptation to, pain. 
When considering these findings, it is important to note that the research process of 
intermittent follow-up may itself have had some intrinsic benefit for people, with the additional 
attention potentially ameliorating the impact of waiting to access treatment.  Similarly, as part of the 
research process, there was an ethical obligation to provide individuals with information about 
options for obtaining psychological assistance during the waitlist period and this may have also had 
benefits.  Thus, qualitative research exploring patient perceptions of waiting appears indicated. 
Nevertheless, the early follow-up data suggest that the very process of being referred to a 
tertiary pain clinic may prompt a shift in the way that individuals and/or their general practitioners 
view, or respond to, pain; indicating this may be a critical aspect of the waiting period that requires 
further examination.  For example, the decreased frequency of health care appointments that 
occurred following referral to the tertiary service, despite targeted increases in the use of specific 
treatment types (psychological, alternative, physical) indicates that health care became more 
focussed.  The reasons for this shift are not clear, but it was suggested that there may have been a 
change in how the individual and/or their treating practitioner(s) conceptualised the pain; re-defining 
it as a chronic, rather than acute, condition which needed to be treated by a tertiary CP service.  
Accordingly, individuals and/or their practitioner(s) may have chosen not to access/recommend other 




active treatments pending review at the tertiary clinic.  Alternatively, it is possible that individuals may 
have improved their self-management practices following referral to the tertiary service, or 
experienced some natural subsidence of their symptoms and/or distress following a period of acute 
exacerbation. 
The findings regarding self-reported work status were also thought to reflect a shift in the 
way that individuals with CP conceptualised their future opportunities.  Specifically, the ‘unemployed 
due to pain’ that was reported at referral (T1) may have implied hope for the future (e.g. “I can return 
to work if I can change/stop the pain”); whereas ‘disability pension’ that was reported at follow-up 
(T2) may have implied hopelessness (e.g. “I can’t work again”).  If it is true that identified work status 
reflects perceptions of hope/hopelessness for the future, then for those participants who were 
receiving disability pensions at intake, but initially identified themselves as unemployed, referral may 
originally have been associated with hope, which then shifted towards hopelessness following 
treatment delay.  Further exploration of individual factors, including hope and optimism across the 
referral and waitlist phases, therefore appears warranted. 
Finally, there were also improvements across a range of functional measures (pain-related 
interference, pain acceptance, QOL) in the short-term follow-up period, many of which were not 
maintained in the longer-term.  Further exploration of factors that can impact the way an individual 
copes with, and responds to, CP during the referral and waitlist period is needed.  A comparison of 
referred and non-referred individuals would also be useful to explore whether these changes are 
specifically related to the experience of being referred and waitlisted, or whether they are temporal 
changes that occur independent of this process. 
In terms of health care delivery, the frequency with which participants in the clinical studies 
(Chapters 4 and 6) were attending health-related appointments at the point of referral to the tertiary 
service is compelling; averaging 10 appointments every three months, with 37% of the sample 
attending at least weekly appointments.  This attests to the substantial economic impact of CP 




(Access Economics, 2007) and highlights the amount of time that individuals spend seeking 
assistance for their condition.  However, the marked increase in the reported dose/strength of 
medication that occurred at each follow-up was of particular concern.  Again, this was far more likely 
to be reported by females than males.  The specific cause of this increase was not examined, but the 
fact that medication dose/strength did not align with reports of pain severity or medication-related 
pain relief, suggests that these increases were potentially ineffective.  Given the recent rise in deaths 
that have been attributed to prescription medication, particularly opioids (Australian Bureau of 
Statistics, 2018b; Rudd, Aleshire, Zibbell, & Gladden, 2016), this finding is very concerning and 
requires urgent review. 
Considerations for Improving Treatment Access at Tertiary Chronic Pain Services 
Staffing and intake models of tertiary pain clinics.  As noted, treatment access is 
impacted by a range of factors including the numbers and disciplines of staffing that are employed by 
services, and the intake processes that clinics use to manage new referrals.  These factors were 
explored via a survey of Australian tertiary CP clinics (Chapters 5) and a large randomised controlled 
trial (Chapter 6).  The survey demonstrated that there was reasonable consistency in the pattern of 
staffing (discipline, amount) that was employed by Australian tertiary clinics (except occupational 
therapy and psychiatry), suggesting that services have identified effective workforce structures.  
Importantly, these data were presented in a way that enables the calculation of staffing profiles 
(amounts and types), based on known/predicted amounts of clinical activity, and thus, can be used 
to inform workforce planning and development. 
This is a first step toward informed service planning, but more information is needed.  The 
lengthy waitlists that exist across Australia (Hogg, et al., 2012) indicate that the existing 
arrangements are inadequate to meet the full level of clinical demand that tertiary CP services 
experience.  Although workforce models have been established, this research suggests that 




improved access to evidence-based care will require more than simply additional staff resources.  
Moreover, it highlights the current disparity in models of care that are offered by tertiary CP services, 
with rates and formats of PMGPs, access to allied health staffing and focus on medical interventions 
all varying across clinics.  The extent to which these factors underpin differences in waitlist lengths 
for individual services needs further examination. 
One model of care that purportedly facilitates treatment access and improves patient 
outcomes involves educating newly referred individuals about how the body processes pain and 
methods for improving self-management during the period between being referred for specialist 
treatment and receiving their first appointment (Davies, et al., 2011).  The current research 
demonstrated that providing education to individuals before they were placed onto a waitlist could 
impact treatment access, although not necessarily in the way it was intended.  Many public CP 
services struggle with high rates of non-response and non-attendance, and so it was not surprising 
that around one third of new referrals in the clinical study declined to engage with the unit.  Indeed, 
this is part of the reason why many Australian clinics have now adopted pre-clinic education as a 
mandatory part of the intake process.  Had attendance at the educational session been a pre-
requisite for being waitlisted for a first appointment in this trial and had attendance levels been the 
same, wait-times at the Pain Management Unit would have significantly decreased; these non-
attendance rates would have resulted in only 44% of new referrals being waitlisted for an 
appointment, rather than 66%.  Other pilot projects have reported similarly low rates of engagement 
and completion for pre-clinic education, as well as decreased future engagement with the tertiary 
service after having attended this type of intervention (e.g., Davies, et al., 2011).  Hence, it is easy to 
see how service efficiencies, such as decreased wait-time, occasions of service and clinic costs, 
could rapidly accumulate using this pre-clinic education model. 
However, from a clinical perspective, this trial proved ineffective; with pre-clinic education 
neither helping nor harming participants.  Two factors may have singularly or jointly contributed to 




the low participation rate that was found for this model of care: individuals and/or their treating 
practitioner(s) may not have perceived the intervention to be valuable, or invitees may have 
experienced difficulties that precluded their attendance at the scheduled session (e.g., pain/disability, 
emotional difficulties, life demands, physical access issues).  In hindsight, it would have been 
beneficial to explore this directly and/or employ some motivational techniques that would enhance 
engagement.  However, although not effective in this study, other studies have demonstrated 
therapeutic benefit from educational sessions (e.g., de Jong, et al., 2005; Engers, et al., 2008; 
Moseley, et al., 2004; Sawhney, Watt-Watson, & McGillion, 2017) and so further examination of this 
model is warranted (e.g., Darnall et al., 2018).  Future researchers could usefully explore options for 
improving participation in, and engagement with, this type of intervention in order to improve 
treatment outcomes and identify the optimal intensity for pre-clinic intervention.  It would also be 
useful to explore the positioning of any pre-clinic intervention within subsequent waitlist 
management, in case the experience of being indefinitely waitlisted immediately following the 
session undermined the potential impact of the intervention.  It may be that the effectiveness of the 
pre-clinic intervention would be enhanced if patients were subsequently treated within a defined time 
period (e.g. six months). 
In short, improving access to evidence-based care will require consideration of a range of 
service-related aspects including: the amount and type of staffing that is employed, the intake 
practices that are used (e.g., pre-clinic education + waitlist vs. waitlist only), the types and amounts 
of treatments that are provided (e.g., group vs. individual sessions, primarily medical intervention vs. 
primarily allied health intervention vs. interdisciplinary intervention), the case-mix/complexity of 
referrals, and links with community-based services; all of which require further exploration.  
Researchers should also examine the amount and type of staffing that clinics employ alongside 
measures of patient outcomes (e.g., level of physical activity, workforce participation, psychological 
functioning, health care usage) and service factors (e.g., waitlist length, number of new patients 




seen, average number sessions per patient treated) in order to determine the staffing profiles that 
optimise clinical performance.  From a broader systems perspective, consumers, clinicians, health 
care decision makers and other key stakeholders all need to be educated (Hogans, Watt-Watson, 
Wilkinson, Carr, & Gordon, 2018) about the detrimental impact of lengthy indefinite waits for CP 
treatment, and the importance of clinically-focussed research to clarify the factors that impede timely 
care delivery and facilitate the development of treatments/strategies to improve outcomes for 
patients. 
Treatment engagement.  This research highlights the importance of better understanding 
the reasons behind poor engagement with tertiary CP services and treatment models.  The low 
participation rate that was associated with our clinical studies (Chapters 4 and 6) indicates that a 
more detailed exploration of the factors that underlie poor/non-engagement is warranted.  This may 
help clarify whether it is better predicted by pre-disposing or individual factors, or aspects of the 
referral process itself; information which may assist clinics to engage more effectively with these 
people.  The current research also suggests that treatment engagement may be associated with 
adjustment during the waitlist period, with the group of non-engagers reporting more distress, lower 
pain acceptance and higher rates of health care usage (Chapter 4) than other individuals during this 
time.  Once again, this highlights a need for a more detailed exploration of the individual factors that 
underlie participation in treatment.  This information may usefully inform the patient-treatment 
matching process, such that clinicians could more effectively identify who might benefit from a 
particular type of intervention (e.g., brief pre-clinic educational session) and who might not; the latter 
group potentially needing an alternative method of engagement and treatment. 
Acceptable waiting periods.  The current data suggest that, at least for females, waiting 
periods of longer than six months lead to deterioration in a range of areas, with individuals reporting 
that they experienced more difficulty performing routine daily activities because of their pain, more 
distress, greater reliance on health care services, increasing prescription of medication 




(doses/strength) and a decreased willingness to experience pain in order to undertake valued 
activities (pain acceptance).  As such, developing national standards which cap waiting periods for 
CP services at six months appears important.  By providing treatment within this time-frame, it may 
be possible to optimise outcomes for individuals with CP, especially females, and avoid the 
deterioration that occurs with longer waits.  This now needs to be directly evaluated. 
It is also possible that providing treatment even earlier, within two to six months of referral, 
may further optimise outcomes for people with CP because a range of functional improvements were 
seen during this time period.  It may be that individuals are better positioned to make changes if 
intervention is provided during this period of relative improvement, thus increasing therapeutic 
engagement and efficacy.  Again, the impact of different wait-times should be directly tested; ideally 
via a randomised controlled trial comparing and contrasting the impact of providing intervention 
within two months of referral to a tertiary CP service versus within six months.  Doing so would 
determine if shorter wait-times are indicated and provide important data to inform future guidelines. 
7.3 Translation of the Research 
This research has had immediate translational effects — directly influencing health care 
reform in the state of South Australia, where the research was undertaken.  Although not intended to 
improve patient outcomes, the Pain Management Unit now uses a pre-clinic education session as 
part of its standard intake process for all non-urgent (i.e., not cancer/palliative) referrals (refer 
https://www.sahealth.sa.gov.au/wps/wcm/connect/public+content/sa+health+internet/health+services
/outpatient+services/outpatient+clinics/central+adelaide+lhn+specialist+and+outpatient+clinics/pain+
management+unit+outpatient+services+at+central+adelaide).  This change was implemented for 
several reasons.  First, staff received feedback from consumers and their care providers about some 
of the benefits that people had experienced after attending the pre-clinic session, when individuals 
attended their initial appointment in the Pain Management Unit.  Second, clinicians also noted 




improvements in individual presentations between attendance at the pre-clinic session and the first 
appointment in the clinic.  These included changed attitudes towards medical management for CP 
and increased openness to self-management as a treatment methodology.  Third, the unit believed 
that it was important to increase motivation for active self-management amongst people who were 
referred for treatment, even during the waitlist period; a group-based pre-clinic session was a 
resource-efficient way to do this.  Fourth, educating patients about what they could (and could not) 
expect from the clinical service and about strategies that they could use to improve their 
management of their pain resulted in fewer people being placed on the clinic’s waitlist, because 
some individuals decided that they did not need/want an appointment.  The pre-clinic session has 
since undergone several revisions to refine the content and delivery style, and continues to be 
evaluated by the Pain Management Unit. 
Perhaps the largest translational impact to date has been achieved by exploring the staffing 
resources that are employed in Australian tertiary CP services (Chapter 5).  It is important to improve 
access to evidence-based care for people living with CP in the state of South Australia, because 
they experience the longest waits in the country to access tertiary CP services (Hogg, et al., 2012).  
Poor treatment access was one of the driving factors that underpinned the current research and it 
was partially addressed in 2016 as part of a broader reform of the public health system that the 
South Australian Government called ‘Transforming Health’ (Department for Health and Ageing, 
2016; Government of South Australia, 2017).  The reform strategy for CP involved a multimillion 
dollar investment over a three-year period (Goodes, 2018), but there was no data to guide the 
development of staffing profiles for the newly developed and/or expanded services.  As such, FTE 
modeling from Study 3 (Chapter 5) and historical referral data from the Pain Management Unit — the 
largest CP service in the state — were used to develop the staffing profiles that provided the basis 
for the service reform.  These figures were then adjusted by the implementation committee on the 
basis of activity and funding levels that were agreed with Department of Health. 




7.4 Limitations of the Research Project 
The limitations of the individual studies have been discussed in the relevant chapters 
(Chapters 3, - 6).  The following discussion focusses on the broader limitations of this research 
project. 
Psychological functioning was examined in the clinical studies (Chapters 4 and 6) using a 
single general measure of distress (K10).  This measure was chosen because it formed part of the 
intake screening questionnaire (PSQ) that all new referrals to the Pain Management Unit were 
required to complete; thus minimising participant burden.  In hindsight, given the findings of the 
meta-analysis (Chapter 3), it would have been useful to examine more specific aspects of 
psychological functioning including depression, anxiety and pain-related anxiety.  Doing so would 
have provided further clarification about the relationship between CP and psychological functioning, 
including the clinical foci that were suggested by the meta-analysis of the existing literature.  
However, as indicated, the longitudinal design of the clinical studies meant that data collection 
commenced before the results of the meta-analysis were available and so it was not possible for the 
clinical study design to be fully informed by those findings.  Moreover, participant burden was a 
primary consideration when selecting questionnaires and it is likely that completion rates would have 
been further eroded if participants were asked to complete additional measures. 
Research that is undertaken in clinical settings faces unique challenges and this is 
particularly relevant for research in pre-clinical settings.  First, data for both clinical studies (Chapters 
4 and 6) were collected simultaneously, which meant that the pre-clinic education study (Chapter 6) 
was effectively prioritised and so timelines were adjusted on the basis of participation in that project.  
In particular, the first follow-up (T2) was specifically timed to occur shortly after attendance at the 
educational session; which, when rescheduled, affected the timing of the next follow-up.  This 
resulted in some individuals being waitlisted longer than was reflected because the time period 
between T1 and T2 was effectively increased when the appointment was rescheduled.  Similarly, the 




speed with which individuals returned their intake measures varied greatly but, consistent with local 
clinical practices at the time, waitlist length was timed from when the person responded.  In 
hindsight, coding for this information may have proven informative in order to examine whether 
delayed responding was associated with participation in treatment and/or clinical outcomes.  It was 
also not possible to identify or eliminate the potential influence of other study design factors in 
mediating outcomes over time; such as intermittent follow-up, the provision of information about how 
to access psychological supports, or repeated-measures assessment. 
Next, this research was reliant on self-report measures because individuals were followed-
up by mail before being assessed in person by the Pain Management Unit, which meant that more 
objective assessments of mood and level of function were not available.  Where possible, checks 
were undertaken to assess the validity of these quantitative responses (social desirability, pain 
severity at the time of responding) and they indicated that, within the bounds of self-report, 
participant responses appeared to be reliable.  In hindsight, including an additional qualitative 
component, exploring individual perceptions about waiting for treatment, may have provided further 
information to guide the development of wait-time standards. 
A large number of people chose not to participate in this research and/or the specific model 
of care (pre-clinic education) that was being piloted (Chapters 4 and 6).  Although checks indicated 
that the final sample was representative of the larger group of referred individuals, it was not 
possible to compare or contrast the experiences of these various groups in additional ways (e.g., 
duration or location of pain, relationship status, reason for pain onset, history of treatments tried) and 
so it remains possible that they differed in other important aspects.  Clinically triaged waitlists are, by 
definition, non-standard, which means that sample attrition is an inherent difficulty in a longitudinal 
study, complicating statistical analyses.  Given the frequency with which lengthy treatment waits are 
experienced by people with CP, and the dearth of publications examining these waiting periods, the 




current longer-term findings represent an important, albeit tentative, addition to the existing 
knowledge base. 
Finally, data for the staffing paper (Chapter 5) was collected by the Australian Pain Society 
as part of the ‘Waiting in Pain’ project and so it was not possible to have any input into the questions 
that were included or their phrasing.  This resulted in omissions in important areas such as service 
quality (e.g. patient outcomes) and efficiencies (e.g., new:return appointment ratios), the full suite of 
treatments provided by a clinic outside of PMGPs and medical interventions, and the number of 
unpaid trainee positions.  This latter point (unpaid trainee positions) is particularly relevant for 
provisional psychologist positions because they were not represented in the staffing profiles; 
whereas provisional psychologist positions are unpaid roles in Australia, medical trainees who are 
participating in the Faculty of Pain Medicine fellowship program (the primary medical training 
program used in Australian CP services) are paid and thus, were included. 
7.5 Conclusion 
This research addresses an important, but largely neglected, area of clinical practice: the 
long and indefinite waits that people with CP face in order to access evidence-based care, and the 
psychological impact of both CP and waiting for treatment.  The current data suggests that treatment 
should be delivered within six months of referral to a tertiary CP service, and have a clear and 
deliberate focus on physically-focussed emotional difficulties (somatisation) and anxiety, particularly 
pain-related anxiety.  It is possible that earlier intervention (e.g. within two to six months of referral) 
may further improve outcomes, but this needs to be evaluated.  National and international standards, 
which include these maximum wait-times, are needed in order to help people avoid the deterioration 
that is associated with longer-term waits for treatment. 
Clinical services must now determine how to most effectively expedite treatment access.  
The current data provide staffing profiles that can usefully guide service development, but they also 




indicate that improved access to treatment requires more than just additional funding for increased 
staff.  This research demonstrated that changing the model of care for service intake can facilitate 
treatment access by reducing the number of people who are placed on a waitlist.  In this instance, 
the provision of a pre-clinic educational session prior to being placed on an indefinite waitlist did not 
improve individual outcomes.  However, the fact that many individuals did not take up this 
opportunity meant that using it as a mandatory part of the intake process would significantly reduce 
the number of people who became waitlisted at a clinic, thus greatly reducing clinical wait-times and 
improving treatment access.  Although effective from a service efficiency perspective, this does not 
promote the individual improvement that clinical health services are ethically required and tailored to 
deliver.  As such, further research is now needed to identify the staffing profiles and models of care 
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"Headache") OR (TI "Myofascial pain" OR AB "Myofascial pain" OR DE "Myofascial pain") OR 
(TI "Neuralgia" OR AB "Neuralgia" OR DE "Neuralgia") OR (TI "Neuropathic pain" OR AB 
"Neuropathic pain" OR DE "Neuropathic pain") OR (TI "Somatoform pain disorder" OR AB 
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2011 Asia 1731 3270 - - - - - - - - - - - - mixed - community no 
Note: abdo = abdominal; FM = Fibromyalgia; neuro = neuropathic; WAD = whiplash associated disorder.  Study number relates to numbered reference list presented at the end of this appendix. 
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Supplementary Table 3.C: Studies included in the analyses for depression, by measure 



























































2, 6, 7, 8, 15, 17, 20, 22, 23, 24, 27, 28, 40, 41, 43, 44, 
46, 47, 49, 53, 58, 66, 67, 69, 80, 81, 89, 90, 91, 99, 




12, 31, 98  
 




33, 60, 108 
 
9, 11, 26, 56, 57, 68, 70, 76, 86, 92, 94, 103, 110 
 










3, 25, 50, 51, 66, 84, 105 
 
19, 29, 30, 34, 52 
Note. BDI = Beck Depression Inventory; BDI-SF = Beck Depression Inventory Short-Form; BSI-D 
= Brief Symptom Inventory, Depression subscale; CES-D = Center for Epidemiologic Studies 
Depression Scale; DASS-D = Depression, Anxiety, Stress Scale, Depression subscale; GDS = 
Geriatric Depression Scale; HADS-D = Hospital Anxiety and Depression Scale, Depression 
subscale; HRSD = Hamilton Rating Scale for Depression; K-10 = Kessler Psychological Distress 
Scale; MHI = Mental Health Inventory, Depression subscale; PHQ = Patient Health 
Questionnaire; POMS-D = Profile of Mood States Depression subscale; SCL-90-R-D = Symptom 
Checklist–90–Revised, Depression subscale; ZSRDS = Zung Self-Rating Depression Scale.  
Study number relates to numbered reference list presented at the end of this appendix. 
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Supplementary Table 3.D: Studies included in the analyses for anxiety, by measure 



















































6, 7, 18, 86, 103 
 
22, 45, 46, 80, 81 
 
















3, 25, 66, 105 
 
6, 7, 10, 24, 27, 40, 61, 89 
 
82 
Note. ASI = Acute Stress Inventory; BAI = Beck Anxiety Inventory; BSI-A = Brief Symptom 
Inventory, Anxiety subscale; DASS-A = Depression, Anxiety, Stress Scale, Anxiety subscale; GAD-7 
= Generalised Anxiety Disorder Assessment; HADS-A = Hospital Anxiety and Depression Scale, 
Anxiety subscale; MHI-A = Mental Health Inventory, Anxiety subscale; MHQ = Middlesex Hospital 
Questionnaire; MMPI-A = Minnesota Multiphasic Personality Inventory, Anxiety subscale; POMS-TA 
= Profile of Mood States, Tension/Anxiety subscale; SCL-90-R-A = Symptom Checklist-90-Revised, 
Anxiety subscale; STAI-S = State-Trait Anxiety Inventory, State Anxiety subscale; STAI-SF = State-
Trait Anxiety Inventory Short-Form.  Study number relates to numbered reference list presented at 
the end of this appendix. 
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Supplementary Table 3.E: Studies included in the analyses for pain 
anxiety/concern, by measure 

































































17, 55, 56 
 








7, 18, 103 
 










49, 74, 100 
Note. BORG-FH = Fear of Harm Back Scale; BORG-FI = BORG, Fear of Injury/Re-injury subscale; 
CIPS = Catastrophising in Pain Scale; CSQ-C = Coping Strategies Questionnaire, Catastrophising 
subscale; FABQ = Fear Avoidance Beliefs Questionnaire; FPQ-III = Fear of Pain Questionnaire; 
IAS-FIP = Illness Attitudes Scale, Fear of Illness and Pain subscale; MSPQ = Modified Somatic 
Perception Questionnaire; PASS = Pain Anxiety Sensitivity Index; PCS = Pain Catastrophising 
Scale, Total score; PCS-H = Pain Catastrophising Scale, Helplessness subscale; PCS-M = Pain 
Catastrophising Scale, Magnification subscale; PCS-R = Pain Catastrophising Scale, Rumination 
subscale; SHAI = Short Health Anxiety Inventory; TSK = Tampa Scale of Kinesphobia.  Study 
number relates to numbered reference list presented at the end of this appendix. 
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Supplementary Table 3.F: Studies included in the analyses for somatisation, 
anger/hostility, self-efficacy and self-esteem, by measure 
Measure Nstudies Study 
Somatisation 
     BAS 
 
     BSI-S 
 
     MHQ-S 
 
     PHQ 
 
     SCL-90-R-S 
 
     SOMS 
 
     SOMS-7 
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     SCL-90-R-H 
 
     STAXI-AE 
 











12, 31, 98 
 






     GSES 
 
     MPI-LC 
 















     RSS 
 









Note. GSES = General Self Efficacy Scale; MPI-LC = Multidimensional Pain Inventory, Life 
Control subscale; PSEQ = Pain Self-Efficacy Questionnaire; RSS = Rosenberg Self-Esteem 
Scale; SSES = State Self-Esteem Scale; BSI-H = Brief Symptom Inventory, Hostility subscale; 
SCL-90-R-H = Symptom Checklist-90-Revised, Hostility subscale; STAXI-AE = State-Trait 
Anger Expression Inventory, Expressed Anger subscale; STAXI-S = State-Trait Anger 
Expression Inventory, State Anger subscale; STAXI-T = State-Trait Anger Expression 
Inventory, Trait Anger subscale; BAS = Barsky Amplification Scale; BSI-S = Brief Symptom 
Inventory, Somatisation subscale; MHQ-S = Middlesex Hospital Questionnaire, Somatisation 
subscale; PHQ = Patient Health Questionnaire; SCL-90-R-S = Symptom Checklist-90-
Revised, Somatisation subscale; SOMS = Screening for Somatoform Symptoms; SOMS-7 = 
Screening for Somatoform Symptoms (7 item short-form); WPSI = Wahler Physical Symptom 
Inventory.  Study number relates to numbered reference list presented at the end of this 
appendix.  
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Supplementary Table 3.G: Studies included in the analyses for general emotional 
functioning, by measure 

















































































1, 4, 28, 36, 39, 40, 50, 54, 59, 61, 78, 77, 79, 95, 
96, 102, 104, 109 
 
97 
Note. BSI-GS = Brief Symptom Inventory, Global Symptom Index; DASS-S = Depression, Anxiety 
and Stress Scale, Stress subscale; Duke-AD = Duke Anxiety Depression Scale; GHQ = General 
Health Questionnaire; HSCL-25 = Hopkins Symptom Checklist; MPI-AD = Multidimensional Pain 
Inventory, Affective Distress subscale; NHP-ER = Nottingham Health Profile, Emotional Reaction 
subscale; POMS = Profile of Mood States; PSS = Perceived Stress Scale; SCL-90-R = Symptom 
Checklist-90-Revised; SF-12-MH = The Short Form (12) Health Survey, Mental Health subscale; 
SF-20-MH = The Short Form (20) Health Survey, Mental Health subscale; SF-36-MH = The Short 
Form (36) Health Survey, Mental Health subscale; WHOQOL-BREF = World Health Organisation 
Quality of Life Scale – Brief, Psychological subscale.  Study number relates to numbered reference 
list presented at the end of this appendix. 
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Note. CP = chronic pain; HC = healthy control; Nfs = Failsafe N’s; I2 > 50 indicates significant heterogeneity; BDI = Beck Depression Inventory; BDI-SF = Beck Depression Inventory Short-Form; 
BSI-D = Brief Symptom Inventory, Depression subscale; CES-D = Center for Epidemiologic Studies Depression Scale; DASS-D = Depression, Anxiety, Stress Scale, Depression subscale; GDS = 
Geriatric Depression Scale; HADS-D = Hospital Anxiety and Depression Scale, Depression subscale; HRSD = Hamilton Rating Scale for Depression; K-10 = Kessler Psychological Distress Scale; 
MHI = Mental Health Inventory, Depression subscale; PHQ = Patient Health Questionnaire; POMS-D = Profile of Mood States Depression subscale; SCL-90-R-D = Symptom Checklist–90–Revised, 
Depression subscale; ZSRDS = Zung Self-Rating Depression Scale.  
Measure Nstudies Sample Size Cohen’s 95% CI Nfs I2 
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Supplementary Figure 3.B: Cohen’s d effect sizes for anxiety; overall and by measure 
 
Measure Nstudies Sample Size Cohen’s 95% CI Nfs I2 













































































































































Note. CP = Chronic Pain; HC = Health Control; Nfs = Failsafe N’s; I2 > 50 indicates significant heterogeneity ; ASI = Acute Stress Inventory; BAI = Beck Anxiety Inventory; BSI-A = Brief Symptom 
Inventory, Anxiety subscale; DASS-A = Depression, Anxiety, Stress Scale, Anxiety subscale; GAD-7 = Generalised Anxiety Disorder Assessment; HADS-A = Hospital Anxiety and Depression 
Scale, Anxiety subscale; MHI-A = Mental Health Inventory, Anxiety subscale; MHQ = Middlesex Hospital Questionnaire; MMPI-A = Minnesota Multiphasic Personality Inventory, Anxiety subscale; 
POMS-TA = Profile of Mood States, Tension/Anxiety subscale; SCL-90-R-A = Symptom Checklist-90-Revised, Anxiety subscale; STAI-S = State-Trait Anxiety Inventory, State Anxiety subscale; 
STAI-SF = State-Trait Anxiety Inventory Short-Form. 
  
Greater anxiety  
Chronic Pain 
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Supplementary Figure 3.C: Cohen’s d effect sizes for pain anxiety/concern; overall and by measure 
 
Measure Nstudies Sample Size Cohen’s 95% CI Nfs I2 







































































































































































Note. CP = chronic pain; HC = healthy control; Nfs = Failsafe N’s; I2 > 50 indicates significant heterogeneity; BORG-FH = Fear of Harm Back Scale; BORG-FI = BORG, Fear of Injury/Re-injury 
subscale; CIPS = Catastrophising in Pain Scale; CSQ-C = Coping Strategies Questionnaire, Catastrophising subscale; FABQ = Fear Avoidance Beliefs Questionnaire; FPQ-III = Fear of Pain 
Questionnaire; IAS-FIP = Illness Attitudes Scale, Fear of Illness and Pain subscale; MSPQ = Modified Somatic Perception Questionnaire; PASS = Pain Anxiety Sensitivity Index; PCS = Pain 
Catastrophising Scale, Total score; PCS-H = Pain Catastrophising Scale, Helplessness subscale; PCS-M = Pain Catastrophising Scale, Magnification subscale; PCS-R = Pain Catastrophising 
Scale, Rumination subscale; PHODA = Photographs of Activities of Daily Living Scale; SHAI = Short Health Anxiety Inventory; TSK = Tampa Scale of Kinesphobia. 
  
Greater pain anxiety 
Healthy Control 
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Note. CP = chronic pain; HC = healthy control; Nfs = Failsafe N’s; I2 > 50 indicates significant heterogeneity; GSES = General Self Efficacy Scale; MPI-LC = Multidimensional Pain Inventory, Life 
Control subscale; PSEQ = Pain Self-Efficacy Questionnaire; RSS = Rosenberg Self-Esteem Scale; SSES = State Self-Esteem Scale; BSI-H = Brief Symptom Inventory, Hostility subscale; SCL-
90-R-H = Symptom Checklist-90-Revised, Hostility subscale; STAXI-AE = State-Trait Anger Expression Inventory, Expressed Anger subscale; STAXI-S = State-Trait Anger Expression Inventory, 
State Anger subscale; BAS = Barsky Amplification Scale; BSI-S = Brief Symptom Inventory, Somatisation subscale; MHQ-S = Middlesex Hospital Questionnaire, Somatisation subscale; PHQ = 
Patient Health Questionnaire; SCL-90-R-S = Symptom Checklist-90-Revised, Somatisation subscale; SOMS = Screening for Somatoform Symptoms; SOMS-7 = Screening for Somatoform 
Symptoms (7 item short-form); WPSI = Wahler Physical Symptom Inventory  
Measure Nstudies Sample Size Cohen’s 95% CI Nfs I2 
  CP HC d LL UL  
 
Somatisation 
    BAS 
    BSI-S 
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Note. CP = chronic pain; HC = healthy control; Nfs = Failsafe N’s; I2 > 50 indicates significant heterogeneity; GSES = General Self Efficacy Scale; MPI-LC = Multidimensional Pain Inventory, Life 
Control subscale; PSEQ = Pain Self-Efficacy Questionnaire; RSS = Rosenberg Self-Esteem Scale; SSES = State Self-Esteem Scale; BSI-H = Brief Symptom Inventory, Hostility subscale; SCL-
90-R-H = Symptom Checklist-90-Revised, Hostility subscale; STAXI-AE = State-Trait Anger Expression Inventory, Expressed Anger subscale; STAXI-S = State-Trait Anger Expression Inventory, 
State Anger subscale; BAS = Barsky Amplification Scale; BSI-S = Brief Symptom Inventory, Somatisation subscale; MHQ-S = Middlesex Hospital Questionnaire, Somatisation subscale; PHQ = 
Patient Health Questionnaire; SCL-90-R-S = Symptom Checklist-90-Revised, Somatisation subscale; SOMS = Screening for Somatoform Symptoms; SOMS-7 = Screening for Somatoform 
Symptoms (7 item short-form); WPSI = Wahler Physical Symptom Inventory 
  
Measure Nstudies Sample Size Cohen’s 95% CI Nfs I2 
  CP HC d LL UL  
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Note. CP = chronic pain; HC = healthy control; Nfs = Failsafe N’s; I2 > 50 indicates significant heterogeneity; BSI-GS = Brief Symptom Inventory, Global Symptom Index; DASS-S = Depression, 
Anxiety and Stress Scale, Stress subscale; Duke-AD = Duke Anxiety Depression Scale; GHQ = General Health Questionnaire; HSCL-25 = Hopkins Symptom Checklist; MPI-AD = Multidimensional 
Pain Inventory, Affective Distress subscale; NHP-ER = Nottingham Health Profile, Emotional Reaction subscale; POMS = Profile of Mood States; PSS = Perceived Stress Scale; SCL-90-R = 
Symptom Checklist-90-Revised; SF-12-MH = The Short Form (12) Health Survey, Mental Health subscale; SF-20-MH = The Short Form (20) Health Survey, Mental Health subscale; SF-36-MH = 
The Short Form (36) Health Survey, Mental Health subscale; WHOQOL-BREF-P = World Health Organisation Quality of Life Scale – Brief, Psychological subscale. 
Measure Nstudies Sample Size Cohen’s 95% CI Nfs I2 
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Refused referral (N=6) 
Unable to contact (N=1) 
Seen at another clinic (N=4) 
Literacy difficulties (N=3) 
Invited to participate 
(N=664) 
Did not respond (N=209) 
Opt out (N=116) 
T1: Total recruited 
(N=339) 
No follow up (n=50): appointment given (n=22), 
patient cancelled referral (n=5), opt out (n=23) 
Did not respond (n=138) 
 
T5: 18 month follow-up (N=40) 
T7: 2.5 year follow-up (N=11) 








T4: 12 month follow up (N=91) 
T2: 2 month follow up (N=195) 
No follow up (n=192): appointment given (n=61), 
patient cancelled referral (n=18), opt out (n=112) 
Did not respond (n=57) 
 
No follow up (n=267): appointment given (n=105), 
patient cancelled referral (n=20), opt out (n=142) 
Did not respond (n=32) 
 
No follow up (n=297): appointment given (n=121), 
patient cancelled referral (n=21), opt out (n=155) 
Did not respond (n=17) 
 
No follow up (n=317): appointment given (n=131), 
patient cancelled referral (n=24), opt out (n=162) 
Did not respond (n=11) 
 
T3: 6 month follow up (N=151) 
No follow up (n=15): appointment given (n=2), 
patient cancelled referral (n=1), opt out (n=12) 







Referrals screened for inclusion 
(N=678) 
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Cancer/palliative pain: for early intervention 
 
Early intervention likely to improve patient outcomes (i.e. Complex Regional Pain 
Syndrome) 
 
Elderly and/or young and/or neuropathic pain (i.e. post-surgical pain) 
 
Mini multidisciplinary panel assessment required (medical, psychology) 
 
Full multidisciplinary panel assessment required (medical, nursing, physiotherapy, 
psychology, psychiatry) 
 
Opiate issues require specific attention 
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Supplementary Table 4.B: Mean (standard deviation) of age and key outcome variables, by time-























































Pain-related interference  
     (BPI) 
Pain severity (BPI) 
Psychological distress (K-10) 
Socially-desirable  
     responding (SDRS-5) 
 
Age 
Pain-related interference  
     (BPI) 
Pain severity (BPI) 
Psychological distress (K-10) 
Socially-desirable  
     responding (SDRS-5) 
 
Age 
Pain-related interference  
     (BPI) 
Pain severity (BPI) 
Psychological distress (K-10) 
Socially-desirable  
     responding (SDRS-5) 
 
Age 
Pain-related interference  
     (BPI) 
Pain severity (BPI) 
Psychological distress (K-10) 
Socially-desirable  
     responding (SDRS-5) 
 
Age 
Pain-related interference  
     (BPI) 
Pain severity (BPI) 
Psychological distress (K-10) 
Socially-desirable  
     responding (SDRS-5) 
 
Age 
Pain-related interference  
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Pain severity (BPI) 
Psychological distress (K-10) 
Socially-desirable  
















































































































































































































































































Supplementary Table 4.C: Estimated means for outcome domains, by Time and Sex 
Outcome Domain T1 (intake) T2 (2 months) T3 (6 months) T4 (12 months) 
Female Male Total Female Male Total Female Male Total Female Male Total 
N 
Pain impact (BPI) 
 Pain-related interference 
 Pain severity 
Psychological distress (K-10) 
Pain acceptance (CPAQ) 
 Pain willingness 
 Activity engagement 
 Overall acceptance 
Quality of life(WHOQOL-BREF) 
 Physical health 
 Psychological health 
 Social relationships 
 Environment 
Health care utilisation 
 Frequency 
 Treatment types 
      Medical 
      Psychological 
      Alternative 
      Physical 
 N (%) tried new treatment 
      Number new tried 
Medication usage 
 % relief received 
 Change since last (N, %) 
      Taking stronger / more 
      Nil, taking same 
      Taking weaker / less 
      Ceased all medication 
      Not reported  

































































































































































































































































































































































































Note: N = number of participants; BPI = Brief Pain Inventory; K-10 = Kessler Distress Scale; CPAQ = Chronic Pain Acceptance Questionnaire; WHOQOL-BREF = World Health Organisation Quality of Life – Brief 







Supplementary Table 4.C: Estimated means for outcome domains, by Time and Sex cont. 
Outcome Domain T5 (1.5 years) T6 (2 years) T7 (2.5 years) SEX 
Female Male Total Female Male Total Female Male Total Female Male 
N 
Pain impact (BPI) 
 Pain-related interference 
 Pain severity 
Psychological distress (K-10) 
Pain acceptance(CPAQ) 
 Pain willingness 
 Activity engagement 
 Overall pain acceptance 
Quality of life (WHOQOL-BREF) 
 Physical health 
 Psychological health 
 Social relationships 
 Environment 
Health care utilisation 
 Frequency 
 Treatment types 
      Medical 
      Psychological 
      Alternative 
      Physical 
 N (%) tried new  
      Number new tried 
Medication 
 % relief received 
 Change since last (N, %) 
      Taking stronger / more 
      Nil, taking same 
      Taking weaker / less 
      Ceased all medication 
      Not reported 

































































































































































































































































































































































Note: N = number of participants; BPI = Brief Pain Inventory; K-10 = Kessler Distress Scale; CPAQ = Chronic Pain Acceptance Questionnaire; WHOQOL-BREF = World Health Organisation Quality of Life 




Supplementary Table 4.D: Estimates of significant interaction effects (Time x Sex) on outcome domains 
Outcome Domain Time Estimate 95% CI d Graphical Representation of Significant Interactions 
 LL UL 
Pain impact (BPI) 















Pain acceptance (CPAQ) 









































































































































































Note: BPI = Brief Pain Inventory; K-10 = Kessler Distress Scale; CPAQ = Chronic Pain Acceptance Questionnaire; WHOQOL-BREF = World Health Organisation Quality of Life – 
Brief Scale; SDRS-5 = Social Desirability Response Set Scale. 


















































LL UL LL UL 
Pain impact (BPI) 


















Pain acceptance (CPAQ) 









































































































































































































































































Note: N=number of participants; BPI=Brief Pain Inventory; K-10=Kessler Distress Scale; CPAQ=Chronic Pain Acceptance Questionnaire; WHOQOL-BREF=World Health 
Organisation Quality of Life – Brief Scale; SDRS-5=Social Desirability Response Set Scale.  Scores represent M (SD) unless indicated otherwise to be N (%). 














LL UL LL UL 










Quality of life (WHOQOL-BREF) 




















































































































































































































































































Note: N=number of participants; BPI=Brief Pain Inventory; K-10=Kessler Distress Scale; CPAQ=Chronic Pain Acceptance Questionnaire; WHOQOL-BREF=World Health 
Organisation Quality of Life – Brief Scale; SDRS-5=Social Desirability Response Set Scale.  Scores represent M (SD) unless indicated otherwise to be N (%). 
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Note: N=number of participants; BPI=Brief Pain Inventory; K-10=Kessler Distress Scale; CPAQ=Chronic Pain Acceptance Questionnaire; WHOQOL-BREF=World Health 
Organisation Quality of Life – Brief Scale; SDRS-5=Social Desirability Response Set Scale.  Scores represent M (SD) unless indicated otherwise to be N (%). 
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      Alternative cont. 
 
 

































































































































































































































































Note: N=number of participants; BPI=Brief Pain Inventory; K-10=Kessler Distress Scale; CPAQ=Chronic Pain Acceptance Questionnaire; WHOQOL-BREF=World Health 
Organisation Quality of Life – Brief Scale; SDRS-5=Social Desirability Response Set Scale.  Scores represent M (SD) unless indicated otherwise to be N (%). 
*** = p<0.001; ** p<0.01; * p<0.05 
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Waiting in Pain: a systematic survey of persistent and chronic pain management 




Date of interview: 
Data sources/quality: 
Do you consent to contact details being collated by APS: Yes/ No 
 
SECTION A: clarification of previous responses from medical director of service 
What is the name of your service?  
 separate name for PMP? 
 
What is the structure of your service? 
 relevant history, development, 
is it associated with an acute pain service, 
predominant disciplines, 
 qa/outcome processes, 
pre-assessment questionnaires. 
 
RMH-Pain Management Services 
Clinics: Rehabilitation, Interventional, Aged Care, 
Neurosurgical 
Cognitive-Behavior-Activity-Therapy Programmes 
Clinical Education and Research 
 
RMH-Pain Management Services office 
Ph: 8387 2254 
Fax: 8387 2149 
Australian Pain Society 
Secretariat: c/o DC conferences 
PO Box 637 North Sydney, NSW 2069 
 
Ph: 02 9954 4400 
Fax: 02 9954 0666 
Email: aps@dcconferences.com.au 
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Staffing levels? FTE fractions of each 
 medical: specialities, 
faculty fellows/trainees, 




CORE Q 1: MDP Centre (multi/inter discipl, meetings, research, teaching) 
  MDP Clinic (no research, teaching) 
  Pain clinic (no multi/inter discipl) 
  Modality orientated clinic (?single pract/modality) 
 
Funding model for your service?  Public (state) Private  Other (describe)  
  relevant %, use of state grants/hospital funding, medicare clinics 
 
CORE Q2: > 90% public 
  Commonwealth 




Numbers of new referrals per annum?  
 focus on outpatient, 
chronic referrals;  
number self-referred from acute service 
 
CORE Q3: referrals pa 
  new pts seen pa 
 
Sources of referrals (%)? GP  Specialists  Hospital 
Predominant speciality? 
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Any explanation of referral base? 
 Do you define a catchment area? 
 
Description of clinical case mix? 
 Eg back, neck, headache, opioid issues 
 
Current numbers of clients on waiting list and average time for initial assessment? 
 how are they managed?;  
any contact with referral source or patient eg telephone? 
 
Do you have a process for more urgent referrals, and if so, approx waiting time? 
 which patients are considered for early assessment? 
 
Do you reject referrals? If so, how many pa? 
 why: regional catchment area, pathology, drug issues? 
where sent? 
 
Additional waiting time for allied health assessments and/or therapy? 
 if its at initial assessment, 
how are they chosen for multidisciplinary review? 
 process for allied health review? 
 % total referrals proceeding to AH review 
 
CORE Q4: current wait time for new persistent pain medical assessment in days 
 
What does your service provide? PLUS approximate numbers pa? 
 
Interventional procedures: eg’s 
 Minor: epidural steroids, nerve blocks, RFA 
 Major: spinal cord stimulation, intrathecal pumps 
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 Other: epiduroscopy, vertebroplasty, IDET 
 
Individual Allied Health therapy: 
 total referrals?  
single vs multiple therapists? 
 
Group Pain Management Programs: eg’s 
 referred for consideration vs total accepted?  
% of total clinic referrals? 
 
Inpatient care  
 how? why?  
 describe process and therapy provided eg with block for CRPS, rehab for country pts? 
 
Other services: eg specialty clinics 
 specifically: palliative care/cancer pain; aged pain; headaches; fibromyalgia 
 how are they triaged, managed? 
 
What external services do you utilise?; relevant numbers pa, linked to your service? 
 Palliative care 
 Liaison psychiatry? 
 Drug and Alcohol? 
 Complimentary therapy: acupuncture, other? 
 
CORE Q5: number of funded Faculty of Pain Medicine training positions 
 
CORE Q6: current number of research projects  clinical (involve pt care) 
       non-clinical (scientific, QA projects) 
 
Any comments:  
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 development plans; current threats? 
 
CORE Q7: barriers to the pain service development/maintenance/growth (major/mild/minor/none) 
 funding 
 referrals 
 lack of trained staff 
 local political support 
 other 
 
SECTION B: an investigation of Allied Health based Pain Management Programs 
Name of PMP’s 
 development history 
 range of programs: aged, disease, culture specific 
 
Staffing structure/levels 









 inclusion/exclusion criteria 
 






 objective measures 




CORE Q9: outcome measures used (list) 
 
Team meeting(s) 
 medical supervision 
 
 frequency, structure 
 
Program structure: 







specific skills/specialist therapy? 
follow-up/revision program? 
 
CORE Q10: hours of therapy involved in your group PMP 
 
Thoughput: 
 numbers assessed pa 
 numbers accepted pa 
 numbers completed pa 
 do you provide long term followup/booster sessions? 
 
Any comments? 
 published outcomes? 
 costs/funding? 
 changes planned?  
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Australian Persistent Pain Services: Multidisciplinary Staffing and Clinical Activity 
Program structure: 







specific skills/specialist therapy? 
follow-up/revision program? 
CORE Q10: hours of therapy involved in your group PMP 
Thoughput: 
numbers assessed pa 
numbers accepted pa 
numbers completed pa 
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